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Time to quit? Non-genetic heterogeneity in cell fate propensity after DNA damage 
Callum James Campbell 
Cellular checkpoints are typically considered to both facilitate the ordered execution of the cell cycle 
and to act as a barrier to oncogene driven cell cycles and the transmission of unresolved genetic lesions 
from one phase to the next. Furthermore, these mechanisms are also believed to underpin the 
responses of cells, both in normal and cancerous tissues, to those therapies that either directly or 
indirectly generate DNA damage. 
In recent studies however, it has become clear these checkpoints permit the passage of significant 
genomic aberrations into subsequent cell cycle phases and even descendant cells, and that 
heterogeneous responses are apparent amongst genetically identical cells. The consequences of this 
checkpoint ‘negligence’ remain relatively uncharacterised despite the importance of checkpoints in 
current models for how genomic instability is avoided in the face of ubiquitous DNA damage. 
Unresolved DNA damage is presumably inherited by subsequent cell cycle phases and descendant cells 
yet characterisation of the consequences of this has been relatively limited to date. 
I therefore utilised microscopy-based lineage tracing of cells expressing genetically encoded 
fluorescent sensors, particularly the Fluorescent Ubiquitination-based Cell Cycle Indicator (FUCCI) 
probes (Sakaue-Sawano et al., 2008), with semi-automated image analysis to characterise the 
response of single cells and their descendants to DNA lesions across multiple cell cycle generations. 
This approach, complemented by generational tracing by flow cytometry, permitted me to 
characterise the timing of cell fate determination in treated and descendant cells, the non-genetic 
heterogeneity in checkpoint responses and overall lineage behaviour, correlations between cells 
(similarly to Sandler et al., 2015) and cell cycle timing dependencies in the response to DNA damaging 
agents. 
With these single cell analytical approaches I show that the consequences of DNA damage on 
descendant cell fate is dramatic, suggesting checkpoint mechanisms may have consequences and even 
cooperate across phases and generations. U2OS cell lineages traced for three generations following 
the induction of DNA damage in the form of strand breaks showed greatly induced cell death in the 
daughters and granddaughters of DNA damaged cells, termed delayed death. Furthermore, lineage 
behaviour was characterised as highly heterogeneous in when and whether cell death occurred. 
Complementary flow cytometric approaches validated the findings in U2OS cells and suggested HeLa 
cells may show similar behaviour. These findings indicate that checkpoint models need to incorporate 
multigenerational behaviour in order to better describe the response of cells to DNA damage. 




our understanding of the development of genomic instability during carcinogenesis and how DNA-
damaging chemotherapeutics drive cells to ‘quit’ the cell cycle. 
 
Declaration 
This dissertation is the result of my own work and includes nothing which is the outcome of work done 
in collaboration except as declared in the Preface and specified in the text. 
It is not substantially the same as any that I have submitted, or, is being concurrently submitted for a 
degree or diploma or other qualification at the University of Cambridge or any other University or 
similar institution except as declared in the Preface and specified in the text.  
I further state that no substantial part of my dissertation has already been submitted, or, is being 
concurrently submitted for any such degree, diploma or other qualification at the University of 
Cambridge or any other University or similar institution except as declared in the Preface and specified 
in the text 
It does not exceed the prescribed word limit for the Degree Committee for Clinical Medicine and 
Clinical Veterinary Medicine. 
 











I would like to thank Dr Alessandro Esposito first of all, without whom this project would have not 
existed and whose day-to-day supervision and support deserves recognition. It has been an enjoyable 
time working with him as part of his team of underlings, the other members of which (past and present) 
also deserve thanks for their contributions to my experience in the lab; I have learnt a very great deal 
from them. Maximilian Fries earns a special mention for having shared the PhD experience with me. 
Thanks go to Professor Ashok Venkitaraman for making room for me in his group. His guidance and 
comments as supervisor have been much appreciated, except perhaps when he announces “so what?” 
or calls me ‘fatface’! 
 The CRUK Cambridge Centre have been generous supporters and I would like to thank them for the 
resources they chose to invest in me and my research (and the dinners!), I hope they feel it was money 
well spent! 
This process has taken a long time, but the roots go back much further and there are too many people 
to mention who helped me along the way. I will however single out my family, and the people like 
Carol Harris, who encouraged me with my interests in science when I was very small. 
 
Callum 




For Granny (Gwendrah Eleanor Smith), who just 









Table of Contents 
Abstract ..................................................................................................................................................... i 
Declaration ............................................................................................................................................... ii 
Acknowledgements ................................................................................................................................. iv 
Table of Contents ................................................................................................................................... vii 
List of Figures ......................................................................................................................................... xii 
List of Tables .......................................................................................................................................... xvi 
List of Frequently Used Abbreviations .................................................................................................. xvi 
Introduction ............................................................................................................................................ 1 
1.1 Cell fate determination, to die or thrive? ............................................................................... 1 
1.2 DNA damage – corrupting the molecule of Inheritance ......................................................... 2 
1.2.1 Endogenous sources of damage ..................................................................................... 2 
1.2.2 Exogenous sources of damage ........................................................................................ 3 
1.2.3 The consequences of DNA damage ................................................................................. 3 
1.3 Cell cycle checkpoints and the maintenance of genetic integrity ........................................... 5 
1.3.1 The Cell Cycle................................................................................................................... 5 
1.3.2 Detection of DNA damage and the response .................................................................. 8 
1.3.3 G1/S checkpoint ............................................................................................................ 11 
1.3.4 G2/M checkpoint ........................................................................................................... 11 
1.3.5 G1/S and G2/M Checkpoint recovery ........................................................................... 12 
1.3.6 S phase checkpoints ...................................................................................................... 12 
1.3.7 Spindle Assembly Checkpoint ....................................................................................... 13 
1.3.8 Significance for cancer and disease............................................................................... 14 
1.3.9 Checkpoint negligence .................................................................................................. 15 
1.3.10 The response of subsequent checkpoints ..................................................................... 17 
1.3.11 Differential checkpoint activation ................................................................................. 18 
1.3.12 Permanent exit from the cell cycle ............................................................................... 19 
Table of Contents 
viii 
 
1.3.13 Programmed cell death - Apoptosis .............................................................................. 19 
1.3.14 Senescence .................................................................................................................... 22 
1.3.15 Apoptosis vs senescence ............................................................................................... 23 
1.4 The analysis of cell cycle dynamics and cell fate ................................................................... 24 
1.4.1 Cell cycle phase determination with the FUCCI system ................................................ 24 
1.4.2 Microscopy-based lineage tracing ................................................................................. 26 
1.5 Understanding the significance of checkpoint responses in subsequent cell cycle phases .. 28 
Microscopy based lineage tracing – cell fate following DNA damage .................................................. 31 
1.6 The development of a microscopy-based lineage tracing approach .................................... 31 
1.6.1 Design of a genetically encoded fluorescent nuclear marker ....................................... 33 
1.6.2 Construction and validation of stable cell lines for lineage tracing .............................. 34 
1.6.3 Development of an analysis workflow .......................................................................... 35 
1.7 Initial characterisation of lineage and fate tracing using the FUCCI-NM system .................. 38 
1.8 Full characterisation and novel analysis of the response of U2OS cells to DNA damage ..... 48 
1.8.1 Lineage Trees ................................................................................................................. 48 
1.8.2 Generational Analyses ................................................................................................... 54 
1.8.3 Treatment relative to cell cycle position ....................................................................... 60 
1.8.4 Family correlations ........................................................................................................ 68 
1.8.5 Lineage fitness scores .................................................................................................... 70 
1.8.6 Paired sister lineage comparisons ................................................................................. 78 
1.8.7 Lineage progression in space and time ......................................................................... 81 
1.8.8 Other cell lines ............................................................................................................... 82 
1.9 Discussion .............................................................................................................................. 83 
1.9.1 Descendant cell death ................................................................................................... 83 
1.9.2 Proposed delayed death mechanism: Inherited DNA damage ..................................... 84 
1.9.3 Proposed delayed death mechanism: Checkpoint memory ......................................... 86 
1.9.4 Proposed delayed death mechanism: DNA damage triggered cell deregulation ......... 86 
1.9.5 Checkpoint negligence in U2OS cells ............................................................................. 87 
1.9.6 Correlations analysis ...................................................................................................... 87 
Table of Contents 
ix 
 
1.9.7 Conclusions.................................................................................................................... 88 
1.10 Supplementary Figures ......................................................................................................... 89 
1.10.1 Experimental repeat 2 ................................................................................................... 89 
1.10.2 Experimental repeat 3 ................................................................................................... 97 
Generational tracing by flow cytometry ............................................................................................. 105 
1.11 Assay development ............................................................................................................. 105 
1.12 Generational tracing in U2OS cells ...................................................................................... 106 
1.12.1 Experimental setup ..................................................................................................... 106 
1.12.2 CellTrace dilution characterisation ............................................................................. 109 
1.12.3 Population size ............................................................................................................ 109 
1.12.4 Comparing CellTrace dilution with population size .................................................... 110 
1.12.5 Estimation of death rate ............................................................................................. 113 
1.12.6 Cell Cycle analysis ........................................................................................................ 114 
1.12.7 The persistence of DNA damage ................................................................................. 115 
1.13 Generational tracing in HeLa cells ....................................................................................... 123 
1.13.1 Initial HeLa comparison to U2OS................................................................................. 123 
1.13.2 Interrogating the response of later generations to DNA damage .............................. 127 
1.14 Generational tracing in HPNE cells ...................................................................................... 132 
1.15 Discussion ............................................................................................................................ 134 
1.16 Supplementary figures ........................................................................................................ 136 
Discussion ............................................................................................................................................ 140 
Materials and Methods ....................................................................................................................... 142 
1.17 Cell culture .......................................................................................................................... 142 
1.17.1 Pre-existing cell lines ................................................................................................... 142 
1.17.2 Cell culture media ....................................................................................................... 142 
1.17.3 Cell culture vessels ...................................................................................................... 142 
1.18 Genetic manipulation .......................................................................................................... 143 
1.18.1 Gene synthesis, plasmids and constructs .................................................................... 143 
1.18.2 Transfection ................................................................................................................. 143 
Table of Contents 
x 
 
1.18.3 Viral particle production and transduction ................................................................. 143 
1.18.4 Stable cell line generation ........................................................................................... 144 
1.19 Cell culture fluorescent dyes ............................................................................................... 144 
1.19.1 Hoechst 33342 ............................................................................................................. 144 
1.19.2 CellTrace™ dyes ........................................................................................................... 145 
1.20 DNA damage induction ........................................................................................................ 145 
1.20.1 Neocarzinostatin .......................................................................................................... 145 
1.21 Western blotting .................................................................................................................. 145 
1.21.1 Cell harvesting and Lysate preparation ....................................................................... 145 
1.21.2 Protein concentration quantification .......................................................................... 145 
1.21.3 Polyacrylamide Gel Electrophoresis ............................................................................ 145 
1.21.4 Western blot protein transfer ..................................................................................... 145 
1.21.5 Antibody probing ......................................................................................................... 145 
1.22 Immunofluorescence sample preparation .......................................................................... 146 
1.22.1 γH2AX staining ............................................................................................................. 146 
1.23 Flow cytometry .................................................................................................................... 146 
1.23.1 Fluorescence-activated cell sorting (FACS) .................................................................. 146 
1.23.2 Flow cytometry analysis .............................................................................................. 146 
1.24 Generational tracing by flow cytometry ............................................................................. 147 
1.24.1 CellTrace™ staining and seeding ................................................................................. 147 
1.24.2 Neocarzinostatin treatment ........................................................................................ 147 
1.24.3 Cell sample harvesting ................................................................................................. 147 
1.24.4 Population Counting .................................................................................................... 148 
1.24.5 Data analysis ................................................................................................................ 148 
1.24.6 γH2AX foci counting..................................................................................................... 148 
1.25 Microscopy .......................................................................................................................... 149 
1.25.1 Widefield microscope .................................................................................................. 149 
1.25.2 Confocal microscope ................................................................................................... 149 
1.25.3 Optogenetic stimulation .............................................................................................. 149 
Table of Contents 
xi 
 
1.26 Microscopy based lineage tracing data acquisition and analytical workflow ..................... 149 
1.26.1 Pre-imaging sample preparation ................................................................................. 149 
1.26.2 Image acquisition ........................................................................................................ 149 
1.26.3 Image segmentation .................................................................................................... 150 
1.26.4 Image tracking ............................................................................................................. 150 
1.26.5 Nuclei measurements and curation ............................................................................ 150 
1.26.6 G1/S phase transition estimation ................................................................................ 150 
1.26.7 Data annotation .......................................................................................................... 150 
1.27 Numerical precision ............................................................................................................ 150 
1.28 Modelling the effect of time of treatment relative to SG2M phase start .......................... 151 
1.29 Correlation analysis ............................................................................................................. 151 
1.29.1 Correlations between paired sister lineages ............................................................... 151 
1.29.2 Familial relationship correlations ................................................................................ 151 
1.30 Modelling generational rate of cell death from CellTrace vs population growth plots ...... 151 
Bibliography ........................................................................................................................................ 154 
Appendix: Optogenetic tool development .......................................................................................... 165 
1.31 Optogenetics ....................................................................................................................... 165 
1.32 Optogenetic examples ........................................................................................................ 166 
1.32.1 LOV2 ............................................................................................................................ 166 
1.32.2 PhyB-PIF3/6 ................................................................................................................. 166 
1.32.3 Magnets ....................................................................................................................... 167 
1.33 The development of novel optogenetic tools for probing checkpoint biology .................. 167 
1.34 Opto-Cre control of oncogenic signalling ............................................................................ 170 
1.35 Conclusion ........................................................................................................................... 171 
Appendix: Microscopy based lineage tracing computational analysis ............................................... 172 
 
  
List of Figures 
xii 
 
List of Figures 
Figure 1: DNA lesions come in a myriad of different forms .................................................................... 2 
Figure 2 The eukaryotic cell cycle ............................................................................................................ 6 
Figure 3 The distribution of cyclins throughout the cell cycle ................................................................ 7 
Figure 4: The DNA Damage Response ................................................................................................... 10 
Figure 5 The intrinsic and extrinsic activation pathways in apoptosis .................................................. 21 
Figure 6: The FUCCI system ................................................................................................................... 26 
Figure 7: Three generations of a lineage and the familial relationships examined .............................. 27 
Figure 8: Identifying cells by microscopy............................................................................................... 31 
Figure 9: Tracking cells via segmented nuclei ....................................................................................... 32 
Figure 10: Idealised representation of FUCCI and nuclear marker fluorescence across cell cycle ....... 33 
Figure 11: Fluorescence excitation and emission electromagnetic spectra ......................................... 34 
Figure 12: Comparison of nuclear-cytoplasm contrast of variant NLS tagged iRFP682 constructs ...... 34 
Figure 13: Characterisation of stable FUCCI-NM U2OS cell line............................................................ 36 
Figure 14: Analytical workflow for analysis of microscopy based lineage tracing ................................ 37 
Figure 15: Multigenerational FUCCI lineage tracing .............................................................................. 38 
Figure 16: Neocarzinostatin (NCS) induces DNA damage rapidly ......................................................... 39 
Figure 17: Lineage trees depict familial relations between cells and convey cellular information ...... 40 
Figure 18: Lineages trees from mock or neocarzinostatin (NCS) treated cells ..................................... 41 
Figure 19: Depicting lineages as family trees allows the heterogeneity of descendant cell fates to be 
visualised. .............................................................................................................................................. 43 
Figure 20: Generational analyses of lineage traced cells ...................................................................... 45 
Figure 21 Swarm plots of G1 length and length of combined S, G2, and M (SG2M) phases. ............... 46 
Figure 22: Swarm plots of cells showing total cell cycle length for FUCCI-NM U2OS cells coloured by 
daughter or own cell fate and separated into their generations. ......................................................... 47 
Figure 23: All lineages analysed from a single experiment can be visualised together in tree diagrams 
allowing the diversity of lineage behaviour and NCS induced changes to be assessed........................ 50 
Figure 24: Depicting lineages as family trees allows the heterogeneity of descendant cell fates to be 
visualised. .............................................................................................................................................. 51 
Figure 25: Sister cells both receiving NCS treatment can produce both similar and dissimilar lineages
 ............................................................................................................................................................... 51 
Figure 26: Neocarzinostatin induces the formation of γH2AX foci ....................................................... 52 
Figure 27: Generational analyses of mock and NCS treated FUCCI-NM U2OS cells ............................. 54 
Figure 28: Swarm plot showing total cell cycle length for FUCCI-NM U2OS cells coloured by the fate of 
their daughter cells if they divide, or by their own cell fate if not. ....................................................... 56 
List of Figures 
xiii 
 
Figure 29: Histograms taken from the indicated generations of cells indicating the cell cycle duration 
for their subpopulations ddivide, dmixed and ddie. ...................................................................................... 57 
Figure 30: Swarm plots of FUCCI-NM U2OS cells with identifiable G1/S transitions plotted by G1 and 
SG2M length. ......................................................................................................................................... 60 
Figure 31: Lineage trees of mock or Neocarzinostatin treated FUCCI-NM U2OS cells ordered with 
respect to position in cell cycle at the time of treatment. .................................................................... 61 
Figure 32: Graphs of cell cycle timing dependencies of the effect of treatments upon SG2M duration
 ............................................................................................................................................................... 62 
Figure 33: Correlation plots for the four possible Mother-Daughter cell cycle duration comparisons.65 
Figure 34: Correlation plots for four Sister-Sister pair cell lifespan comparisons. ............................... 66 
Figure 35: Correlation plots for two Cousin-Cousin pair cell lifespan comparisons. ............................ 67 
Figure 36: Lineage fitness can be assessed by three different metrics. ............................................... 71 
Figure 37: Heterogeneity and  NCS induced changes in lineage fitness can be better understood by 
scoring lineage fitness ........................................................................................................................... 72 
Figure 38: Lineage Fitness Space is defined by the various possible PI and SI scores. ......................... 75 
Figure 39: NCS treatment induces a clear shift in lineages away from high fitness and towards low 
fitness characterised by increased cell death and reduced proliferation ............................................. 77 
Figure 40: Mock and NCS treated sister lineages appear to moderately correlate in both PI and SI scores 
to varying extents across experimental repeats. .................................................................................. 78 
Figure 41:Bootstrapped probability density functions for calculated Spearman Correlation coefficient 
for sister lineages and control randomised pairs. ................................................................................. 80 
Figure 42: Cell lineages can be visualised in three dimensions with two-dimensional movement against 
time. ...................................................................................................................................................... 81 
Figure 43: FUCCI-NM in HPNE hTERT and HeLa cell line ....................................................................... 82 
Figure 44: Lineage trees from experimental repeat 2 .......................................................................... 89 
Figure 45: Generational analyses of experimental repeat 2 ................................................................. 90 
Figure 46: FUCCI-NM U2OS total cell cycle length swarm plot with dividing cells colour coded by 
daughter cell fates, data from experimental repeat 2. ......................................................................... 91 
Figure 47: G1/SG2M duration swarm plots of FUCCI-NM U2OS cells with identifiable G1/S transitions, 
data from experimental repeat 2. ......................................................................................................... 92 
Figure 48: Lineage trees of mock or Neocarzinostatin treated FUCCI-NM U2OS cells ordered with 
respect to position in cell cycle at the time of treatment, data from experimental repeat 2. ............. 93 
Figure 49: Graphs of cell cycle timing dependencies of the effect of treatments upon SG2M duration, 
data from experimental repeat 2 .......................................................................................................... 94 
Figure 50: Lineage fitness as assessed by three different metrics, data from experimental repeat 2 . 95 
List of Figures 
xiv 
 
Figure 51: Stem plots indicating the proportion of all lineages with the given combination of PI and SI 
score in each experimental condition, data from experimental repeat 2 ............................................ 96 
Figure 52: Lineage trees from experimental repeat 3 ........................................................................... 97 
Figure 53: Generational analyses of experiment repeat 3 .................................................................... 98 
Figure 54: FUCCI-NM U2OS total cell cycle length swarm plot with dividing cells colour coded by 
daughter cell fates, data from experimental repeat 3. ......................................................................... 99 
Figure 55: G1/SG2M duration swarm plots of FUCCI-NM U2OS cells with identifiable G1/S transitions, 
data from experimental repeat 3 ........................................................................................................ 100 
Figure 56: Lineage trees of mock or Neocarzinostatin treated FUCCI-NM U2OS cells ordered with 
respect to position in cell cycle at the time of treatment, data from experimental repeat 3. ........... 101 
Figure 57: Graphs of cell cycle timing dependencies of the effect of treatments upon SG2M duration, 
data from experimental repeat 3 ........................................................................................................ 102 
Figure 58: Lineage fitness as assessed by three different metrics, data from experimental repeat 3 103 
Figure 59: Stem plots indicating the proportion of all lineages with the given combination of PI and SI 
score in each experimental condition, data from experimental repeat 2 .......................................... 104 
Figure 60: CellTrace dyed cells halve in fluorescence with each cell division allowing generational 
progression to be inferred via flow cytometric measurements. ......................................................... 106 
Figure 61: Experimental protocol for generational tracing by flow cytometry .................................. 107 
Figure 62: CellTrace profiles and total population graphs for U2OS cells. .......................................... 108 
Figure 63: Changes in CellTrace fluorescence and population size can be compared to infer 
generational behaviour. ...................................................................................................................... 111 
Figure 64: Comparing population changes to the dilution of CellTrace fluorescence allows generational 
death in U2OS cells to be inferred. ..................................................................................................... 112 
Figure 65: Cell cycle distributions over time of U2OS cells receiving mock or NCS treatments. ........ 114 
Figure 66: Mock treated cells show few γH2AX foci across the course of the experiment ................ 117 
Figure 67: 100ng/ml NCS treated cells show induction of DNA damage that persists over the five days 
of the experiment. ............................................................................................................................... 119 
Figure 68: Further examples of immunofluorescence images taken from the NCS treated (100ng/ml) 5 
days sample show the range of residual DNA damage (γH2AX foci) and the diversity of nuclear 
morphology (Hoechst 33342 stained DNA). ........................................................................................ 121 
Figure 69: Automatic γH2AX foci counts for each timepoint for mock and 100ng/ml NCS treated 
samples ................................................................................................................................................ 122 
Figure 70: CellTrace profiles and total population graphs for HeLa TetOn cells. ................................ 124 
Figure 71: Comparing population changes to the dilution of CellTrace fluorescence allows generational 
death in HeLa TetOn cells to be inferred ............................................................................................. 126 
Figure 72: Cell cycle distributions over time of HeLa TetOn cells receiving mock or NCS treatments 127 
List of Figures 
xv 
 
Figure 73: CellTrace profiles and total population graphs for HeLa BRC4.23 cells. ............................ 129 
Figure 74: Induction of BRC4 expression appears to have little effect on generational death in NCS 
treated HeLa BRC4.23 cells ................................................................................................................. 130 
Figure 75: Experimental protocol for testing whether the induction of the BRC4 fragment alters death 
in descendant cells as inferred by flow cytometry generational tracing ............................................ 131 
Figure 76: Western blot confirming induction of HeLa BRC4 fragment in dox treated samples after 
dox/control media addition after the 1 day timepoint ....................................................................... 131 
Figure 77: Cell cycle distributions over time of HeLa BRC4.23 cells ................................................... 132 
Figure 78: HPNE hTERT show very different behaviour to U2OS and HeLa cells. ............................... 133 
Figure 79: Cell cycle distributions over time of HPNE hTERT cells receiving mock or NCS treatment 134 
Figure 80: Measured U2OS viable population, as determined by ViCell trypan blue discrimination, 
changes over time for each experimental condition .......................................................................... 136 
Figure 81: Generational tracing with flow cytometry of U2OS cells experimental repeats show similar 
trends .................................................................................................................................................. 137 
Figure 82: Measured HeLa TetOn viable population, as determined by ViCell trypan blue discrimination, 
changes over time for each experimental condition .......................................................................... 138 
Figure 83: Measured HeLa BRC4.23 viable population, as determined by ViCell trypan blue 
discrimination, changes over time for each experimental condition ................................................. 139 
Figure 84: Illustration of principle of use of LOV2 and PhyB-PIF6 light responsive domains ............. 165 
Figure 85: Illustration of Cas9 activity ................................................................................................. 168 
Figure 86: Diagram of nuclear shuttling LOV2 based optogenetic construct ..................................... 169 
Figure 87: The nuclear import LOV2 optogenetic construct can be further sequestered at the 
mitochondria ....................................................................................................................................... 170 
Figure 88: TopBP1-mCherry-LANS construct localises to the nucleus upon blue light stimulation ... 170 
Figure 89: Opto-Cre construct with the addition of an NLS flanked mCherry for cell tracing ............ 170 
Figure 90: Activation of Opto-Cre in specific cells allows light control over gene expression ........... 171 
Figure 91: Cell nuclei segmentation in NIS Elements AR software ..................................................... 172 
Figure 92: Extracted nuclei masks were tracked through time with custom MATLAB software ....... 173 
Figure 93: Custom MATLAB software to automatically extract fluorescence measurements and permit 
manual trace validation and curation ................................................................................................. 173 
Figure 94: Reviewing FUCCI probe fluorescence is used to determine the G1/S transition............... 174 
Figure 95: Many of the analyses presented here required custom software to extract and depict the 
relevant information ........................................................................................................................... 174 
  
List of Tables 
xvi 
 
List of Tables 
Table 1: Estimation of numbers of DNA lesions generated daily endogenously and from specific 
exogenous sources .................................................................................................................................. 4 
Table 2: Fluorophores used in combination with hGem/hCdt1 based probes ..................................... 25 
Table 3: Plasmid vectors used for cloning constructs used in this work ............................................. 143 
Table 4: Antibodies used ..................................................................................................................... 146 
 
List of Frequently Used Abbreviations 
aa Amino acid(s) 
ATM Ataxia Telangiectasia Mutated protein 
ATR Ataxia Telangiectasia and Rad3 related protein 
CDK Cyclin Dependent Kinase 
DDR DNA Damage Response 
DNA Deoxyribonucleic Acid 
DNA-PK DNA dependent protein kinase 
FUCCI Fluorescent Ubiquitination-based Cell Cycle Indicator 
G1 Gap 1 (phase ) 
G2 Gap 2 (phase) 
hCdt1 Human Cdt1 protein 
hGem Human Geminin protein 
HPNE Human Pancreatic Nestin-Expressing 
HR Homologous Recombination 
hTERT Human Telomerase Reverse Transcriptase 
M Mitosis 
mAG Monomeric Azami Green 
NES Nuclear Export Signal 
NHEJ Non-Homologous End Joining 
NLS Nuclear Localisation Signal 
PIKK Phosphatidylinositol 3-kinase-related kinase 
Plk1 Polo-like Kinase 1 
Rb Retinoblastoma protein 
S Synthesis (phase) 
SAC Spindle Assembly Checkpoint 





1.1 Cell fate determination, to die or thrive? 
Mammalian organisms are composed of large numbers of cells each developed into a specific state 
that normally carries out a physiological role for the development and maintenance of the soma or 
reproductive germline cells. The differences between cells can be vast, some actively proliferate, e.g. 
blood cell progenitors, producing a great many descendants, some, such as hepatocytes, may cycle 
only when necessary to repair injury and others, once terminally differentiated, should never divide 
again; cells making up the outer layers of the skin are disposable and short lived while neurones can 
last a lifetime; a motor neuron may stretch the entire length of a limb while red blood cells are a few 
microns in diameter (Milo et al. 2009). Despite this diversity, almost all cell types possess the same 
genome, the few exceptions including immune cells that have undergone recombination to generate 
sequences encoding novel antibodies, germ cells that have undertaken meiosis and red blood cells 
which lack nuclei. This diversity is generated during the processes of development as cells integrate 
information and make decisions over which programmes of behaviour encoded in DNA to activate and 
which to suppress in order to determine their ultimate cell fate. This cell fate determination continues 
throughout life as cells maintain organismal homeostasis in response to tissue turnover, damage, 
injury and infectious agents. When cells make inappropriate cell fate decisions, whether during 
development or during homeostasis, diseased states such as cancer, the abnormal growth of cells in 
the body, may result. 
Of particular relevance to cancer are the fate decisions cells make over life, proliferation and death. In 
tissues and organs these decisions must be balanced to maintain function over time; excessive cell 
death will lead to organ degeneration and excessive proliferation will lead to tissue metaplasia, the 
risk of tumour formation and thus potentially organismal death. Furthermore, these decisions are 
important in ensuring correct tissue function in response to cellular damage, cells must evaluate 
whether they can continue to function normally or if they must sacrifice themselves to facilitate their 
own replacement.  
This work focuses on the cell cycle arrest, proliferation, survival and death decisions made in the 
circumstance of responding to damage to DNA, a form of cellular damage that has particular 
significance as it may produce mutations that alter the encoded information governing cellular 
processes. Certain mutations are capable of deregulating cellular pathways in such a way to promote 
the development of cancer, with the creation of oncogenes or the loss of tumour suppressors being 
two well studied classes of several characteristically cancer-promoting changes (Hanahan & Weinberg 
2011). Thus, DNA damage in one cell may lead to negative consequences for the whole organism if this 




DNA damage is ubiquitous (Ciccia & Elledge 2010) and with an estimated 37 trillion cells in the human 
body (Bianconi et al. 2013), many of which presumably possess some potential capability to give rise 
to cancer, the chances of one of these many cells experiencing DNA damage induced mutations that 
result in the formation of a tumour might be expected to be very high. Indeed, many humans do 
develop cancer, but typically after many decades of life (CRUK 2016) and thus the turnover of trillions 
of cells, suggesting that the vast majority of DNA damage received by cells does not lead to the 
development of cancer. Our current understanding of the decisions taken by cells following DNA 
damage has explained one of the major mechanisms for restraining carcinogenesis, namely the 
existence of DNA damage monitoring ‘checkpoints’. However, as these checkpoints have in recent 
years been demonstrated to possess some apparent failings (Deckbar et al. 2011), there remain open 
questions over how DNA damage is dealt with by the damaged cells and indeed, by their descendants. 
1.2 DNA damage – corrupting the molecule of Inheritance 
Despite being a long-term information storage molecule, DNA is susceptible to numerous types of 
alterations that may result in information corruption or loss. These chemical modifications, often 
termed ‘DNA damage’ and ‘lesions’, come in many forms (Figure 1), for example conversion of bases, 
loss of bases, base modification, base dimerisation, single and double strand deoxyribose-phosphate 
backbone breaks, and DNA crosslinks (Griffiths et al. 2000).  
1.2.1 Endogenous sources of damage 
There are many different specific endogenous sources of DNA damage which fall into several broad 
categories. Firstly, the cell’s own metabolic activity, in a perhaps surprisingly self-sabotaging role, is 
one source of damage through the generation of reactive oxygen species (ROS) capable of reacting 
with DNA to produce oxidised bases and strand breaks (Ames 1989; Fraga et al. 1990). Secondly, 
spontaneous chemical reactions result in base deamination, where cytosine converts to uracil, a base 




not found in DNA and capable of pairing with adenine, and depurination, the breaking of the bond 
between the deoxyribose moiety and the base resulting in an abasic site (Lindahl 1993). Thirdly, the 
activities of transposable elements such as the human L1 retrotransposon introduce DNA breaks 
during the process of transposition, in this particular example via an encoded L1 endonuclease (Feng 
et al. 1996). Finally, errors arising in the processes of replication can also lead to the generation of DNA 
lesions (Branzei & Foiani 2005), while induction of DNA breaks have been implicated in the regulation 
of transcription (Ju et al. 2006; Haffner et al. 2010). 
1.2.2 Exogenous sources of damage 
Internal sources of damage are far from the only significant source of damage (Ciccia & Elledge 2010). 
There are numerous known environmental sources including: Ionising particle (e.g. 
alpha/beta/proton/neutron) and electromagnetic (X- and gamma rays) radiation, ultraviolet light, 
chemicals which react directly with DNA and chemicals which interfere with the proper processing of 
DNA by the cell, for example topoisomerase I and II inhibitors which abolish religation of DNA after a 
deliberate enzymatic cleavage.  
Estimations of the number and type of lesions introduced from endogenous and exogenous processes 
are included in Table 1. 
1.2.3 The consequences of DNA damage 
The specific consequences of DNA damage vary depending upon the particular lesion, for example an 
abasic site in a codon can no longer encode an amino acid for a protein, a base transition may change 
the amino acid encoded and a double strand break structurally breaks the chain of information which 
would prevent transcription from generating a full length RNA, but conceptually there are two major 
negative considerations. Firstly, the ability of the cell to survive or carry out its function in tissue may 
be impaired, this could arise if genes essential for survival or function experience a deleterious 
mutation. Thus the organism experiences an actual or functional loss of a cell in a tissue. An individual 
cell might be dispensable but if it happens too frequently then tissue function will be impaired. 
Secondly, mutations arising from DNA damage may drive or predispose the cell to inappropriate 
proliferation giving rise to cancer, disruption of tissues, organ dysfunction and ultimately organismal 
death. Many of the most well studied genes in relation to cancer feature mutations that are highly 
selectively advantageous and so occur in multiple tumour types, arising independently in individual 
patients (Vogelstein et al. 2013). Even a single mutation can change cell behaviour, for example the 
mutation of the codon for Glycine to one that encodes Aspartic acid in the KRasG12D mutation. This 
results in a mutant KRas impaired in GTPase activity and which thus drives aberrant pro-growth 





DNA damage may itself also lead to further DNA damage and loss of genome integrity. Unrepaired or 
misrepaired DNA breaks present the possibility of producing chromosomes or chromosome fragments 
missing centromeres (acentric) that are not correctly, if at all, attached to the mitotic spindle during 
mitosis. These are likely to lead to the failure to segregate genomic DNA evenly to the daughter cells 
causing extensive losses or gains of DNA sequences. If these then fail to be incorporated into the 
nucleus of the daughter cell they are known to form ‘micronuclei’ (Carrano & Heddle 1973), separate 
smaller nucleus-like structures, which have been shown to generate further DNA damage in two ways. 
Firstly, via aberrant inefficient replication no longer synchronous with the rest of the genome and 
secondly, as a consequence of the DNA in micronuclei undergoing DNA replication during mitotic 
chromosome compaction resulting in chromosome ‘pulverisation’ (Crasta et al. 2012). This 
pulverisation entails further breaking of the DNA strands into multiple fragments, rejoining of these 
may explain the phenomenon of ‘chromothripsis’ (Stephens et al. 2011), the observation of extensive 
rearrangements within a chromosome in some cancer cells. Clearly such extensive structural changes 
Endogenous DNA damage Lesion type: Lesions generated (per cell per day): 
Depurination Abasic site 10,000 a 
Cytosine deamination Base transition 100-500 a 
Oxidation Oxidised guanine 400-1500 b 
Exogenous DNA damage Lesion type: Lesions generated (per cell): 
Peak sunlight Pyrimidine dimers and 
photoproducts 
100,000 per day c 
Cigarette smoke Aromatic DNA adducts 45-1029 d 
Chest X-ray Double-strand breaks 0.0008 e,f,g,h 
Body CT scan Double-strand breaks 0.28 e,h 
Airline travel Double-strand breaks 0.0002 per hour e,h 
Chernobyl Double-strand breaks 12 e,h 
Hiroshima and Nagasaki atomic 
bombs 
Double-strand breaks 0.2-160 h,i 
Table 1: Estimation of numbers of DNA lesions generated daily endogenously and from specific 
exogenous sources 
Adapted from (Ciccia & Elledge 2010) 
a(Lindahl & Barnes 2000) 
b(Klungland et al. 1999) 
c(Hoeijmakers 2009) 
d(Phillips et al. 1988) 
e http://www.merckmanuals.com/home/injuries-and-poisoning/radiation-injury/radiation-injury (originally published link: 
http://www.merck.com/mmhe/sec24/ch292/ch292a.html) 
f https://www.fda.gov/Radiation-EmittingProducts/RadiationSafety/RadiationDoseReduction/ucm199994.htm#ft6  
g(Hall & Giaccia 2006) 
h(Elkind & Redpath 1977) 




to the DNA represent a significant loss of genome integrity and, as with simpler mutations, pose the 
risk of facilitating cancerous transformation by deregulating typical cell functions. 
Fortunately however, cells are equipped with many processes facilitating repair of the DNA and, where 
necessary, a permanent exit from the cell cycle via senescence or programmed cell death in order to 
protect the organism from the proliferation of aberrant cells. Such mechanisms explain, at least in part, 
the apparent contradiction of ubiquitous DNA damage with the ability of multicellular organisms like 
humans to survive for decades and turn over trillions of cells before experiencing life threatening loss 
of function of tissues or the development of cancer. Many of these processes are ordered and 
regulated by the existence of cell cycle checkpoints. 
1.3 Cell cycle checkpoints and the maintenance of genetic integrity 
1.3.1 The Cell Cycle 
 The eukaryotic cell cycle whereby a cell reproduces to form two daughter cells is characterised by a 
series of four sequential phases (G1, S, G2 and mitosis) facilitating the timely separation of DNA 
synthesis from DNA segregation (Figure 2) (The cell cycle is reviewed extensively in Poon 2016). The 
first phase, G1 (or gap phase 1), involves growth of the cell and preparation for beginning the synthesis 
of DNA. G1 contains the Restriction Point where an irreversible commitment to continuing the cell 
cycle may be made if certain cell-type dependent conditions relating to external, e.g. growth factor 
signalling, and internal stimuli are met, allowing the cell to continue to S phase. S phase, named for 
‘Synthesis’, is when the cell copies its entire nuclear genome via semi-conservative replication to allow 
for the subsequent division into two cells. G2 (or gap phase 2), another growth phase, allows further 
time for the cell to prepare for Mitosis, the final phase where the cell divides into (typically) two 
daughter cells, segregating the DNA into both daughter cells along with the contents of the cell, 
including organelles and macromolecules. There exists also a G0 phase where a cell may withdraw 
from the cell cycle either temporarily, commonly referred to as quiescence, re-entering the cell cycle 
subsequently when certain environmental conditions are met, or for the duration of its lifespan in the 
case of terminally differentiated cells. 
At its simplest, progression through the cell cycle is driven by the regulation of target proteins by 
phosphorylation by Cyclin Dependent Kinases (CDK) complexed with regulatory Cyclins (Obaya & 
Sedivy 2002). Which complexes are active changes throughout the cell cycle as different Cyclins are 
expressed, resulting in changing patterns of protein regulation and thus the resultant changes in the 




















Figure 3 The distribution of cyclins throughout the cell cycle 
Particular cyclins are only expressed at certain points in the cell cycle. Adapted from ‘Regulation of cyclin-Cdk activity in 




Further controlling cell cycle progression are many layers of regulatory complexity that govern entry 
into and commitment to the cell cycle, progression through the individual phases, the activity of the 
processes taking place in each phase and exit from the cell cycle in the form of either terminal 
differentiation, quiescence or senescence (Reviewed extensively in Poon 2016; Ruijtenberg & van den 
Heuvel 2016; Chandler & Peters 2013; Johnson & Skotheim 2013). Many of these regulatory processes 
address the problem of maintaining genetic integrity and cell function in the face of the myriad forms 
of DNA damage that can result from endogenous and exogenous sources. Depending on the position 
in the cell cycle, DNA damage presents different challenges as the cellular machinery operates different 
processes, for example, mRNA transcripts may be truncated or incorrect if the DNA template is 
damaged, DNA replication during S phase may stall leaving regions of the genome unreplicated, 
replication may fix damage as permanent base mutations in the copied strand if a damaged template 
is misread, and broken DNA strands may prevent correct segregation of chromosomes to descendant 
cells during mitosis. 
Certain cellular processes are capable of detecting DNA damage, initiating repair, slowing or halting 
progression through the cell cycle and determining the ultimate cell fate. Together these mechanisms 
are known as the DNA Damage Response (DDR) and allow for damage to be repaired where possible 
and for permanent exit from the cell cycle in the form of cell death or senescence where DNA damage 
cannot be resolved adequately (Reviewed extensively in Ciccia & Elledge 2010).  
1.3.2 Detection of DNA damage and the response 
The many types of DNA damage possible must all be sensed in order for any repair to be effected; 
while our understanding of these processes remains far from complete the components of this sensing 
system oriented around activation of the phosphatidylinositol 3-kinase-like protein kinase (PIKKs) 
family proteins ATM, ATR and DNA-PK are fairly well characterised. The binding of initial sensing 
proteins to the site of damage is followed by the recruitment of other mediators, signalling through 
transducers and ultimately the regulation of effectors that lead to DNA repair and cell fate 
determination, so forming the complete DDR (Figure 4). Some of the detail known about the DDR is 
discussed here. 
The DDR-related PIKK family proteins are recruited to the site of damage and activated early in the 
DDR by the sensing proteins/complexes that directly recognise DNA lesions. The Mre11-Rad50-Nbs1 
(MRN) complex detects double-strand breaks where it recruits and activates ATM (Lee 2005). The 
Ku70/Ku80 heterodimer ring complex loads onto the ends of double strand breaks then recruits and 
activates DNA-PK (Uematsu et al. 2007; Mahaney et al. 2009). For ATR, single stranded DNA, as might 
be exposed by a replication fork that has stalled in response to a DNA lesion, is recognised and coated 




recruits the 9-1-1 complex and TopBP1 to the coated DNA which then stimulate ATR activity (Kumagai 
et al. 2006; Delacroix et al. 2007; Lee et al. 2007). 
The poly(ADP-ribose) polymerase (PARP) family proteins PARP1 and PARP2 also play an important role 
in sensing DNA damage, achieving this through interacting with both double and single strand broken 
DNA via zinc finger motifs where they then generate poly(ADP-ribose) (PAR) chains on histone proteins 
(Caldecott 2008). These PAR chains are disassembled soon after by the PAR hydrolysing enzyme PARG 
(Davidovic et al. 2001) but while present provide a recruitment platform for chromatin modifying 
complexes (Polo et al. 2010; Chou et al. 2010), permitting reorganisation of chromatin structure to 
facilitate DNA repair, and many DDR factors, some of which are the effectors of DNA repair themselves, 
e.g. XRRC1 and Lig3, or are mediators like ATM (Gagné et al. 2008).  
Once recruited to a site of DNA damage and activated, the PIKK proteins ATM, ATR and DNA-PK can 
then phosphorylate their substrates at characteristic S/TQ amino acid sites (Kim et al. 1999). ATM and 
ATR have hundreds of substrates influencing a great many processes (Matsuoka et al. 2007) while DNA-
PK is mostly concerned with regulating substrates that favour a mechanism of DNA repair called Non-
Homologous End Joining (NHEJ) (Mahaney et al. 2009). One of these substrates is the variant histone 
H2AX which upon phosphorylation allows amplification of the DDR (Rogakou et al. 1998). This 
phosphorylation site provides a docking site for MDC1, which can then recruit further ATM, which in 
turn phosphorylates more H2AX (Stucki & Jackson 2006), so propagating phosphorylated H2AX across 
up to a megabase from the site of damage (Rogakou et al. 1999). As well as providing further ATM 
activity, the phosphorylation of H2AX and of MDC1 provides a platform for recruitment of other DNA 
damage response components, for example the assembly of 53BP1 and BRCA1 at the site of damage 
via the actions of the Rnf8 ubiquitin ligase (Wang & Elledge 2007; Huen et al. 2007; Kolas et al. 2007; 
Mailand et al. 2007). This process results in a large focus of a great many DDR factors around the DNA 
lesion. Other DDR PIKK substrates include further kinases, such as Chk1 for ATR and Chk2 for ATM, 
which can themselves phosphorylate various substrates, as well as a range of effectors of other 
behaviour, such as regulators of p53 signalling, DNA repair, cell cycle progression and DNA replication 
(Matsuoka et al. 2007).  
Ultimately a vast number of proteins are altered during the DDR which allows for the activation of all 
the processes necessary to attempt DNA repair. While many of these processes may be common across 
the cell cycle some differ and observation of these differences has resulted in the definition of multiple 
checkpoints that can be activated by the DDR, including the G1/S, intra-S and G2/M (Shaltiel et al. 
2015). These along with the Spindle Assembly Checkpoint (SAC) present the major surveillance 







Figure 4: The DNA Damage Response 
DNA lesions are directly sensed by proteins resulting in the recruitment of PIKK family proteins. These then act via mediators, 
transducers and directly with the effectors to bring about cell cycle arrests and DNA repair. Cells may subsequently resume 
progression through their cell cycle or permanently exit the cell cycle via a death mechanism such as apoptosis or by entering 
a state of senescence. 




1.3.3 G1/S checkpoint 
DNA damage experienced before Restriction during the G1 phase poses particular challenges in that it 
occurs before cells have made an irreversible commitment to entering the cell cycle. Additionally, even 
if the commitment to cycling has been made the damage now presents a problem for the following S 
phase where DNA replication must take place. Damaged DNA templates may disrupt replication or 
result in the production of mutant copied strands that will then be inherited as fixed mutations. The 
G1/S checkpoint allows for these problems to be avoided via the induction of a cell cycle arrest that 
gives time for DNA damage recognition, repair and cell fate determination where necessary. 
Mechanistically there are two major pathways achieving this, quick posttranslational modifications 
and a slower p53 mediated transcription based process. In the former ATM and ATR kinase activity 
results in the phosphorylation of the phosphatase Cdc25a, inhibiting it from dephosphorylating 
inhibitory phosphorylations on Cdk2 (Mailand 2000). Furthermore, cyclin D1 is rapidly degraded 
inhibiting the formation of active CyclinD-Cdk4/6 complexes (Diehl et al. 1997; Agami 2000). In the 
latter process phosphorylations stabilise p53 and inhibit its negative regulator Mdm2, thus allowing its 
transcriptional activity to activate expression of multiple target genes (Vogelstein et al. 2000). These 
genes are involved in many relevant processes for DNA damage repair but one target in particular, 
p21, is a CDK inhibitor that prevents cell cycle progression by binding CyclinE-Cdk2 and CyclinD-Cdk4/6 
(Wade Harper et al. 1993; Harper et al. 1995; Sherr & Roberts 1995; Dotto 2000).  
1.3.4 G2/M checkpoint 
During G2 DNA damage occurs in a different context to G1, forthcoming DNA replication is no longer 
an issue but the irreversible separation into two cells in mitosis is. While in G2 each chromosome has 
a copy that can be used for error-free DNA damage repair via homologous recombination, but after 
mitosis this is no longer possible and more error-prone methods become necessary potentially 
permanently fixing mutations. Furthermore, unrepaired DNA damage during mitosis presents further 
problems such as the formation of micronuclei as discussed above. Therefore, similarly to G1, the 
G2/M checkpoints induce a cell cycle arrest following DNA damage. 
As in G1, progression from G2 to mitosis is controlled by cyclin-CDK activities, in this case CyclinB1-
Cdk1, and the response to DNA damage by this checkpoint involves post-translational modifications to 
proteins and transcriptional changes (Deckbar et al. 2011). CyclinB1-Cdk1 is kept in an inactive state 
by phosphorylation by Wee1 and Myt1, while opposing dephosphorylation by Cdc25 phosphatases 
serves to activate the complex allowing progression into mitosis (Parker & Piwnica-Worms 1992; Liu 
et al. 1997; Booher et al. 1997; O’Connell et al. 1997). DNA damage signalling through the ATM and 
ATR kinases leads to the phosphorylation of Cdc25C, which results in Cdc25C being bound by the 14-




the inactive state of CyclinB1-Cdk1 is favoured and cell cycle progress arrested (Furnari 1997; Peng 
1997; Sanchez 1997; Chaturvedi et al. 1999; Kumagai & Dunphy 1999; Lopez-Girona et al. 1999). Then, 
much as in G1, p53 activation by the DNA damage recognition pathways leads to the upregulation of 
genes, for example p21, that maintain the arrest over longer time periods (Bunz 1998; Taylor & Stark 
2001; Bruno et al. 2006). 
1.3.5 G1/S and G2/M Checkpoint recovery 
The processes by which resumption of the cell cycle from an arrest occurs are not fully known but it is 
believed necessary that the activation of DNA damage signalling components be reversed by some 
means to allow the relevant Cyclin-Cdk complexes to resume their activity (Calonge & O’Connell 2008; 
Wang et al. 2015). Two observed mechanisms are reversal of DDR kinase induced phosphorylations by 
phosphatases and degradation of signalling components. 
The PP2A phosphatase has been observed to dephosphorylate ATM, γH2AX and Chk1 while Wip1 
phosphatase dephosphorylates Chk1, Chk2, p53, γH2AX and p38 (Bulavin et al. 2004; Chowdhury et al. 
2005; Shreeram et al. 2006; Macůrek et al. 2010; Yan et al. 2010). Ubiquitin-mediated protein 
degradation has been shown to be involved in degradation of Wee1, see above, and Claspin, a protein 
which assists ATR activation of Chk1 (Mailand et al. 2006). (Van Vugt et al. 2004; Mailand et al. 2006) 
In addition to its role in mitotic progression Plk1 is also known to be involved in triggering the 
degradation of Wee1 and Claspin (Van Vugt et al. 2004; Mailand et al. 2006) and promoting recovery 
from the G2/M checkpoint arrest by antagonising the pro-arrest pathways. Plk1 phosphorylation of 
Cyclin B1 conceals its cytoplasmic retention signal favouring nuclear localisation (Toyoshima-Morimoto 
et al. 2001) and phosphorylation of Cdc25 triggers nuclear translocation where it removes inhibitory 
phosphorylations on Cdk1 (Toyoshima-Morimoto et al. 2002). These changes thus favour the 
formation of an active Cyclin-CDK complex that drives the cell into mitosis.  
1.3.6 S phase checkpoints 
S phase marks the period the cell is undertaking duplication of its DNA content in preparation for 
mitosis and the division into two daughter cells. During this period the entire genome must be 
accurately replicated and any DNA damage encountered by replication forks, the assembled machinery 
of protein complexes that facilitate DNA replication, risks mutations being permanently fixed in the 
genome. Three different forms of cell cycle checkpoints active in S phase have been identified, the 
replication checkpoint, the intra-S-phase checkpoint and the S-M checkpoint, of which the first two 
are responsive to DNA damage (reviewed extensively in (Bartek et al. 2004). In contrast to the relatively 
robust G1 and G2 cell cycle arrests following DNA damage detection cell cycle progression in S phase 
is considered to slow transiently upon the induction of DNA damage and will inevitably continue onto 




The replication checkpoint manages active replication forks which encounter stresses, such as 
damaged DNA or aberrant DNA structures, capable of stalling replication fork progression. DNA 
helicases ahead of the now stalled replication fork continue to unwind DNA, so exposing single 
stranded DNA which when coated with RPA activates ATR signalling. Activation of this checkpoint 
inhibits DNA replication beginning from unfired origins of replication by targeting the cyclin-CDK and 
CDC7-DBF4 kinases responsible for origin firing (Dimitrova & Gilbert 2000; Jares et al. 2000). This allows 
time for the DNA repair machinery to repair the damage and for the stalled fork to restart progression 
following resolution of the damage.  
The intra-S-phase checkpoint is activated by double-strand breaks and unlike the replication 
checkpoints acts independently from active replication forks. This checkpoint appears to have little 
effect upon the extension of active replication forks but is capable of inhibiting firing of unfired 
replication origins by inhibiting the recruitment of replication initiation proteins (Painter & Young 
1980; Merrick et al. 2004; Costanzo et al. 2000; Falck et al. 2002). As in the G1/S and G2/M checkpoints, 
ATM and ATR play a central role, with ATM recognising double strand breaks and ATR recognising those 
breaks that have undergone processing to reveal stretches of single stranded DNA. ATM and ATR signal 
through their downstream effectors to inhibit cell cycle progression through Cdc25a inhibition (Bartek 
& Lukas 2003). 
1.3.7 Spindle Assembly Checkpoint 
The spindle assembly checkpoint differs from the DNA damage responsive checkpoints in how it 
maintains genomic integrity. This checkpoint contributes to ensuring the reliable segregation of 
chromosomes to daughter cells, crucial to ensuring that the correct complement of DNA is inherited 
at each division, preventing daughter cells from having extra or fewer copies of DNA and thus having 
altered genomes. Following S phase a cell has two copies of each chromosome paired together as sister 
chromatids. Condensation of the DNA into highly compacted chromatin during mitosis generates sister 
chromatids physically linked by a multimeric protein ring structure known as cohesin. During 
metaphase these sister chromatids align at the centre of the cell along the metaphase plate due to 
regions of the chromatids called centromeres interacting via structures called kinetochores with the 
mitotic spindle, a microtubule based structure that forms a bipolar structure. Each chromatid in the 
chromatid pairs binds to a spindle fibre emanating from one of the two poles of the cell. Upon the 
transition to anaphase the remaining cohesin binding chromatids together is broken, the sister 
chromatids separate and segregate to the opposite poles of the cell due to the forces generated 
through the action of motor proteins. Cytokinesis of the cell thereby permanently separates the 




However, if this process occurs before all chromatid pairs have attached to the mitotic spindle, those 
left unattached will fail to appropriately separate and segregate, potentially leading to one daughter 
cell having more copies of some chromosomes than the other. The solution to this problem exists in 
the form of the mitotic checkpoint complex (MCC), a complex formed of BubR1, Bub3, Mad2 and 
Cdc20. Assembly of this complex is catalysed by unattached kinetochores ensuring it will remain active 
until all kinetochores have achieved a bipolar attachment to the mitotic spindle. This MCC is capable 
of inhibiting the activation of the anaphase promoting complex (APC/C), an ubiquitin ligase responsible 
for driving degradation of proteins required for completion of mitosis, including securin, the inhibitor 
of separase, the enzyme responsible for cleaving the cohesin ring. Thus the MCC prevents cleavage of 
cohesin and so delays the transition to anaphase until all kinetochores are attached (these and other 
aspects of the SAC are reviewed extensively in Lara-Gonzalez et al. 2012). 
1.3.8 Significance for cancer and disease 
Intuitively the idea of a period of extra time for DNA repair in the form of a cell cycle arrest before 
resuming the cell cycle makes sense as a mechanism to restrain mutation of the genome and so avoid 
the resultant risks of cancer and loss of functional cells. Repairing DNA damage before transitioning 
from G1 to S avoids fixing mutations by replicating damaged DNA, while repairing DNA damage before 
mitosis prevents missegregation of damaged strands during mitosis and daughter cells inheriting 
damaged DNA without having sister chromatids as a template to correct from. The most striking 
evidence supporting their importance comes from patients carrying germline mutations in various 
components of checkpoint signalling, indeed some of these components were discovered due to the 
severe disease that results. One such example is Ataxia Telangiectasia, the syndrome that gives its 
name to ATM (Ataxia Telangiectasia mutated protein) which is characterised by neurodegenerative 
symptoms from a young age and an increased predisposition to developing cancer (Painter & Young 
1980; Hecht & Hecht 1990; Savitsky et al. 1995). Another example is Li-Fraumeni syndrome, a condition 
again resulting in a much greater incidence of cancer, but associated with mutations in p53, an 
important mediator of the checkpoint response (Li & Fraumeni Jr 1969; Kamihara et al. 2014). Clearly 
the checkpoints are of great importance in restraining the development of cancer and other diseases 
as losses of even individual components can produce dramatic phenotypes. Furthermore, the 
importance of checkpoint mechanisms in day-to-day cellular processes is further revealed when one 
considers that ATR, one of the DNA damage recognition kinases, is an essential gene and that knockout 





1.3.9 Checkpoint negligence 
Our understanding of the ability of checkpoints to detect and respond to damage has evolved over 
time. At one point it was thought that both the G1 and the Spindle Assembly Checkpoint (SAC) were 
likely to be stringent enough to reliably catch a single aberration. For the G1/S checkpoint this is based 
on studies involving injecting DNA constructs equivalent to a double strand break, such as linearised 
plasmids, and from estimations of the kinetics of arrest in response to varying doses (Huang et al. 1996; 
Steven P Linke et al. 1997). Destruction of a single remaining unattached kinetochore was shown to 
result in the cell entering anaphase, suggesting the SAC was capable of responding to a single 
unattached kinetochore (Rieder et al. 1995).  
However, further studies for both the G1 checkpoint and SAC have revealed that the checkpoints are 
not so stringent as perhaps thought. Instead they are known under certain circumstances to either not 
trigger a checkpoint response or once one has been triggered to resume cell cycle progression without 
fully resolving the damage. For the purposes of this work, this process will be described as ‘checkpoint 
negligence’, as used in (Löbrich & Jeggo 2007). One study of the response of the G1/S checkpoint to 
DNA damage induced when a cell is in late G1 phase proposes the block on S phase entry takes several 
hours to initiate fully and so late G1 phase fibroblast cells can enter S phase without arresting following 
irradiation. This period of time has been estimated to extend to as much as 4-6 hours after irradiation 
even with high doses of DNA damage (Gadbois & Lehnert 1997; S P Linke et al. 1997; Deckbar et al. 
2010). Similarly, another study indicates that 65% of late G1 primary Mouse Embryonic Fibroblasts 
(MEFS) receiving 5 Gy irradiation can enter S phase and that there may exist a point in the G1 phase  
where cells can no longer respond to the signals that would otherwise initiate a cell cycle arrest (Cann 
& Hicks 2006).  
In terms of actual DNA damage, Artemis -/- fibroblasts (cells defective in repairing a subset of double 
strand breaks) entering S phase early after irradiation were observed to do so with elevated 53BP1 
foci, while wild type fibroblast cells entering S phase early after irradiation in G1 were observed to 
have elevated γH2AX foci. Furthermore, the formation of chromosome breaks in the subsequent G2 
and mitosis of fibroblast cells irradiated in G1 (Deckbar et al. 2010). These results would suggest that 
even if the G1/S checkpoint can be responsive to single breaks, the ability to initiate and maintain an 
effective cell cycle arrest until the damage is resolved is lost before the end of the phase. 
Similarly, for the SAC experimental manipulation of chromosome attachment to the spindle suggests 
that cells can still enter anaphase even in the presence of a failed alignment. In one example over 30% 
of HeLa cells entered anaphase following laser detachment of one chromosome from the metaphase 




onset of anaphase in which the APC/C is no longer responsive to unattached chromosomes (Dick & 
Gerlich 2013). 
The fidelity and behaviour of the G2/M checkpoint has been characterised by a number of observations 
as being relatively negligent regarding the residual number of double strand breaks left when the 
transition to mitosis takes place. In yeast cells a G2 arrest with an irreparable double strand break can 
eventually undergo a process sometimes termed 'checkpoint adaptation' whereby the cell cycle 
undergoes recovery from the arrest and so continues despite the presence of apparently unresolved 
DNA damage (Syljuåsen 2007), interestingly a similar phenomenon appears to occur in mammalian 
cells. Artemis deficient human fibroblast cells are defective in the repair of a subset of double strand 
breaks, and so they have a number of breaks that persist longer than in wild type cells. Nonetheless 
these cells were observed to enter mitosis following a G2 arrest when a predicted 9-12 double strand 
breaks would be present. Assessing chromosomal aberrations in the cells entering mitosis in both 
Artemis deficient and wild type fibroblast cells revealed that for both cell types chromosome breaks 
were present at a rate significantly greater than in undamaged cells. The observation that DNA 
damaged Artemis cells take longer than wild type cells to enter mitosis but do so with similar number 
of γH2AX foci suggested that a threshold of double strand breaks may exist which determines when 
cells can enter mitosis. Assessing premature chromosome condensation breaks in cells that entered 
mitosis provided further evidence suggesting the existence of such a threshold, premature 
chromosome condensation breaks have been associated with 3-6 double strand breaks thereby giving 
an estimate of approximately 10-20 breaks. Furthermore, counting of γH2AX foci in various cell types 
at the entry into mitosis also suggests around 20 breaks per cell. These varying estimates give slightly 
different but comparable thresholds. (These findings are detailed in Deckbar et al. 2007) 
Similarly demonstrating checkpoint negligence, but suggesting a different mode of regulation, a recent 
study from our laboratory  proposed another model to explain the behaviour of the G2 checkpoint 
regarding unrepaired DNA damage (Liang et al. 2014). Utilizing a FRET reporter for Plk1 activity, U2OS 
(a human osteosarcoma cell line) cells were seen to accumulate Plk1 activity as they progress towards 
mitosis, eventually reaching a threshold of activity that results in entry into mitosis. Examining the cells 
damaged during their G2 phase which went on to enter mitosis revealed that Plk1 activity continued 
to increase following DNA damage, but at a slower rate than in undamaged cells. In this model 
therefore it is not the amount of DNA damage that is most important, rather it is Plk1 activity relative 
to a threshold sufficient for mitotic entry. Supporting this were the observations that cells with higher 
Plk1 activity at the time of damage tended to enter mitosis earlier than those with lower Plk1 activity 
and that these cells had higher levels of residual DNA damage, suggesting that in this case the 
checkpoint was not operating with a defined DNA damage threshold. Instead cells were moving 




time of damage these cells were already more predisposed to mitotic entry. As these observations 
were based upon those cells that eventually entered mitosis within the experimental timeframe there 
remain open questions over whether longer G2 arrests might be regulated more directly by the level 
of DNA damage remaining and/or whether Plk1 activity can decline or remain static rather than always 
increasing. 
These examples demonstrate that checkpoints are clearly capable of varying degrees of negligence, 
albeit manifesting in different and only partly understood ways, despite the established importance of 
checkpoints in maintaining genome stability. In the case of a single celled organism such as yeast this 
is understandable, faced with damage still unresolved after many hours the cell may as well attempt 
to continue proliferation rather than arrest indefinitely. In the case of multicellular organisms however, 
the risk of re-entering the cell cycle with unresolved damage is that the damage will ultimately be 
resolved in a deleterious manner that compromises the cell. This may be as serious as a cell newly set 
upon the path to unrestrained proliferation. That multicellular organisms apparently tolerate this 
rather than reliably activating senescence or cell death programmes of behaviour is a curiosity. How 
we reconcile the observed checkpoint negligence with the apparently low risk of any individual DNA 
damaged cell acquiring sufficient mutations to lead to cancer is an open question. 
1.3.10 The response of subsequent checkpoints 
If checkpoints have been established as negligent then this raises the question of what happens to the 
damage in subsequent phases of the cell cycle and how the cell cycle checkpoint mechanisms respond 
to it. Perhaps DNA damage tolerated by negligent checkpoints has little consequence as DNA repair 
mechanisms can fix it in later cell cycle phases. However, if subsequent checkpoints are similarly 
negligent then DNA damage could potentially persist indefinitely which would be expected to 
eventually lead to one or more of the consequences outlined previously in 1.2.3. Another possibility is 
that either DNA damage passing through checkpoints is marked in some way or that DNA damage in 
previous phases changes the cell context by some mechanism, for example changes in the proteome. 
This could create an effective ‘memory’ of having previously experienced DNA damage such that 
checkpoint responses are altered in how they respond to the inherited DNA damage. Such mechanisms 
could conceivably compensate for previous negligent behaviour.  
There are not yet definitive answers to whether any of these speculations are accurate, but there have 
been several observations of checkpoint responses in both subsequent cell cycle phases and in 
descendant cells indicating that transmission of DNA damage between cell cycle phases is likely to be 
a significant biological phenomenon. 
In one study NHF3 and RPE-h cells irradiated in G1 which progressed into the first S phase were 




observed in p53 null cells that were insensitive to arrest at the initial G1 (Steven P Linke et al. 1997). 
Similarly, in wild type and Artemis -/- fibroblast cells irradiated during G2 that pass through the G2/M 
checkpoint and mitosis it was found there were fewer subsequent G2-M phase cells (in the next cell 
cycle) than unirradiated controls, interpreted as daughter cells having potentially undergone 
prolonged G1-S arrest (Deckbar et al. 2010). 
In another study it was observed that human RPE cells treated transiently with nocodazole, a 
microtubule depolymerising agent, were capable of completion of mitosis but their daughter cells 
experience a p38 and p53 dependent G1 arrest if prometaphase took over 1.5 hours. Interestingly, if 
the activity of p38 in the G1 arrested daughter cells is abolished by a small molecule inhibitor (SB 
203580), the G1 arrest is abrogated, cells continue the cell cycle and divide. The resultant cells 
themselves then, in the absence of the inhibitor, arrest again in G1. These cells are the granddaughters 
of those cells that were initially treated with nocodazole, suggesting a persistence of the signal to arrest 
through the generations even when the intervening generation had experienced a cell cycle and 
mitosis of apparently normal duration (Uetake & Sluder 2010). 
Similarly, endogenous replication stress can also cause consequences in daughter cells; for instance, 
53BP1 foci containing daughter cells, a marker of unresolved replication errors from the mother cell, 
were found to enter a transient quiescent state, as determined by a Cdk2 activity sensor, for a duration 
correlated to the extent of the damage. (Arora et al. 2017) 
Therefore, it is becoming apparent that while checkpoints demonstrate a degree of negligence in 
response to DNA errors, there may be responses by subsequent checkpoints to unresolved damage. 
Cross-checkpoint cooperation could conceivably compensate for the negligence of earlier checkpoints 
allowing for DNA damage to be reassessed, further repair to be undertaken or cell cycle exit via 
senescence or apoptosis to be triggered. 
1.3.11 Differential checkpoint activation 
Different lesions signal through different components of the checkpoint signalling apparatus but it has 
also become apparent that the genomic context of a lesion is also important in determining the 
signalling and resultant cell fate. Telomeres are the end regions of linear chromosomes and therefore 
represent a break in the DNA strand and inappropriately carrying out DNA repair processes on such 
ends can trigger massive changes in chromosomal organisation (Artandi et al. 2000). These ends are 
therefore typically protected by the formation of a T-loop whereby the end of the DNA inserts into a 
region upstream and by the binding of a protein complex called shelterin which inhibits the DNA repair 
machinery attempting to process the ends of the chromosomes (Griffith et al. 1999; De Lange 2010). 
Deprotection of these telomere ends by partial loss of TRF2, a component of shelterin, was shown to 




phosphorylation on residue S1981 indicating ATM activity. However, no activating Chk2 T68 
phosphorylation was observed and no G2/M arrest could be inferred from changes in the cell cycle 
profile of populations of cells experiencing telomere deprotection. Instead cells were observed to pass 
through to G1 and subsequently arrest there via a p53-mediated G1 arrest and thereafter permit 
senescence to develop (Cesare et al. 2013). The rationale for this may be that as telomere erosion 
occurs during replication any resultant deprotected telomeres will be present during G2. If these were 
to trigger the typical DDR the cell would arrest and attempt to repair what is not actually a genomic 
break, possibly resulting in fusion of separate chromosomes. The resultant mutant cells could then 
enter mitosis, risk further mutation via breaking of fused chromosomes, and then risk continued 
proliferation. Instead, by avoiding the typical DDR in G2 a stable senescence response can be 
undertaken in the resultant diploid G1 daughter cells withdrawing them permanently from the cell 
cycle. In this instance, and perhaps in other as yet undiscovered cases by other mechanisms, genomic 
context influences checkpoint behaviour and ultimately cell fate determination. 
1.3.12 Permanent exit from the cell cycle 
Activation of the checkpoint arrest allows time for DNA repair by arresting progression of the cell cycle, 
but in certain circumstances, for example severe levels of DNA damage, it may no longer be capable 
of accurate repair. In this case there are three options, continue with the cell cycle regardless, activate 
a programmed cell death mechanism such as apoptosis, or enter a state of senescence (Norbury & 
Zhivotovsky 2004; d’Adda di Fagagna 2008). The negligence of checkpoints described above clearly 
indicates the first option is possible, albeit problematic considering the consequences of un/mis-
repaired DNA damage. The latter two however provide mechanisms to permanently restrain aberrant 
cells from proliferating and thus risking cancer development. Additionally, these mechanisms are 
known to be triggered by other stimuli, for example the activation of oncogenes, also helping restrain 
the proliferation of aberrant cells. 
1.3.13 Programmed cell death - Apoptosis 
Prolonged cell cycle arrest allows for numerous pathways promoting cell death to be upregulated. One 
of the most well studied forms of programmed cell death is apoptosis, a non-inflammatory process 
resulting in orderly destruction of the cell which can be activated by both an intrinsic and extrinsic 
pathway (Figure 5) (Reviewed extensively in Nowsheen & Yang 2012). The intrinsic pathway refers to 
activation of apoptosis by pro-apoptotic Bcl-2 family proteins triggering mitochondrial 
permeabilisation. This leads to the release of cytochrome c, which activates APAF-1 leading to the 
formation of the apoptosome which activates caspase 9 by cleavage, caspase 9 then activates 
downstream effector caspases such as caspase 3 and 7 which themselves lead on to activation of 




nuclear genome. The extrinsic pathway in contrast is activated by signalling through external cell 
receptors called Death receptors. One such receptor is FAS, which is bound by the Fas ligand leading 
to activation of caspase 8 which in turn activates caspases 3 and 7 much like the intrinsic pathway. 
These pathways are not mutually exclusive as the extrinsic can trigger the intrinsic pathway via 
cleavage of BID to tBID, a pro-apoptotic BH3 family protein. A number of signalling pathways are 
known to activate apoptosis following DNA damage, some of which are described here. 
One of the most important signalling nodes is the ‘guardian of the genome’ p53. p53 is post-
translationally modified and expressed at high levels following DNA damage due to the influence of 
upstream DDR components. Depending on its abundance, dynamics and modification status, p53 
influences numerous processes including cell cycle arrest, DNA repair, senescence and indeed 
apoptosis by several means (Vogelstein et al. 2000). p53-dependent transactivation of pro-apoptotic 
Bcl-2 family proteins BID, BAD, PUMA and NOXA promotes permeabilisation of the mitochondrial 
membrane triggering apoptosis via the intrinsic pathway (Oda 2000; Nakano et al. 2001; Sax et al. 
2002; Jiang et al. 2006). Additionally, p53 also upregulates FAS, a cell surface receptor for the Fas ligand 
capable of activating the extrinsic pathway to apoptosis, thus predisposing the cell to apoptosis when 
Fas ligand is also present (Owen-Schaub et al. 1995). p53 is also capable of activating apoptosis through 
other means than its role as a transcription factor, p53 directly activates apoptosis through interactions 
at the mitochondrial membrane via the pro-apoptotic proteins BAK and BAX (Marchenko et al. 2000; 
Chipuk 2004; Leu et al. 2004).  
Several p53-independent mechanisms also exist, explaining apoptotic cell death following DNA 
damage in cells lacking wild type p53 function. Chk2, once activated by ATM, phosphorylates E2F-1 
shifting its specificity for transcriptional upregulation to selected targets, including p73, a homolog of 
p53 also capable of promoting apoptosis (Nahle et al. 2002; Stevens et al. 2003; Pediconi et al. 2003). 
Rad9, a component of the Rad9-Hus1-Rad1 (9-1-1) complex involved in DNA damage recognition has 
been shown to interact with anti-apoptotic Bcl-2 and Bcl-XL and is reported to induce apoptosis when 
overexpressed, suggesting it may be able to antagonise anti-apoptotic members of the Bcl-2 family 
(Komatsu et al. 2000). Nur77, a nuclear receptor, is induced by DNA damage and has been implicated 
in the activation of the intrinsic pathway of apoptosis possibly by translocation to the cytosol (Li et al. 
2000; Wilson et al. 2003). Procaspase 2, the inactive form of caspase 2 resident in the nucleus, is 
activated following DNA damage where it then activates the intrinsic pathway of apoptosis by 







Figure 5 The intrinsic and extrinsic activation pathways in apoptosis 




An important consideration is that cells differ in their likelihood to engage cell death mechanisms 
following DNA damage (Liu et al. 2014). The characteristic symptoms of radiation sickness and DNA-
damaging chemotherapeutics used to treat cancer comes from the death of many of the cells that 
actively divide to maintain tissues such as in hair follicles and the intestinal lining (Yu 2006; Blanpain 
et al. 2011). In contrast, there is evidence that terminally differentiated cells can be less sensitive 
(Latella et al. 2004; Schneider et al. 2012). This behaviour suggests that cell fate decisions at the DNA 
damage checkpoint are weighted choices between survival and death: some cells are more at risk of 
causing cancer than others and so these may preferentially die while less at risk cells are instead more 
tolerant of DNA damage and survive to prevent unnecessary challenges to the maintenance of tissue 
homeostasis. 
1.3.14 Senescence 
Senescence in contrast to apoptosis leaves the cell alive but in a distinctive state of permanent cell 
cycle arrest mediated by p16 and p21 which potently inhibit Cyclin-Cdk4/6 and Cyclin-Cdk2, so 
preventing all the steps necessary to commit to cycling at restriction and enter S phase. Senescent cells 
adopt a different morphology becoming much larger and flatter, exhibit persistent DNA damage foci 
known as Senescence-Associated Heterochromatin Foci (SAHF), and exhibit a characteristic 
Senescence-Associated Secretory Phenotype (SASP) featuring the upregulated production and 
secretion of interleukins, chemokines, growth factors and other inflammatory factors (extensively 
reviewed in Campisi & d’Adda di Fagagna 2007). Senescence can be triggered by several stimuli 
including DNA damage, replication stress following erosion of telomeres, and the activation of 
oncogenes, it has also been implicated in normal development (Muñoz-Espín et al. 2013), acting to 
shape development of organs and tissues in a similar way to apoptosis, and in wound repair, where 
senescent cell ablation leads to greater fibrosis and scarring (Krizhanovsky et al. 2008; Jun & Lau 2010; 
Demaria et al. 2014). It is known to be possible to enter the state of senescence from both G1 and G2 
following DNA damage and in the latter case this can involve a ‘skipping’ of mitosis resulting in the 
formation of tetraploid senescent cells (Johmura et al. 2014). 
In the context of DNA damage senescence therefore is an alternative way of achieving the same end 
as cell death in the sense of removing the risk of mutated cells proliferating. However, it is becoming 
clear that other attributes of senescence are also of great relevance to cancer. In contrast to cells 
undertaking apoptosis, generation of the SASP by senescent cells results in inflammatory paracrine 
signalling, which has been characterised as being capable of both promoting and preventing the 
development of tumours. A number of observed effects on cell proliferation, invasion, migration, 
metastasis and immune infiltration show pro-tumourigenic effects (reviewed extensively in Coppe et 
al. 2010) while evidence that the SASP can hinder tumour development comes in the form of 




Acosta et al. 2008; Kuilman et al. 2008; Wajapeyee et al. 2008), induce senescence in neighbouring 
(and thus possibly cancerous) cells through a senescence ‘bystander’ effect (Acosta et al. 2013), and 
attract immune cells to clear cancerous cells (Xue et al. 2007; Kang et al. 2011). 
1.3.15 Apoptosis vs senescence 
Whether a cell undertakes apoptosis or senescence following DNA damage involves decision making 
processes within the cell that are not completely understood, although, there are some clues to how 
this decision is made. Different cell types are known to have different sensitivities to senescing; it has 
been reported that human fibroblasts senesce upon 50 Gy of radiation, while T lymphocytes senesce 
following only 2 Gy (Childs et al. 2014). Intensity of damage appears to play a role too as MCF7 breast 
cancer cell lines senesce when treated with relatively low doses of doxorubicin but apoptose following 
high doses (Song et al. 2005). Human fibroblasts show the same trend of senescence vs apoptosis 
depending on intensity of dose when treated with UVB irradiation (Debacq-Chainiaux 2005). The type 
of damage also plays a role as WI38 fibroblasts receiving busulfan treatment, which produces bulky 
DNA adducts,  senesce and do not apoptose at all tested dose intensities (Probin et al. 2006). 
Mechanistically, control between temporary cell cycle arrest, apoptosis and senescence is in part 
regulated through p53 signalling (Kirschner et al. 2015). p53, as discussed above, is a transcription 
factor known to control the expression of many sets of genes involved in various processes. Regulation 
of which sets of genes are upregulated is extremely complex but is known to depend on which post-
translational modifications are present on p53 molecules, the levels of p53, and the kinetics and 
dynamics of p53 activation. Examples of these include: 
 Loss of acetylation on K117 shifts cell fates to apoptosis as PUMA and NOXA are no longer 
upregulated, while additionally loss of acetylation on K161 and K162 results in loss of cell cycle 
arrest and senescence (Li et al. 2012). 
 Upon treatment with H2O2 human diploid fibroblasts that go on to apoptose have around 
twice the levels of p53 as those that senesce (Chen et al. 2000). 
 Transient pulsatile activation of p53 results in cell cycle arrest and eventual recovery while 
sustained p53 stabilisation results in senescence. (Purvis et al. 2012)  
The p53 target p21 plays a significant role in influencing the senescence vs apoptosis decision. p21 is 
involved in facilitating cell cycle arrests in the initial response to DNA damage but also functions to 
generate the permanent state of cell cycle arrest manifested in senescence. Studies have suggested 
there may be an inverse relationship between p21 and apoptosis whereby high p21 suppresses 
apoptosis and low p21 is permissive for apoptosis (Gartel & Tyner 2002). Knockdown of the p21 




switch the cells from apoptotic cell fates to senescence instead (Zhang et al. 2011), similarly caspase 3 
inhibition switched neuroblastoma cells from apoptosing to senescing (Rebbaa et al. 2003). 
The level of mediators of apoptosis in the cell are also known to have a role in influencing which of the 
terminal cell fates is adopted. Overexpression of anti-apoptotic Bcl-2 can switch irradiated fibroblasts 
from favouring apoptosis to favouring senescence (Yang et al. 1997), while knockdown of anti-
apoptotic Bcl-XL can switch the typical fate of irinotecan-treated colon cancer cells from senescence 
to apoptosis (Hayward et al. 2003). 
Clearly the many ways in which p53 activity can be modulated and how susceptibility to apoptosis 
depends in part upon the abundance of mediators indicates that whether apoptosis or senescence is 
favoured by a cell type depends on the proteome. 
What exactly the evolutionary rationale might be for some cells favouring apoptosis over senescence 
and vice versa following DNA damage is unclear but it may be related to whether the relatively cell-
autonomous mechanism of apoptosis is sufficient to prevent tumour development or whether the 
communication with adjacent cells and the engagement of the immune system that the SASP allows is 
beneficial within the tissue that the cell normally resides (Childs et al. 2014). 
1.4 The analysis of cell cycle dynamics and cell fate 
In the past decade several studies have advanced the tools and experimental approaches to facilitate 
greater analysis of cell cycle dynamics and understanding of the significance of these for cell fates. 
Several examples of these and how they have advanced understanding of the cell cycle are discussed 
below. 
1.4.1 Cell cycle phase determination with the FUCCI system 
Progression through the cell cycle can be visualised with a well-established set of fluorescent reporters 
known as the Fluorescent Ubiquitination-based Cell Cycle Indicator (FUCCI). These genetically encoded 
reporter proteins are formed from the fusion of fluorescent proteins (proteins that generate a 
fluorophore capable of emitting light following excitation with light of a higher frequency) with the 
sequences responsible for ubiquitination mediated degradation of the endogenous hCdt1 and 
hGeminin proteins within the cell. During the cell cycle the APCCdh1 and SCFSkp2 E3 ligase complexes tag 
proteins for degradation with ubiquitin. The activities of these two ligases alternate throughout the 
cell cycle with APCCdh1 activity present during mitosis and G1, while SCFSkp2 is active during S and G2. 
Certain proteins are targeted by these ligases for degradation which allows for cell cycle regulation of 
protein abundance. Cdt1 and Geminin are two such proteins, Cdt1 is targeted for destruction in S and 
G2 while Geminin is degraded in S and G2. Regions of the proteins identified as responsible for the cell 




to fluorescent proteins. Importantly, these minimal degradation sequences were also found to not 
alter the cell cycle so allowing for the generation of sensors that would not directly perturb the cell 
cycle. The original publication used monomeric Kusabira Orange 2 (mKO2) tagged hCdt1 (mKO2-
hCdt(aa30-120)) and monomeric Azami Green (mAG) tagged hGeminin (mAG-hGeminin(aa1-110)), 
while subsequently an mCherry tagged hCdt1 was also developed (Table 2). 
Name: Biological Origin Excitation (nm) Emission (nm) Reference: 
mAG Galaxeidae 492 505 (Karasawa et al. 2003) 
mKO2 Fungia concinna 551 565 (Sakaue-Sawano et al. 2008) 
mCherry Discosoma 587 610 (Shaner et al. 2004) 
This produced sensors that allow the identification of which cell cycle phase a cell is in, G1 cells are 
fluorescently red (mKO2 or mCherry), S and G2 phase cells are green (mAG), mitotic cells show little to 
no fluorescence and cells transitioning from G1 to S phase exhibit both red and green fluorescence 
(Sakaue-Sawano et al. 2008) (Figure 6A and B). Furthermore, monitoring the fluorescence in time-lapse 
microscopy allows determination of the duration of G1 and the combined S&G2 phases of the cell cycle 
(Figure 6C). This ability has been utilised in a great many studies where cell cycle dynamics are of 
interest and in the context of DNA damage allows identification of cell cycle arrests following DNA 
damage. This has been demonstrated in studies assessing the response of HeLa cells to UV and X-ray 
irradiation which found the FUCCI system to be capable of identifying the known HeLa deficiency in G1 
arrest, observed that UV irradiation resulted in differential survival depending on the phase of the cell 
cycle in which they were treated, and observed that cells arresting for longer following X-ray radiation 
appeared to have daughter cells that also demonstrated longer cell cycles suggesting some inherited 
DNA damage response (K Kaminaga et al., 2015; Kiichi Kaminaga, Kanari, Narita, & Noguchi, 2014; 
Miwa et al., 2015; Narita et al., 2015). Another example has been the use of the FUCCI system to 
investigate cell cycle checkpoints in three-dimensional spheroid cultures of Capan-2 cells treated with 
etoposide. This allowed the cell cycle dynamics within a three-dimensional structure to be assessed, 
revealing a proliferation gradient whereby cells in the outermost layer proliferate the most while those 
in the centre proliferate by much less, indeed likely entering a state of quiescence. Etoposide 
treatment indicated that etoposide treatment was able to induce phospho-H2AX throughout the 
spheroid and a G2/M checkpoint arrest was evident by the increase in abundance of S/G2 FUCCI probe 
positive cells relative to the G1 FUCCI probe positive cells (Laurent et al. 2013).  






1.4.2 Microscopy-based lineage tracing 
Time-lapse microscopy also permits lineage tracing whereby familial relationships between cells can 
be identified, and thereby correlations be made. Two examples of studies employing these methods 
are discussed below in order to exemplify how their work inspired and informed the approaches taken 
in this work. 
Figure 6: The FUCCI system 
A) The FUCCI probes are formed from the fusion of a fluorescent protein with the sequences responsible for cell cycle 
dependent degradation. hCdt1(aa30-120) and hGeminin (aa1-110) confer G1 and S&G2 specificity of the fluorescent probes 
respectively. Fluorescent protein diagrams kindly provided by Dr Alessandro Esposito. 
B) As cells progress through the cell cycle their nuclei will fluoresce different combinations of colours. Red/orange in G1, yellow 
as the two probes overlap during the transition into S phase and green during  the remainder of S phase and G2. During mitosis 
all FUCCI fluorescence is lost. 
C) Example traces of nuclear fluorescence measured throughout a cell’s lifetime and the start of a daughter cell’s. At birth 
fluorescence is low but cells accumulate red fluorescence quickly. As the cells transitions into S phase the G1 probe begins to 





One recent study taking this approach with 
L1210 human lymphoblast cells expressing 
the two FUCCI probes allowed the cell cycle 
dynamics of three generations of cells (Figure 
7) to be analysed and compared (Sandler et 
al. 2015). From this data total cell cycle (Ttot), 
G1 (TG1) and combined S, G2 and M (TG2) 
lengths could be obtained on a single cell 
basis and compared to their relatives. All 
three measures of length were found to correlate highly and statistically significantly between sister 
cells (correlation coefficients ρ = 0.71 ± 0.007 P < 0.002) while mother-daughter correlations were close 
to zero and not statistically significant. Initially these results suggested an inherited factor at birth that 
siblings inherit together that determines at least partially the length of the cell cycle and the 
subsequent cell cycle phases. As mothers and daughters do not correlate this factor might be reset at 
each division leading to the lack of correlation observed. However, somewhat surprisingly, cousin cells 
were found to correlate significantly as well (ρ = 0.58 ± 0.07 P < 0.002) casting doubt on this initial 
interpretation. If the inherited factor were reset at each division then this cannot explain the 
correlation of cousins, which are related via mother-daughter relationships. This type of data could 
then be analysed with the Grassberger-Procaccia algorithm to indicate that deterministic processes 
were likely to underlie the cell cycle lengths observed, allowing the authors to develop a model of cell 
cycle behaviour that could better explain their observations than a previously published model (R. & 
R. 1986). This ‘kicked cell cycle’ model proposed a cellular oscillator that determines the duration of 
the cell cycle depending on what phase it is in. Siblings inherit the same phase of the oscillator and 
thus their cell cycle lengths correlate well together. Mothers and daughters by contrast inherit phases 
of the oscillator which may be similar or very dissimilar and so do not correlate well. This could also 
explain the cousin correlations, sisters born with the same phase of the oscillator have cell cycle 
durations of similar length, thus when they themselves divide, forming a series of cousins, these 
cousins are also likely to inherit similar phases of the oscillator and thus have cell cycles that will 
correlate together. This demonstrates that assessment of cell cycle dynamics with the FUCCI system 
combined with lineage information was capable of providing insights into cell behaviour via 
mathematical modelling. 
As this study concerned only unperturbed cells, taking similar approaches to cells that have 
experienced DNA damage and their descendants might yield further insights. Indeed, one recent 
publication, briefly mentioned above (Arora et al. 2017), has identified endogenous replication stress 
in the mother cell’s S phase as a cause of a period of entry into a quiescent G0 phase in the daughter 





cells. Tracking of unperturbed dividing MCF10A cells showed that a subset of around 20-30% of the 
resultant daughter cells entered a state of low Cdk2 activity, as reported by a fluorescent sensor, 
distinct from senescence and appearing to be quiescence due to the extension of time spent in G1. 
Analysing these cells for the presence of DNA lesions and for the status of the cell cycle regulators and 
DDR components Rb, p21 and 53BP1 revealed that much of the adoption of quiescence in daughter 
cells could be linked to spontaneous or experimentally induced damage occurring in S phase, as 
marked by 53BP1 foci, leading to hypophosphorylation of Rb and elevated levels of p21.  Importantly 
however, it was also clear that 53BP1 foci status was not the sole determinant of hypophosphorylated 
Rb in daughter cells, as 43-66% of cells, depending on cell lines, with hypophophorylated Rb did not 
have detectable 53BP1 foci. Thus a model results wherein the population’s evident non-genetic 
heterogeneity in the adoption of the quiescent phenotype and associated altered signalling can be 
explained in part, but not exclusively, by a deterministic component, namely the inherited replication 
stress damage marked by 53BP1 (Arora et al. 2017). 
The significance of this study was in the identification of an inherited deterministic component 
contributing to the heterogeneity of cell cycle lengths observed in populations and that this inherited 
component appears to be either the DNA damage itself from a previous cell cycle phase in the case of 
53BP1 foci or the possibility of inheriting a particular signalling context to determine cell behaviour in 
the case of upregulated p21 and hypophosphorylated Rb. This exemplifies the importance of previous 
cell cycle phases in determining subsequent behaviour and that the consequences of DNA damage, in 
this case unreplicated regions, can persist and cause consequences in subsequent cell cycles. Critically 
it was longitudinal time-lapse studies of single cells that made these observations apparent. 
These studies suggest an opportunity in combining the FUCCI based cell cycle dynamics lineage tracing 
with DNA damage that is likely to prove fruitful in revealing facets of checkpoint behaviour that operate 
across multiple cell cycle phases and indeed across lineages. 
1.5 Understanding the significance of checkpoint responses in subsequent cell 
cycle phases 
In summary, cell cycle checkpoint mechanisms and the DDR occupy a central role in our conceptual 
models of how cells maintain genomic integrity in the face of DNA damage. Despite this, as we have 
learnt more about them, especially in recent years, it has becoming increasingly apparent that 
checkpoints have been repeatedly observed to allow the passage of genomic lesions to subsequent 
cell cycle phases and even descendant cells. Despite emerging findings concerning how DNA damage 
incurred in a cell can affect the behaviour of descendant cells, as discussed in 1.3.10, the consequences 




Therefore, the goal of this project is to investigate the determination of cell proliferation vs cell cycle 
exit across multiple generations following DNA damage. This area of research is of critical importance 
in developing better models of the role of cell cycle checkpoints in protecting genomic integrity. If a 
single double strand break is as dangerous to genomic integrity or as lethal to the cell as often cited in 
the scientific literature why has the G2 checkpoint been reported to allow an order of magnitude more 
breaks into mitosis, a critical time for the cell and genomic integrity, and thus into the daughter cells 
that result? Furthermore, given the widespread use of DNA damage to drive cell death or senescence 
in cancer therapy, characterisation of whether these cell fates are adopted by the treated cells or their 
descendants may yield insights into improving efficacy. 
To this end, I have developed two main approaches. Firstly, I have utilised microscopy-based lineage 
tracing of cells expressing genetically encoded Fluorescent Ubiquitination-based Cell Cycle Indicator 
(FUCCI) probes with semi-automated image analysis to characterise the response of single cells and 
their descendants to DNA lesions induced by neocarzinostatin treatment across multiple cell cycle 
generations. This approach has allowed me to characterise the timing of cell fate determination, the 
non-genetic heterogeneity in checkpoint responses, correlations between cells, cell cycle timing 
dependent sensitivities to neocarzinostatin treatment and overall lineage behaviour. This approach 
along with several novel analyses have allowed the resultant behaviour to be well described and a 
number of interesting observations to be made. Chiefly amongst which has been the observation of 
abundant descendant cell death in U2OS cells following the induction of DNA damage, indeed the rate 
of death in descendant generations typically exceeds the death rate of the cells that actually received 
the DNA damage. The death of descendant cells, termed ‘delayed death’, subsequently drives the 
extinction of a great proportion of cell lineages, in effect contributing as much as death of treated cells 
to eliminating the proliferation of DNA damaged clones. These results suggest that cell cycle 
checkpoint processes are operating, and possibly co-operating, across multiple cell cycle phases and 
generations. This provides a new paradigm for how checkpoint mechanisms could restrain the 
proliferation of DNA damaged cells by considering the behaviour of lineages instead of simply single 
cells. Further research is merited into how delayed death is triggered in descendant cells and 
determining whether lineages that show delayed cell death but do not exhaust during the 
experimental timespan eventually regain typical proliferative capacity. Furthermore this also raises 
questions about how elimination of cell lineages over multiple generations rather than through the 
death of the initially DNA damaged cell might influence the evolution of tumours treated with DNA 
damage.  
Secondly, I developed a complementary flow cytometry based method to allow indirect tracing of 
generations and estimation of cell fate determination. This approach has allowed me to produce 




characterise the behaviour of further cell lines and will permit the testing of a greater range of 
experimental conditions than are practical via microscopy based means. Furthermore, I have observed 
evidence of the persistent elevated presence of DNA damage in cells following treatment over many 
days, suggesting a possible explanation for the delayed death observed. 
In summary, through single cell based experimental work I have been able to characterise the response 
of cancer cells to DNA damage over multiple generations demonstrating that descendant cells show 
dramatically altered cell fate determination in response to DNA damage received by their ancestor, so 
revealing the importance of considering descendant cell responses. Understanding these responses, 
namely how, why and when cells die, will have implications for therapeutic approaches.  
Microscopy based lineage tracing – cell fate following DNA damage 
31 
 
Microscopy based lineage tracing – cell fate following DNA 
damage 
1.6 The development of a microscopy-based lineage tracing approach 
One approach, as demonstrated by the literature discussed previously in 1.4.2, for understanding how 
DNA damage can have consequences over multiple cell cycle phases and across multiple generations 
of cells is to follow and track cells as they move and divide via the acquisition of time-lapse microscope 
images. Several cell measurements can be made from such an approach, including, for example: the 
duration of its lifetime, so allowing any cell cycle arrests to be inferred; its movement; and its fate, 
namely whether it divides, dies or does neither during the period of observation. Significantly, this 
approach allows the tracing of familial relationships between cells, thereby conveying direct 
information about cell lineages and their component generations of cells, thereby revealing how cells 
behave when an ancestor has experienced DNA damage. The addition of sensors can provide yet 
further cellular information, for example, the FUCCI probes discussed previously allow estimation of 
when the cell transitions from G1 to S phase, granting the ability to infer which cell cycle phase a cell 
is arrested in, thus giving a more precise description of cell lineage behaviour following DNA damage. 
In practical terms however, most mammalian cells in culture are not easy to follow via methods that 
merely illuminate the cell, for example brightfield, phase contrast and differential interference 
contrast microscopy (Figure 8). Furthermore, to follow the numbers of cells required to make 
meaningful biological inferences is extremely laborious. A solution to the former is the use of 
fluorescent probes with fluorescence microscopy allowing cells to be better identified in a microscope 
image. The discovery and development of a great many fluorescent proteins has allowed fluorescent 
species to be genetically encoded in cells and targeted to particular cell locations. The use of nuclear 
localised fluorescent proteins allows the production of images where cells can be identified by the 
presence of discrete fluorescent 
nuclei (Figure 8). This approach 
lends itself to relatively simple 
computer-based image analysis 
whereby these nuclei can be 
discerned from the background 
with a reasonable level of 
accuracy by appropriate 
segmentation algorithms; these 
may then be compared to the 
nuclei identified in previous and 
Figure 8: Identifying cells by microscopy 
Transmitted light microscopy images allow cell morphology to be visualised. 
Identifying individual can be difficult by both eye and computational analysis. 
Nuclear localised fluorescence can be identified via fluorescence microscopy 
allowing discrete nuclei to be identified relatively easily by computational analysis. 
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subsequent images allowing automated cell tracking (Figure 9), thus reducing the laborious nature of 
cell lineage tracing. Segmented cell nuclei also allow the measurement of fluorescent sensors present 
in a cell, for example FRET based sensors.  
 
The FUCCI probes are themselves nuclear localised and also convey information about the progression 
through the cell cycle in the changes in fluorescence intensity over time. This permitted the semi-
automated analysis of hundreds of L1210 lymphoblast cells discussed previously in 1.4.2. Nevertheless, 
it has also been reported that the loss of FUCCI probe fluorescence during mitosis can present difficulty 
in the continuous tracking of cells and identification of the daughter cells generated by a mitosis. One 
solution to this problem was the substitution of the S&G2 probe mAG-hGem(aa1-110) with a 
chromatin, and thus nuclear, localised H2B-eGFP fusion construct producing the ‘CycleTrak’ system 
whereby the fluorescence of the G1 probe was used to determine the timing of the G1/S transition 
and the H2B-eGFP allowed continuous tracking even through mitosis (Ridenour et al. 2012). 
Clearly the use of a fluorescence nuclear marker facilitates continuous cell tracking and thus total cell 
cycle length calculation. Furthermore, a nuclear marker spectrally compatible with co-expression of 
both FUCCI probes would also permit the use of both probes to identify the timing of transitions 
between cell cycle phases and correct for the difficulty in cell tracking during mitosis and early G1 when 
the fluorescence of the FUCCI probes is absent or low (Figure 10). 
Figure 9: Tracking cells via segmented nuclei 
Nuclei identified by fluorescence microscopy can be used as a proxy for the location of cells. Comparison of nuclei identified in 
multiple time points (t) allows the movement of nuclei, and thus cells, to be tracked over time. 
 





1.6.1 Design of a genetically encoded fluorescent nuclear marker 
The emission spectra of the two FUCCI probes mAG-hGem(aa1-110) and mCherry-hCdt1(aa30-120) 
cover a large region of the visible spectrum (Figure 11) leaving the violet, blue, and near-infrared 
regions of the spectrum available for a third fluorescent component. The use of shorter wavelength 
light to excite fluorescent species presents a greater risk of phototoxicity during imaging and therefore 
the use of a far-red fluorescent nuclear marker would be preferable. Similarly to the FUCCI probes, the 
use of genetically encoded fluorescent proteins would also allow for the creation of stable cell lines 
and avoid the use of dyes that often cannot be used for extended periods of time without toxic side 
effects. Several near-infrared fluorescent proteins have been discovered and developed, of which 
iRFP682 was selected for use on the basis of spectral compatibility with the FUCCI probes and 
microscopy, and sufficient brightness when expressed in mammalian cells (Shcherbakova & Verkhusha 
2013). 
Expression of this protein alone will however result in fluorescence throughout the cell, rendering 
adjacent cells difficult to discern. In order to confer nuclear localisation appropriate amino acid 
sequences need to be added. In the CycleTrak example (Ridenour et al. 2012) this was achieved by 
fusion of eGFP to H2B sequences which results in the incorporation of the eGFP into the nucleosomes 
around which DNA is wrapped to form chromatin. Such an approach results in a fluorescent nucleus 
during interphase when chromatin is uncondensed and visualisation of the condensed chromatin 
structures during mitosis. An alternative approach is to tag proteins with a nuclear localisation signal 
(NLS) to drive nuclear import of the protein. During interphase this also results in a fluorescent nucleus, 
while during mitosis nuclear envelope breakdown will release the fluorescent protein throughout the 
rounded-up cell. 
Figure 10: Idealised representation of FUCCI and nuclear marker fluorescence across cell cycle 
The FUCCI components vary in nuclear intensity throughout the cell cycle causing red→yellow→green transitions and are 
typically absent during mitosis and immediately after division (represented as grey). The consistently expressed nuclear 
marker allows automated cell segmentation and tracking. 
 





As different NLS sequences and NLS combinations can result in varying degrees of nuclear to 
cytoplasmic contrast several variant NLS fusions to iRFP682 were tested to determine the optimum for 
image analysis. Microscopic analysis (Figure 12) indicated the best contrast was achieved by tagging 
iRFP682 N-terminally with an NLS from the Large T antigen of Simian virus 40 (amino acid sequence 
PKKKRKV) and C-terminally with the human myc NLS (amino acid PAAKRVKLD) hereafter referred to as 
NLS-iRFP682, had the best nuclear to cytoplasm fluorescence contrast. A single NLS alone was 
sufficient to drive nuclear import but with a reduced contrast between the nucleus and cytoplasm, 
while three tandem N-terminal NLS sequences in addition to a C-terminal NLS resulted in very high 
nuclear import but also caused the appearance of large nuclear foci, possibly indicating this construct 
tends to localise to the nucleoli. 
1.6.2 Construction and validation of stable cell lines for lineage tracing 
Monoclonal U2OS cells stably expressing mCherry-hCdt1(aa30-120), mAG-hGem(aa1-110) and NLS-
iRFP682 were produced by transfection with a dual promoter plasmid (pBudCE4.1) containing the two 
Figure 11: Fluorescence excitation and emission electromagnetic spectra 
Three fluorescent markers, mAG-hGeminin (1-110) (S&G2 probe), mCherry-hCdt1(30-120) (G1 probe) and NLS-iRFP682-NLS 
(nuclear marker) can be used simultaneously due to the separation of their excitation and emission peaks across the 
electromagnetic spectrum. 
 
Figure 12: Comparison of nuclear-cytoplasm contrast of variant NLS tagged iRFP682 constructs 
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FUCCI probes and with a plasmid (pcDNA3.1(-)) containing the iRFP nuclear marker (see materials and 
methods). U2OS cells are a bone osteosarcoma derived cell line amenable to genetic manipulation, 
microscopy imaging and have been previously used in the group to study the role of Plk1 signalling in 
recovery from the G2/M checkpoint (Liang et al. 2014 discussed previously). Expression of the tripartite 
nuclear marker and FUCCI system, hereafter FUCCI-NM, resulted in the expected measurable changes 
in the fluorescence intensities of the FUCCI probes as cells pass through the cell cycle (Figure 13). 
1.6.3 Development of an analysis workflow 
Time-lapse cell microscopy involves the acquisition of images of cells in the relevant experimental 
conditions at regular time intervals. At each time point, imaging of the FUCCI-NM cells requires 
acquisition of multiple image channels, a brightfield channel to indicate cell morphology and a 
fluorescence channel for each of the three fluorescent proteins expressed. Ultimately a series of image 
files are produced from which the appropriate data series must be extracted. 
In lineage tracing, cells must be identified within each image, accurately tracked through time, and the 
relevant measurements and observations made to produce the final data series. This was achieved for 
FUCCI-NM time-lapse series via a semi-automated workflow (Figure 14). Firstly, cell nuclei were 
identified automatically in each image by segmentation algorithms using the nuclear-localised 
fluorescence (nuclear segmentation). Nuclei were then tracked automatically from one timepoint to 
the next by comparing the distances between the nuclei identified in one frame to another. The regions 
identified as nuclei were then used to measure the fluorescence intensity of the FUCCI probes for each 
cell through time. Inevitably the automatic segmentation and tracking introduces occasional major 
errors where cell nuclei are temporarily lost or misidentified necessitating a process of manual 
validation and correction of the cell traces. Additionally, the time of cell death and division was curated 
manually as was the assignment of daughter cells to the mother following cell division. Finally, 
validated cell traces were used to estimate the G1/S transition time by observing where the average 
fluorescence intensity of the G1 FUCCI probe began to decline. This allows the duration of G1 and the 
duration of the combined S phase, G2 phase and mitosis, hereafter SG2M, to be calculated. An example 
of a lineage constructed with G1 and S&G2 and mitosis assignments is given in (Figure 15). 
  















































































































































































































































Figure 14: Analytical workflow for analysis of microscopy based lineage tracing 
 Nuclei were identified by automated image segmentation. 
 Identified nuclei were automatically tracked through time based on distances between nuclei centroids. 
 Fluorescence was automatically measured for each identified nucleus allowing the changes in FUCCI probe 
fluorescence to be determined. 
 Automatically identified cell traces were validated by manual assessment and the timing of division and death 
assigned based on the cellular morphology. 
 Validated cell traces were used to determine the approximate timing of G1/S transition. 
 Fluorescence traces from related cells were collated together as lineages allowing further analyses. 




1.7 Initial characterisation of lineage and fate tracing using the FUCCI-NM system 
As discussed previously, there are a great range of possible DNA lesions to which cell cycle checkpoints 
are responsive. In terms of the responses of checkpoints DNA strand breaks are amongst the best 
studied and were used to investigate the checkpoint response in U2OS cells previously (Liang et al. 
2014). Of the many agents capable of inducing DNA damage, neocarzinostatin (NCS), an enediyne 
chromophore bound to a stabilising apoprotein, was selected (Figure 16A). Neocarzinostatin has been 
characterised as producing both single and double strand breaks via a proposed direct chemical 
reaction with DNA (Kappen & Goldberg 1997) within minutes of addition to cell media (Figure 16B). 
Neocarzinostatin has also been characterised as being rapidly inactivated following addition to culture 
media in the presence of cells, as it is degraded by light, heat and serum containing media, and is 
consumed in the reaction with DNA (Yoko Kuroda, Takehito Sasaki 1991; Richard M. Burger, Jack 
Peisach 1978). This property allows the rapid induction of DNA damage over a relatively brief time, 
which may be advantageous over ionising radiation, which in contrast, has been characterised as 
potentially having long term consequences via the generation of radical oxygen species that can cause 
cellular damage long after the initial treatment (Azzam et al. 2012). 
I hypothesised that the descendants of cells that received DNA damage but managed to divide would 
show changes in cell phenotypes and sought therefore to identify using lineage tracing whether NCS-
induced DNA damage would induce observable changes in the cell fates and cell cycle durations, not 
only in the treated cells, which has clearly been done before, but in their descendant cells as well. 
Furthermore, I sought to establish new analytical methods to explore this data and thus determine 
Figure 15: Multigenerational FUCCI lineage tracing 
Example of multi-generational FUCCI fluorescent traces of undamaged regularly dividing cells (one cell in each generation 
shown). The red G1 probe peaks before the green S&G2 probe indicating the end of the G1 phase of the cell cycle. The green 
S&G2 probe peaks just before mitosis. 
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whether these measurements and construction of cell lineages can enable meaningful inferences to 
be made about the behaviour of these cells and their responses to DNA damage. 
 
 
Asynchronous cells were therefore given mock or NCS treatment shortly before beginning time-lapse 
microscopy lasting for five days in an exploratory experiment (protocol: Figure 20A, and further 
discussed in materials and methods). Lineages were analysed according to the workflow detailed 
above, Figure 14, to a maximum of three generations, i.e. treated cells, daughters and granddaughter 
cells. Where possible, lineages were analysed to the full three generations but some cells are lost either 
due to tracking difficulties or migration out of the microscope field of view and some cells that would 
have gone on to divide are not recorded as having done so as the experiment ended before they could. 
Therefore, two important constraints on the lineage analysis are the three generations analysed and 
the experimental duration, while loss of cells through migration and difficulties in tracking means some 
lineages will be incomplete. 
The resultant lineage data is by its nature complex, containing information about familial relationships, 
cell fates and cell phase transitions over time. Such complexity presents a challenge for both 
description and visualisation of the data, and determining the appropriate analyses. Although the 
problem of describing relationships between cells is aided by the use of terms like ‘mother’, ‘daughter’, 
‘sister’ and ‘generation’ borrowed from genealogy these terms are imperfect analogies with important 
distinctions. For example, in symmetrically dividing cells the division of a mother cell represents the 
end of its existence and its replacement by its daughter cells. Therefore, unlike in human relationships 
a descendant cell and its ancestor never coexist. Regarding visualisation, tree diagrams permit the 
Figure 16: Neocarzinostatin (NCS) induces DNA damage rapidly 
A) The chemical structure of the Neocarzinostatin chromophore responsible for inducing DNA damage. Chemical structure 
kindly provided by Miss Robyn Hardisty. 
B) DNA damage is evident by the formation of punctate MDC1 foci as soon as 5 minutes after treatment with NCS. U2OS cells 
expressing the fluorescent reporter construct MDC1-mCherry. 
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depiction of lineages in a format that can be read by the human eye and which encapsulates a great 
range of information, in particular indicating the status and presence of cells at any particular time. An 
example of such a representation and the associated terminology is shown in Figure 17. 
 
 
Visualising all the analysed lineages together in the form of such family trees (Figure 18) reveals the 
diversity of lineage behaviour within each experimental condition but also allows the changes that NCS 
treatment induces in lineages to be observed. Considering only the mock treated lineages shows that 
even unperturbed cells can lead to very different lineage outcomes. Approximately half of these 
lineages show what might be considered the ideal behaviour, namely that there are regular cell 
divisions with each cell having similar total, G1 and SG2M durations, ultimately reaching the maximum 
expected 4 granddaughter cells in the final generation analysed, which then divide themselves. This 
lineage behaviour indicates that both the founder cell and the lineage overall can be considered to 
demonstrate high fitness. High fitness can be defined as a cell or lineage having high proliferative 
capacity, i.e. multiple divisions taking place regularly without cell cycle delay, and high survival of the 
lineage where no branches of the family tree terminate in a cell that dies. The remaining lineages show 
varying degrees of fitness in their behaviour. Some show multiple divisions but have members of the 
lineage which take abnormally long to divide. Other lineages show regular divisions but occasionally 
cell death truncates a branch of the tree.   
Figure 17: Lineage trees depict familial relations between cells and convey cellular information 
 






Figure 18: Lineages trees from mock or neocarzinostatin (NCS) treated cells 
All lineages analysed from a single experiment can be visualised together in tree diagrams allowing the diversity of lineage 
behaviour and NCS induced changes to be assessed. 
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Furthermore a few lineages die out completely, several end with the mock treated cell dying and one 
dies out when the mock treated cell divides to produce two daughters that die. Clearly even without 
the perturbation of NCS-induced DNA damage cells show varied fitness in the lineages they give rise 
to indicating the presence of non-genetic heterogeneity. Such non-genetic heterogeneity in the 
background fitness of these cancer cells may be an intrinsic property, perhaps given their cancerous 
origins low levels of spontaneous cell death might be expected to arise if the normal homeostatic 
regulatory networks that maintain cell fitness have been disrupted during the evolution of the 
ancestral tumour. Alternatively, it might be a chance effect triggered by stresses placed on the cells by 
the experimental procedures. In any case, this apparent heterogeneity only becomes clear by taking 
this single cell lineage tracing approach. 
The patterns of lineage behaviour in NCS treated cells obviously differ from those in the mock treated, 
in particular it is immediately apparent that there is much more cell death, an expected response to 
DNA damage. Interestingly, the lineage trees reveal that most cell death is not occurring in the NCS 
treated cells, most cell death is instead occurring in later generations. This observation alone 
demonstrates the suitability of using NCS-induced damage to probe the consequences of DNA damage 
for descendant cells. 
NCS treated lineage trees are also greatly heterogeneous. Some lineages are very similar to the 
predominant lineage type in the mock treated sample, i.e. regularly dividing with no cell death, 
suggesting that the treated cell in the lineage either experienced little DNA damage (later analyses of 
NCS induced DNA damage suggest this is unlikely) or that it was able to tolerate the damage so no 
obvious consequences have arisen in its descendant cells. However, these lineages are clearly a 
minority, in contrast to their predominance in the untreated cells. The remaining lineages all 
demonstrate to varying degrees defects in their fitness. A subset of archetypal lineages are included in 
Figure 19, treated cells may themselves die, Figure 19B, but the proportion that do so appears similar 
to the proportion that do in the mock treated sample, daughter cells may die (Figure 19C), 
granddaughter cells may die (Figure 19D), cell death may occur in a mixture of generations (Figure 19E) 
and some cells in a lineage may die while others survive (Figure 19F). This indicates that the DNA 
damage given to these cells is often capable of exhausting a lineage within three generations but that 
this exhaustion can occur in different ways. Furthermore, it is clear that cell death can occur in some 
branches of a lineage while other descendant cells survive. While lineages with surviving members may 
have eventually been observed to die out if the experiment and analysis had proceeded for longer, it 
appears reasonable to presume that some would have been able to proliferate indefinitely. These 
intra-lineage generational differences in when cell death occurs and intra-lineage differences whereby 
some members of the lineage die while others survive and proliferate indicate that the consequences 
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To facilitate further analysis of cell cycle durations and cell fates cells were grouped into which 
generation they belong to and then plotted both as a swarm plot showing the actual data points and 
as half-violin plots, indicating the distribution of the data (Figure 20). This approach allows cells to be 
compared regardless of their birth in absolute time, but by what their relative position in the lineage 
is, namely a treated cell, a daughter or a granddaughter cell. To further aid analysis the data is colour 
coded with the fate of the cell, i.e. whether it divides, dies or survives until the end of the experiment. 
In this experiment, asynchronous cells received mock or NCS treatment shortly before the microscopy 
began. Therefore, at the time of treatment these cells would be expected to be at various degrees of 
progression through their cell cycles. Measurements of the treated cell’s lifetime during the 
experiment will thus be an underestimate of the true length as it will have been born before the 
experiment began. In the mock treated cells, this would be expected to manifest as a distribution of 
total cell cycle durations for dividing cells predominantly between 0 and the length of a normal cell 
cycle, while for NCS treated these would be expected to undertake a cell cycle arrest and so should 
produce a distribution of measured cell cycle lengths reaching longer lengths than the mock. 
Subsequent generations in contrast should give true measurements of the cell’s life time for those cells 
Figure 19: Depicting lineages as family trees allows the heterogeneity of descendant cell fates to be visualised. 
Cells treated with Neocarzinostatin to induce DNA double strand breaks show a variety of responses when multiple 
generations are assessed. Some lineages show regular division with no apparent cell death (A) but most feature obvious cell 
death (B-F). Cell death may occur in the treated cell (B) or manifest in daughter and granddaughter cells (C-F). 
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that are measured from birth to death or division, while those cells that survive until the end of the 
experiment will have truncated lifespan measurements. 
Indeed, this is evident in Figure 20C, mock treated cells that divide are predominantly measured as 
having cell lifetimes distributed widely between 0 and around 20 hours, while their daughters and 
granddaughters that divide have more tightly distributed total cell cycle durations of 20.5hrs±2 
(median cell cycle length ± median absolute deviation) for the daughters and 18.5hrs±2.5 for the 
granddaughters. When considering the NCS treated cells one observes the measured cell lifetimes for 
cells that divide are mostly between 0 and 60 hours in length, which when compared to the mock 
treated controls indicates that many of these cells have experienced cell cycle delays. Interestingly, 
when considering the cell cycle lengths of those daughter (18hrs±4) and granddaughter cells 
(20.3hrs±4.3) of NCS treated cells which divide, most of these complete their cell cycles within the 
same distribution of time as the daughter and granddaughters of the mock treated cells. This would 
suggest that most of these cell cycle lengths should be considered phenotypically normal, in contrast 
to previous reports, albeit in other cell types, that indicated cell cycle arrests in the descendants of 
DNA damaged cells could be detected. 
Considering cell death (black) yields further insights, inspecting lineage family trees indicated there is 
some level of death even in the mock treated cells. This, if anything, appears to be greatest in the mock 
treated generation, which may reflect a stress response to the experimental procedures or may be a 
product of the smaller sample of cells present for the first generation compared to those of the later. 
The NCS treated cells appear little different to the mock treated in terms of dying cells indicating that 
the DNA damage induced in this experiment was not particularly driving cell death in the treated 
generation. However, as soon as we consider the daughter and granddaughter cells for the mock 
versus NCS treatments the differences become stark. The proportion of cells dying in the daughter and 
granddaughter generations of the NCS treated cells is much higher than for their mock treated 
counterparts. The distribution of dying cell lifetimes is spread over a range of times with some cells 
dying shortly after birth and others dying three days later. Unlike the dividing cells in these generations 
this distribution does not have a pronounced clustering about any particular time suggesting that the 
time for a cell to die is relatively uniformly distributed. As some of the dying daughter and 
granddaughter cells die after many hours longer than a typical cell division would take, this shows 
these cells are undergoing active cell cycle arrest mechanisms, perhaps in response to DNA damage or 
other signals, thus prolonging the cell’s lifetime until the cell death process finally begins. I have termed 
the observation of significant cell death in descendant cells ‘delayed death’. 
 
  





Figure 20: Generational analyses of lineage traced cells 
A) Experimental protocol. FUCCI-NM U2OS cells were seeded in Ibidi 4 well chamber slides and treated with either mock 
treatment or cell culture media containing either NCS (20ng/ml) followed by timelapse microscopy for 5 days with 30 minute 
intervals. B) The resultant lineage trees can be divided into treated cells, their daughters, granddaughters and further 
descendants. Cells were analysed up to the granddaughter generation. C) Swarm plot showing total cell cycle length for 
FUCCI-NM U2OS cells coloured by cell fate and separated into their generations. D) Half-violin plots show distribution of 
swarm plot data and pie charts showing proportion of cell fates adopted in each generation. Cell proliferation shown on left 
hand side, death or survival until the end of the experiment fates shown on right hand side. DNA damage by neocarzinostatin 
results in increased cell death in Daughters and Granddaughters indicating a delayed death phenotype. 





Extending this analysis to the G1 and combined SG2M durations measured with the FUCCI probes 
permits the determination of the behaviour of the G1 and SG2M cell cycle subdivisions in the mock 
and NCS treated lineages (Figure 21). Unfortunately, as very few G1/S transitions were observed in the 
treated population generations, very few cells are represented in this generation and so the results 
are likely to be artifactual and not worth further analysis. The daughter and granddaughter generations 
of NCS treated lineages however, do show that both G1 and SG2M durations of most cells which go on 
to divide appear to be similar to their corresponding generations in the mock treated lineages. This 
would be expected as the total cell cycle duration did not appear different in these generations 
following NCS treatment. Cell death in the daughter and granddaughter cells is predominantly, but not 
Figure 21 Swarm plots of G1 length and length of combined S, G2, and M (SG2M) phases. 
A) Swarm plot showing G1 length for FUCCI-NM U2OS cells with identifiable G1/S transitions coloured by cell fate and 
separated into their generations B) Swarm plot showing SG2M length for FUCCI-NM U2OS cells with identifiable G1/S 
transitions coloured by cell fate and separated into their generations. 
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exclusively occurring in G1, suggesting that G1 phase mechanisms may be more important in delayed 
death. As was observed with total cell cycle duration, the time spent in each phase for those cells that 
go on to die is very variable with no pronounced clustering. 
 
 
The observation that death during the granddaughter generation is very abundant is perhaps slightly 
surprising given the observation that the cells from which they are born (the daughter generation) 
exhibit an apparently normal cell cycle in the majority of cases. To examine whether this is a correct 
interpretation of the lineage data, cells of the daughter generation were colour coded by their 
offspring’s fate (Figure 22). This representation confirms that apparently phenotypically normally 
cycling cells can divide into cells where one or both daughters die. This raises the question of what 
triggers death in granddaughter cells, if it is remaining DNA damage then why does it not trigger 
discernible cell cycle arrests in the normally cycling daughter cell and if not then what is the trigger of 
the delayed death phenotype? 
In conclusion, these initial observations were successful in probing the consequences of DNA damage 
in later generations, having identified the delayed death and lineage heterogeneity. The shortcoming 
of this approach however, is that there is no information about where the treated cells are in their cell 
cycle at the time they are exposed to the DNA damaging agent, thus limiting the inferences that can 
be made, for example, how long any individual treated cell spends in a cell cycle. An improved 
approach is to treat cells partway through time lapse microscopy, at a point where most of the cells 
receiving the treatment will have been born during the experiment allowing the full length of their 
Figure 22: Swarm plots of cells showing total cell cycle length for FUCCI-NM U2OS cells coloured by daughter or own cell fate 
and separated into their generations. 
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lifetimes to be determined. In order to confirm the initial conclusions from this preliminary work and 
examine how the behaviour of descendant cells may relate to the response to treatment of the treated 
cells several such experiments were undertaken. 
1.8 Full characterisation and novel analysis of the response of U2OS cells to DNA 
damage 
1.8.1 Lineage Trees 
The optimization of this assay proved technically challenging as it required the integration of long term 
imaging, fluidic control and the development of experimental strategies aimed to ensure 
reproducibility; ultimately, an optimal protocol to treat cells partway through time-lapse microscopy 
was obtained as briefly outlined in Figure 27A and detailed in the Materials and Methods. Initially it 
was observed that the rate of cell death could be very variable from experiment to experiment even 
when using the same concentration of NCS. This variability is likely due to a combination of factors that 
can vary each time the experiment is carried out, the stress the cells experience during the seeding 
process, the number of cells seeded, the time between preparation of the NCS solution and applying 
it to the cells during which some of the NCS will degrade, and the amount and flow rate of NCS 
containing media applied to the cells. These processes were all controlled as carefully as was practical 
but inevitably some variation remains influencing the severity of the phenotype. To deal with this 
variability, several concentrations of NCS were given during each experimental attempt. Whichever 
concentration triggered a clear cell cycle arrest while still allowing most treated cells to complete 
division qualified for full analysis. These criteria exclude NCS conditions that prevent cell division within 
the experimental timeframe or are too mild to effectively discern from the untreated control without 
otherwise biasing the analyses. Qualifying analyses from different experiments can then be compared 
to see if they demonstrate the same trends in behaviour. Three experimental repeats are presented in 
this work, each demonstrating the same trends and phenotypes, but differing in the degree of severity. 
One dataset is presented as the best representative of the trends and observations from Figure 23 to 
Figure 42, while the remaining two and their associated analyses are presented together from Figure 
44 to Figure 59. 
Similarly to the preliminary work, cells were tracked from the beginning of the experiment and they 
and their descendants analysed by constructing lineage trees. However, as the NCS treatments were 
applied after the experiment began two possibilities now arise for where in the lineage the treated 
cells are located (Figure 27B). Either the cell tracked from the beginning of the experiment experienced 
the NCS treatment or, more commonly, descendant cells did, typically the daughter cells of the cell 
present at the start of the experiment. In the former case then the time of treatment could be 
calculated relative only to the G1S transition if it occurred before the time of treatment as the birth 
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time of the cell is unknown. In the latter case, the time of treatment could be determined relative to 
both the known birth of the cell and relative to the G1S transition. Furthermore, where two known 
sister cells receive treatment this also allows sister pairwise comparison of the resultant lineages. 
The resultant lineage trees are displayed in Figure 23. Mock treated cells show fairly regular division 
with the large majority of all descendants surviving within the three generations analysed and the 
experimental timespan. Nonetheless many lineages exhibit some aberrant phenomena, including cell 
death, lengthened cell cycles, failure to complete cytokinesis and even a few mitoses that produce 3 
daughter cells. Aberrant cell cycling can be observed where cells enter multiple apparent G1 phases as 
measured by the return of the red FUCCI probe in the absence of an intervening mitosis. A plurality of 
different lineages exists, once again demonstrating significant non-genetic heterogeneity in untreated 
cycling cells. Similar behaviour is also observed in the other experimental repeats (Figure 44 and Figure 
52), albeit these datasets demonstrating a greater proportion of mock treated lineages showing 
defects in fitness. 
The NCS treated lineages, unsurprisingly, exhibit a much higher degree of cell death following DNA 
damage. Moreover, at the levels of damage used in these experiments, this increase is evident in the 
treated generation but even more pronounced in the following generations. Visual inspection reveals 
a great deal of heterogeneity in the behaviour of the lineages, with examples of the different trees 
possible shown in Figure 24. As in the preliminary data, cell death can take place in any of the three 
generations analysed and in any particular lineage the cells that die may all belong to the same 
generation, e.g. both daughters, or may belong to different generations, e.g. daughter and 
granddaughter cells. Furthermore, the severity of the death varies greatly between lineages, some 
exhibit complete exhaustion of the lineage wherein all branches of the tree dies out within the three 
generations analysed. Others show a reduced degree of death ‘penetrance’ whereby some of the 
branches of the tree are still viable after three generations or at the end of the experiment. There are 
even some lineages produced from NCS treated cells that feature regularly dividing cells and no cell 
death, despite all cells being extremely likely to have received damage from the NCS treatment, Figure 
26. These lineages may show no defects in fitness due to successful DNA damage repair. The ability to 
identify sisters at the time of NCS treatment means the pair of lineages they give rise to can also be 
compared. The lineage trees visualised in Figure 25 show examples of similar and dissimilar pairs, 
indicating at least that there is no absolute relationship between the sister pairs. One final observation 
is that somewhat more cells appear to survive without dividing during the experimental timeframe 
suggesting that these could be either in a state of survival with prolonged arrest or that they simply 
would have died after the end of the experiment. Similar trends can be observed in the datasets 
presented in Figure 44 and Figure 52, albeit with varying frequency of cell death following NCS 
treatment.  





Figure 23: All lineages analysed from a single experiment can be visualised together in tree diagrams allowing the diversity 
of lineage behaviour and NCS induced changes to be assessed. 
Treatment was applied partway through the experiment (horizontal black line). 








Figure 24: Depicting lineages as family trees allows the heterogeneity of descendant cell fates to be visualised. 
A) Mock treated undamaged cells typically divide regularly B-F) Cells treated with Neocarzinostatin to induce DNA double 
strand breaks show a variety of response when multiple generations are assessed. The treated cell may itself die (B) or 
descendant cells may die in various subsequent generations (C-F). Some descendants will survive and proliferate (F) 
Figure 25: Sister cells both receiving NCS treatment can produce both similar and dissimilar lineages 






































































































































1.8.2 Generational Analyses 
Analysis by visual inspection allows identification of the broad trends in changes in cell fate following 
DNA damage and allows the heterogeneity of the lineages to be conveyed. To explore the changes 
further by comparing cells across generations the cells were plotted by generation and cell fate in the 
swarm and half-violin plots (Figure 27C and D). Hereafter, the treated cells, their daughters and 
granddaughters for mock and NCS treated lineages are referred to as: mockTreated, mockDaughters, 
mockGranddaughters, NCSTreated, NCSDaughters and NCSGranddaughters. 
Dividing mockTreated, mockDaughters and mockGranddaughters cells predominantly do so after fairly similar cell 
cycle durations. Each subsequent generation appears to divide slightly faster than the previous 
(mockTreated 23hrs±3 (median cell cycle length±median absolute deviation), mockDaughters 19.5hrs±2.5, 
mockGranddaughters 19hrs±2) but only the mockTreated generation shows statistically discernible differences 
in distribution from the other two (Two-sample Kolmogorov-Smirnov test with 5% significance level: 
mockTreated-mockDaughters p = 7.7E-10, mockTreated-mockGranddaughters p = 2.4E-19). Why this is happening is 
unclear but may reflect differences in the populations that result from changes in the cell culture media 
over time, increases in cell confluence with time, time since the seeding process, acclimatising to the 
microscope environment, and the washing of mock treatment in fresh media that the treated cells 
received and the descendants did not. In any case, the change is relatively small and not particularly 
concerning. Each generation features a similar small proportion of cells undergoing cell death 
spontaneously perhaps indicating a background rate of cell death due to endogenous cell processes or 
any stresses generated by the experimental setup. The proportion of cells surviving to the end of the 
experiment increases with each generation, as is to be expected given cells in each generation tend to 
be born later in the experiment than previous generation cells making it more likely each cell in that 
generation will reach the end of the experiment without dividing or dying. This effect is also visible as 
a reduction in the maximum cell lifespan recorded with each passing generation (Figure 27C). 
The proportion of cells that die is increased in the NCSTreated generation compared with the mockTreated 
generation, as one might expect from treating cells with DNA damage. The proportion of cells that 
survive until the end of the experiment without dividing appears little changed suggesting that in this 
cell type these doses of DNA damage do not trigger prolonged cell cycle arrests of the order of 5 days 
Figure 27: Generational analyses of mock and NCS treated FUCCI-NM U2OS cells 
A) Experimental protocol for microscopy-based lineage tracing with treatment part way through timelapse microscopy. 
B) Lineage trees can be divided into pre-treatment cells, treated cells, their daughters, granddaughters and further 
descendants. Depending on whether a cell identified from the start of the experiment dies or divides before or after 
treatments were applied it will belong to the pre-treatment or treated cell generations respectively. The artifactual population 
of pre-treatment cells were not further analysed. 
C) Swarm plot showing total cell cycle length for FUCCI-NM U2OS cells coloured by cell fate and separated into their 
generations. 
D) Half-violin plots show distribution of swarm plot data and pie charts showing proportion of cell fates adopted in each 
generation. Cell proliferation shown on left hand side, death or survival until the end of the experiment fates shown on right 
hand side. DNA damage by neocarzinostatin results in cell cycle arrests in NCS treated cells and increased cell death in 
Daughters and Granddaughters indicating a delayed death phenotype. 
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in the NCSTreated generation. This would suggest that these doses are predominantly not triggering 
senescence in this generation. Over 75% of cells divide even after the DNA damage but these typically 
have longer cell cycle durations, 40.5hrs±12, than the dividing mockTreated cells, 23hrs±3, indicating the 
activation of cell cycle arrest mechanisms. This arrest can be seen as both an increase in the peak of 
the half-violin plot indicating where most cells cluster, but also in an increased tail of cells with even 
longer cell cycle durations. However, the most striking differences between mock and NCS treated 
lineages are clearly apparent in the daughter and granddaughter generations where the proportion of 
cells undergoing cell death continues to remain higher than the corresponding generation in the mock 
treated lineages. Indeed, the increase in cell death relative to the corresponding control generation is 
much greater in the daughter and granddaughter cells than the increase in cell death in the actual NCS 
treated cells. The distribution of lifespans of cells that go on to die is much less clustered than the 
distribution of cell cycle durations of dividing cells, instead showing a more uniform distribution over 
time. These observations therefore support the previous identification of a delayed death phenotype 
where cells that survive the DNA damage treatment divide to produce descendants that die instead. 
In this experiment, in the NCS treated lineages almost half of all daughter cells are observed to die and 
less than half of the daughter cells are observed to divide leaving the population size of the 
granddaughter generation actually smaller than the daughter generation. The experiments presented 
in Figure 45 and Figure 53 while varying in the magnitude of the observable cell cycle arrest and 
proportion of cell fates in each generation show the same trends and, in particular, similarly show the 
phenomenon of delayed death being at least as significant as death in the treated generation if not 
more so. Figure 45B and C indicate that in one experiment the mockTreated cells that divide appeared to 
have an unusually long cell cycle compared to the later generations indicating that these cells may 
have experienced a degree of cell cycle arrest for unclear reasons, nevertheless there is still a clear 
contrast between the NCS and mock treated lineages with the same trends observed above. 
Given the increased rate of cell death in the NCSGranddaughters I hypothesised this would be accompanied 
by the NCSDaughters that divided to produce the NCSGranddaughters having clearly prolonged cell cycles due 
to the presence of DNA damage that ultimately goes on to cause the death of their offspring. However, 
comparing the distribution of cell cycle durations of dividing mockDaughters and NCSDaughters shows these 
distributions peak and cluster in very similar locations, i.e. most cells in both conditions appear 
phenotypically normal by cell cycle duration. There is however, an increase in the proportion of 
dividing cells that take longer which can be seen as an increased tail in the half-violin plots which is 
likely responsible for the two populations distributions appearing to be statistically different (Two-
sample Kolgorov-Smirnov test p = 0.019). Most dividing NCSDaughters generation cells therefore appear 
normal, with the differences from its corresponding mockDaughters generation being due to the increased 
proportion of the minority of cells that take longer. I hypothesised that the daughter cells that take 
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longer to divide produce the granddaughter cells that die while the daughters with normal cell cycle 
lengths produce granddaughters that contrinue to cycle. To investigate this, dividing cells were 
reclassified by their daughter cell fates (for the avoidance of doubt daughter here refers to the 
daughter of the cell under consideration, not in the sense of mockDaughters and NCSDaughters) and redrawn 
in the swarm plot Figure 28. Here, three different subpopulations are of relevance for comparison, 
those cells whose daughters also divide, ddivide (coded in green), those cells whose daughters all die, 
ddie (coded in red), and those cells who have a mixture of daughters that die and daughters that 
divide/survive to the end of the experiment, dmixed (coded in yellow). From Figure 28 it is clear that 
dividing NCSDaughters generation cells with apparently normal cell cycle durations, i.e. between 16-24 
hours in length, as compared to the corresponding MockDaughters generation, can belong to 
subpopulations ddie and dmixed, i.e. produce granddaughter cells that will die. There is clearly no absolute 
dividing line between ddivide, ddie and dmixed. However, I hypothesised there could be a more subtle 




Examining the distributions of the cell cycle durations of the ddivide, ddie and dmixed subpopulations of the 
NCSDaughters generation allows this comparison to be made. The median cell cycle duration of ddie 
Figure 28: Swarm plot showing total cell cycle length for FUCCI-NM U2OS cells coloured by the fate of their daughter cells if 
they divide, or by their own cell fate if not. 
Daughter cells from NCS treated lineages can produce Granddaughter cells that go on to die after having cycled with 
apparently normal cell cycle duration when compared to their mock treated counterparts. 
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(18.75hrs) is greater than ddivide (22hrs) by 3.25 hrs, while dmixed (21.5 hrs) is greater than ddivide by 2.75 
hrs suggesting that there could be some difference. Viewing the data in histogram format however, 
Figure 29, there are no obvious stark differences between the populations, nor does any difference 
appear to be discernible statistically (Two-sample pairwise Kolmogorov-Smirnov (K-S) test 5% 
significance level with multiple comparison Bonferroni test). Extending this analysis to the ddivide, ddie 
and dmixed subpopulations of the NCSTreated generation does not show any statistically significant 
differences either between their distributions either. Considering generations from the mock treated 
lineages as well, the only comparison passing the K-S statistical test (at the 5% statistical significance 
level with multiple test Bonferroni correction) is the comparison between the ddivide and dmixed 
subpopulations of the mockDaughters generation (p=0.00005). However, when considering the three 
experimental datasets together neither this nor any of the comparisons had reproducibly statistically 
discernible differences (data not shown). 
 
 
Figure 29: Histograms taken from the indicated generations of cells indicating the cell cycle duration for their subpopulations 
ddivide, dmixed and ddie. 
A and B) The highest of the three subpopulations for MockTreated and MockDaughters generation cells is ddivide. dmixed and ddie are 
much smaller in population but do not appear dramatically different. 
C) The NCS induced cell cycle arrest is evident in all three subpopulations of NCSTreated generation cells, there are no stark 
differences between the distributions three subpopulations. 
D) The three subpopulations of the NCSDaughters generation cells all have similar distributions. 
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In conclusion, this analysis has two main findings, firstly, NCSDaughters cells that are phenotypically 
normal with regard to the cell cycle duration can produce descendant NCSGranddaughters cells that die in 
the next generation. Secondly, although across the three experiments differences can be observed in 
the median values for the three subpopulations in each generation differences in the distributions of 
the cell cycle durations of the three subpopulations were not statistically discernible. 
These observations are consistent with the preliminary findings and present the interesting 
conundrum that granddaughter cells that engage cell death mechanisms, and in many cases have 
prolonged cell lifespans before death, can be born of cells demonstrating no apparent abnormalities 
in the duration of their cell cycles. If this prolonged lifespan and eventual death is triggered by DDR 
mechanisms responding to residual inherited DNA damage then one might have expected their parent 
cell to also show some checkpoint response. 
The proportion of cells that survive to the end of the experiment (cyan) also increases in the NCSDaughters 
and NCSGranddaughters generations compared to the corresponding mock generations mockDaughters and 
mockGranddaughters, possibly suggesting an increase in the number of cells that undergo a prolonged arrest 
without death or division. However, caution in interpreting this data is necessary as the NCSDaughters and 
NCSGranddaughters generations are born later in the experiment on average than the corresponding control 
generations due to the DNA damage induced cell cycle arrest of the treated cells. As discussed above, 
if a generation is born later in the experiment it would be expected to have a greater proportion of 
these cells as they have had less time to adopt their final fate. 
The FUCCI component of the data allows information about the subdivisions of the cell cycle to be 
gleaned, I hypothesised that cell cycle delays and cell death may occur predominantly in one of the 
two subdivisions and so examined the data subdivided into the two measurable phases G1 and SG2M. 
The contributions of G1 and the combined SG2M phases to the cell lifespans are seen in Figure 30, 
where all cells for which a G1S transition could be identified are plotted by the duration of the 
respective G1 and SG2 phases. This reveals that the cell cycle arrests observed in the NCSTreated 
generation are mostly due to lengthening during S or G2. This is in part because those cells that only 
received NCS treatment during SG2 would be expected to have normal G1 durations. These plots reveal 
that death in the mockDaughters, mockGranddaughters, NCSDaughters and NCSGranddaughters generations occurs more 
often in G1 than SG2. In contrast death occurs more commonly in SG2M in the cells that actually 
received the mock and NCS treatments. In the case of the mock treated cells this is likely an issue of 
sampling, very few cells die and so the sample is unlikely to be representative of what is actually 
happening. In the case of the NCS treated cells death in SG2M is likely more common because in this 
experiment most were treated after the G1S transition. These observations indicate that in this cell 
type death can occur in either part of the cell cycle but that it operates more commonly through G1 
based processes. Otherwise, these two subdivisions show similar trends to the total cell lifespan 
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duration figures, for example the durations of G1 and SG2M in dividing cells in the NCSDaughters 
generation are comparable to the corresponding mockDaughters generation durations. There is a 
statistically discernible difference between the distributions of mockDaughters and NCSDaughters SG2 lengths 
(p=0.0076 Two-sample pairwise Kolmogorov-Smirnov (K-S) test 5% significance level with multiple 
comparison Bonferroni test), but as for total cell cycle duration it is likely this effect is due to the 
increased proportion of cells in the distribution’s tail, indeed the mean and median values differ only 
by 2.8 and 0.75 hrs respectively, which are rather subtle changes. There is therefore little evidence 
that the majority of dividing NCSDaughters cells undertake any obvious dramatic cell cycle arrest 
behaviour in either phase measured. Similar trends can be observed in Figure 47 and Figure 55. 
 




1.8.3 Treatment relative to cell cycle position 
An alternative depiction of the lineage trees that helps visualise some of these generational findings is 
given in Figure 31, here the pre-treatment generation of cells are omitted and the resultant lineage 
trees from cells that received mock or NCS treatment are plotted. These have then been ordered by 
where the cells were treated in their cell cycle so cells treated at similar times have their lineages 
drawn together. As cells proliferate the visual density of the tree branches increases and when all three 
analysed generations are complete the tree terminates leaving blank space in the chart. These plots 
therefore convey cell proliferation by both how quickly tree density increases over time and how 
quickly the tree is complete. Furthermore, the death markers indicate the abundance of death and 
where in the experimental time frame this is occurring. For example, the mock treatment plot shows 
how cells proliferates quickly with around half of the lineages having completed three generations with 
little cell death by halfway through the experiment. The NCS treated plot in contrast shows the cell 
cycle arrests in the lengthening of treated cell traces, particularly evident in the increase in the green 
SG2 trace when cells are treated in early SG2 (presumably S phase), the greater abundance of cell 
death markers as cells die and the accumulation of red traces as many of the cells that go on to die do 
so without a detectable transition from G1. Death can then be seen to occur most abundantly 
distributed throughout the latter half of the experiment, reflecting that most death is occurring in 
descendant cells, which are only born later in the experiment. This approach also facilitates 
comparison between experimental datasets, for example the proportion of G1 cells in the samples in 
Figure 48 and Figure 56 is higher than the proportion in Figure 31. These sampling differences may 
contribute to variation between experiments. Another observable difference is in the fitness of the 
mock treated samples, Figure 48 and Figure 56 show these mock treated lineages tend to have slightly 
more cell death and cells that survive to the end of the experiment without dividing or dying than 
shown in Figure 31, as is consistent with the generational analyses shown previously. 
 
  
Figure 30: Swarm plots of FUCCI-NM U2OS cells with identifiable G1/S transitions plotted by G1 and SG2M length. 
NCS induced cell cycle arrests are most evident in the increased SG2M length, in part because many treated cells were treated 
in SG2M. 
A) Swarm plot showing G1 length for FUCCI-NM U2OS cells with identifiable G1/S transitions coloured by cell fate and 
separated into their generations. The proportions of cells dying in G1 or SG2M are indicated in the pie charts. Death occurs 
most frequently in G1 phase, with the exceptions in MockTreated generation cells being likely due to small sample size, 7 cells, 
and in NCSTreated generation cells to the effect that many cells received NCS treatment after successfully completing G1. 
B) Swarm plot showing SG2M length for FUCCI-NM U2OS cells with identifiable G1/S transitions coloured by cell fate and 
separated into their generations. 


































































































































Figure 32: Graphs of cell cycle timing dependencies of the effect of treatments upon SG2M duration 
A) Total duration of SG2M for mockTreated or NCSTreated FUCCI-NM U2OS cells treated during SG2M that subsequently divide 
against the time of treatment relative to the G1/S transition. Neocarzinostatin treated cells show a cell cycle arrest compared 
to their mock treated counterparts. This arrest appears to diminish in magnitude the later the treatment time is. B) Time 
spent in SG2M after treatment for mockTreated or NCSTreated FUCCI-NM U2OS cells that divide. The modelled line of best fits 
summarise the trends in the data with slopes indicating cell cycle timing dependencies on inducing lengthening of SG2M. 
Slope values reported to two significant figures. 
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These figures give the impression that dividing cells treated with NCS during the green section of their 
cell cycle, i.e. the combined SG2M phases, tend to spend longer in SG2M the earlier in SG2M the 
treatment was applied, indicating a possible relationship between the cell cycle timing of treatment 
and the resultant cell cycle delays. I therefore hypothesised that the earlier NCS treatment was given 
in SG2M the longer the resultant DNA damage induced cell cycle delay would be. I examined this 
relationship by plotting the time of treatment relative to the start of SG2M against the length of that 
SG2M phase indicating the effect that the timing of mock and NCS treatments have on the duration of 
that phase (Figure 32A). Mock treated cells tend to have quite a flat distribution aside from a few 
outliers that spontaneously take a long time to progress through the cell cycle, thus indicating, as 
would be expected, that the timing of mock treatment did not influence the progression through the 
cell cycle. Cells that received NCS treatment show different behaviour, the SG2M phase length tends 
to decreases as the time of treatment increases which would suggest that the later the NCS treatment, 
the shorter the resultant cell cycle arrest. The scatter around this trend appears much larger than the 
scatter in the mock treated cells which may be due to the variation in arrest that NCS treatment 
induces even in cells in similar phases of the cell cycle. This downwards trend breaks down for cell 
treated later in SG2M than around 16 hours. As such cells have already experienced an unusually long 
SG2M phase this complicates the analysis leading to the effect that after 16 hours the SG2M phase 
length begins to trend upwards in both conditions. The source of this effect is highlighted by the black 
line indicating the minimum possible cell cycle phase length for the given treatment time, i.e. a cell 
cannot have a SG2M phase of length less than 18 hrs if it was treated 18hrs into that phase. From the 
data here and the data presented in Figure 49 and Figure 57 I surmised that there may be two 
subpopulations of cells. One population, comprising the majority of cells treated in SG2M, proceeds 
through SG2M relatively synchronously. In contrast, a minority of cells that have already exhibited an 
abnormal cell cycle progression at the time of treatment by spending longer than normal in that phase 
have already become desynchronised relative to other cells. Therefore, the analysis of cell cycle arrest 
timing will only be meaningful in the former population. 
If we were to consider normally cycling cells (median SG2M length 16 hrs) mock treated at 2 hr, 6 hr 
and 12 hr after the G1/S transition for example, they are likely to progress to mitosis 14 hr, 10 hr and 
4 hr after treatment, respectively. Therefore, if plotting the experimental time of treatment against 
the time since treatment until the transition to mitosis, we should expect a linear trend for the majority 
of the cells bound by the length of an average SG2M with an approximately -1 slope. The minority of 
cells with abnormal SG2M progression would not demonstrate this trend and might be expected to 
show uncorrelated timings. For NCS treated cells, if the duration of the arrest is linked to the time of 
treatment, as appears evident by eye, we would expect to see a change in the trend, either to a more 
negative slope or a non-linear relationship, both of which would indicate dependency of the arrest on 
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the time of treatment. Figure 32B shows the data replotted in this format, where the trends were 
modelled with two lines, one accounting for the majority population of normally cycling cells and the 
other for slow cycling cells expected to be uncorrelated and so likely to exhibit shallow slopes. 
Here this data indicates that cells treated with NCS soon after the transition from G1 to S phase 
undergo cell cycle arrests leading to an increase of the remaining phase length to between 35 and 85 
hours compared to the approximately 16 hours left in SG2M for mock treated cells treated with 
equivalent timings. As treatment occurs later in SG2M (indicated by increasing time of treatment) the 
difference between the NCS treated and the mock declines until the populations start approaching 
closely to each other around 10 hours into SG2M. At this point it seems that the magnitude of the cell 
cycle delay following NCS is much diminished and cell cycle phases are starting to approach normal 
lengths again. Experimentally, the first fitted line for mock treated cells returns a gradient very close 
to the expected value of -1, i.e. for every hour further into SG2M mock treatment is applied there 
tends to be one hour fewer left in the phase. In contrast, the data and fitted line for the NCS treated 
cells shows a clearly stronger negative relationship between the relative time of treatment and the 
time spent in the phase after treatment, allowing a slope of -4.5 to be determined. This value indicates 
that every hour later in SG2M NCS treatment is applied the remaining time in the phase will be on 
average 4.5 hours shorter. This can be phrased alternatively as each hour further a cell progresses into 
SG2M the duration of the arrest the NCS treatment can induce is reduced by 3.5 hours, once the 
expected 1 hour decrease is accounted for. The second fitted line provides slopes closer to 0, as 
expected from a population of that have not passed through SG2M typically and so collectively hold a 
much weaker relationship between time of treatment and the amount of time remaining in SG2M. 
 In summary therefore, the earlier NCS treatment occurs in SG2M the greater the extent of the 
resultant cell cycle delay. This behaviour is also seen in Figure 49, while this behaviour is less obvious 
in Figure 57, perhaps due to a lower effective dose of DNA damage being received and a less clear 
arrest, which would be consistent with the reduced severity of the death observed for this experiment. 
An initial assessment was made similarly of the effect of the timing of treatment relative to the start 
of G1 in G1 treated cells, however across the three experimental datasets no obvious or reliable trends 
could be determined (data not shown), likely due to insufficient sample size at this point. 
  





Figure 33: Correlation plots for the four possible Mother-Daughter cell cycle duration comparisons. 
Results for three experimental repeats shown. Example lineage trees indicate the familial relationships examined in each plot. 





Figure 34: Correlation plots for four Sister-Sister pair cell lifespan comparisons. 
Correlations calculated where both sister cells divide (magenta) or both die (black) Results for three experimental repeats 
shown. Example lineage trees indicate the familial relationships examined in each plot. 






Figure 35: Correlation plots for two Cousin-Cousin pair cell lifespan comparisons. 
Correlations calculated where both cousin cells divide (magenta) or both die (black). Results for three experimental repeats 
shown. Example lineage trees indicate the familial relationships examined in each plot. 
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1.8.4 Family correlations 
The work by (Sandler et al. 2015) discussed in 1.4.2, introduced the use of the FUCCI system and cell 
tracking across lineages to observe and measure correlations in lengths of the cell cycle, G1 and SG2M 
between cells of three different particular relationships, i.e. mother-daughter pairs, sister-sister pairs 
and cousin-cousin pairs. They observed a tendency for sister pairs and cousin pairs to be correlated 
while mother-daughter pairs were not. I hypothesised that the U2OS cells used here also demonstrate 
this behaviour and that correlation would change following DNA damage and so I made similar 
calculations of correlation. In the original Sandler paper there were only three comparisons made, 
based on dividing cells with the three different relationships analysed. In this work I divide the 
relationship comparisons into cells from NCS and mock treated lineages and further subdivide these 
relationships based on whether they feature cells from the mockTreated/NCSTreated generations or are 
derived solely from the post-treatment generations of each lineage, i.e. Daughters and Granddaughters. In 
addition to the cell cycle durations of pairs of dividing cells I also compare the lifespans of pairs of dying 
cells. The results for all three experimental repeats are presented together in Figures Figure 33 - Figure 
35. 
The cell cycle duration of dividing mother cells show low to no correlation with the cell cycle durations 
of their daughter cells in all comparisons made, Figure 33. Across the three experiments and across all 
mother-daughter cell comparisons the magnitude of the correlation coefficients vary from 0.32 to -
0.30 all of which would indicate very low correlation and even this low correlation does not 
reproducibly pass a statistical test of difference from no correlation. Furthermore, when comparing 
across different experimental treatments there are no reproducible differences in correlation 
between: 
1) mockTreated-mockDaughters and mockDaughters-mockGranddaughters mother-daughter pairs. 
2) NCSTreated-NCSDaughters and NCSDaughters-NCSGranddaughters mother-daughter pairs. 
3) mockTreated-mockDaughters and NCSTreated-NCSDaughters mother-daughter pairs. 
4) mockDaughters-mockGranddaughters and NCSDaughters-NCSGranddaughters mother-daughter pairs. 
I therefore conclude that there is negligible correlation between mother and daughter U2OS cell 
cycling durations in all experimental conditions and that NCS treatment, which induces a cell cycle 
arrest, does not appear to be inducing any changes in correlation either positively or negatively, i.e. 
the length of cell cycle arrest does not induce a systematic lengthening or shortening of the cell cycle 
of dividing daughter cells. The observations of the mock treated cells are consistent with the findings 
of Sandler et al. where the authors observed mother-daughter cells showed very low correlation in 
otherwise untreated cells. That there is no correlation induced following NCS treatment is, much like 
the observation that dividing NCSDaughters generation cells do so with fairly normal cell cycle durations, 
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somewhat surprising based on my initial assumption that DNA damage can be inherited and so affect 
cell cycle duration in descendant cells. 
Dividing sister-sister pairs show more significant levels of correlation, although this too is characterised 
by variation between experiments, Figure 34. In two out of three experiments the mockTreated 
generation sister cells show statistically significant moderate correlation (correlation coefficient rho = 
0.69 and 0.58, p values < 5% significance with multiple test Bonferroni correction). In all three 
experiments the correlations between cell cycle durations of sister pairs from either the mockDaughters 
or mockGranddaughters generations also show statistically discernible correlation and the correlation 
coefficients are much less variable than other conditions (ranging from 0.48 to 0.51). Sister cells in the 
unperturbed mock conditions therefore appear to be demonstrating correlation similarly to as 
reported by Sandler et al. albeit with typically lower magnitude of correlation than the Sandler 
reported correlation of ρ = 0.71±0.07. Considering dying sister pairs also allows us to observe whether 
the cell lifespan before death occurs also shows correlation. Very few sister pairs from the mockTreated 
generation both die in either of the three experimental datasets and so no conclusions can be drawn 
from this data. 10-13 pairs of sisters that die can be drawn from the mockDaughters and mockGranddaughters 
generations across the three experimental datasets and these all show high correlation greater than 
0.8 and pass the 5% statistical significance test. Thus, spontaneous death that occurs in the mock 
treated lineages appears to results in highly correlated cell lifespans for those cells that die. This might 
indicate that the cause of death is inherited and processed in the same way. However, with the small 
sample sizes of sister pairs that die in mock treated lineages this should be treated cautiously. 
The dividing sister pairs taken from the NCSTreated generation of cells also show moderate correlation 
that passes the statistical test in 2 out of 3 experiments (correlation coefficient rho = 0.65 and 0.59, p 
values < 5% significance with multiple test Bonferroni correction). These results suggest that when 
sister cells both received NCS treatment and thus likely experienced some degree of a cell cycle delay, 
but nonetheless eventually continued to divide they tended to do so with similar cell cycle durations. 
The lack of obvious decorrelation is consistent with sister cells being typically treated in similar 
positions in their cell cycle and receiving similar amounts of DNA damage thus undertaking cell cycle 
arrests that are similar. Nonetheless, it is important to recognise as this is moderate correlation 
comparable in magnitude to the mock treated lineages, there has been no obvious increase or 
decrease in correlation that would suggest cell cycle arrests are more or less correlated than 
unperturbed cell cycle durations. Furthermore, the dividing sister pairs taken from the NCSDaughters and 
NCSGranddaughters generations show similar degrees of correlation passing statistical significance in 2 out 
of 3 experiments (correlation coefficient rho = 0.57 and 0.52,  p values < 5% significance with multiple 
test Bonferroni correction). Thus, there appears to be no clear evidence that NCS treatment in 
ancestors results in changes in the correlation between descendant sister pairs that divide. Dying sister 
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pairs from the NCSDaughters and NCSGranddaughters generations show either very low correlation or moderate 
correlation that does not pass the statistical significance test in contrast to the high correlation seen 
in dying sister pairs drawn from the mockDaughters and mockGranddaughters generations. This would suggest 
that the NCS driven death of sister pairs is significantly decorrelated with respect to the spontaneous 
cell death observed in mock treated lineages. Given the small sample size of the dying pairs in mock 
treated cells this may not be reproducible, but hints at the involvement of stochastic processes in 
determining cell death timing in the descendant cell death driven by NCS treatment compared to the 
spontaneous death seen in mock treated lineages. 
The final relationship examined was between cousin cells in both mock and NCS treated lineages, 
Figure 35. There are very few identifiable cousin pairs from the MockTreated and NCSTreated generations 
as these can only be born from cells that undergo two divisions between the start of the experiment 
and the time of treatment, a rare event given this is only 24 hours. Therefore, only cousin pairs from 
the MockDaughters, NCSDaughters, MockGranddaughters and NCSGranddaughters were examined. Cousin pairs from the 
mock treated lineages display very low correlation that is statistically indiscernible from no correlation 
in two out of three experiments and low correlation in the remaining experiment. This is in contrast to 
the reported findings of Sandler et al. where cousin cells demonstrated correlation of a magnitude only 
slightly less than sister cells, ρ = 0.58±0.08. This U2OS stable cell line does not appear to demonstrate 
their observed ‘cousin-mother inequality’ which may simply reflect a difference in the mechanisms 
regulating cell cycle progression between the two cell lines. Notably the correlation coefficients 
between cousin pairs from NCS treated lineages are typically higher than the coefficients for mock 
lineage cousin pairs in every experiment. However, it is unclear whether these observations are 
meaningful. 
In summary, the mock treated lineages show correlations that broadly recapitulate the sister-sister 
and mother-daughter correlations reported previously, however cousin-cousin pairs failed to 
demonstrate meaningful correlation. NCS treatment neither induced correlation in dividing mother-
daughter pairs nor did it abolish it in dividing sister pairs. In contrast, there is some evidence from 
these results that in dying sister pairs correlation is much lower when death is driven by NCS compared 
to spontaneous cell death in mock treated lineages. Finally, NCS treatment shows a trend to increase 
correlation in cousin cells but without greater statistical power this observation cannot be confirmed. 
1.8.5 Lineage fitness scores 
Although limited by the three generations of analysis and the experimental timespan, the lineages 
presented here can exhibit a great range of outcomes leading to the diversity of lineages depicted 
previously (Figure 24). This variety arises from differences in the number of generations a lineage 
passes through, whether different branches of the tree die or survive, and even more unusual 
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outcomes such as the formation of three cells after a single mitosis. Conceptually, understanding these 
lineages in terms of their ‘fitness’ might allow better characterisation of the changes that occur 
following DNA damage. The extremes of lineage behaviour are easy to conceptualise in terms of 
fitness, a lineage that features two rounds of division with no cell death will produce 4 viable cells from 
the original founder cell, suggesting this lineage or indeed the founder cell could be considered to have 
high fitness. In contrast, a cell that fails to divide at all and then dies could be considered to have very 
low fitness having given rise to no descendants and failed to survive. Intermediate fitness can be 
manifested in various ways, a lineage might feature two rounds of division but see two of the resultant 
granddaughters die. Alternatively, a cell might divide once and then neither of the daughter cells 
divide, in both cases the same number of cells are alive at the end of the analysis but this has been 
arrived at by different routes. Understanding how apparently similar endpoints may be reached by 
different patterns of proliferation and death may have implications for understanding tumour 
evolution, particularly in response to chemotherapies. To achieve this I developed methods to score 
the fitness of the lineages, in order to better understand how lineage fitness changes upon NCS 
treatment and the heterogeneity of the lineages. 
A reasonable assumption following DNA damage is that the more generations a lineage passes through 
the more chances there are for this lineage to survive long term without dying out. Therefore, one 
measure for how much a DNA damage treatment reduces the fitness of lineages is to compare the 
maximum number of generations reached by lineages between treatments. In these experiments a 
maximum of three generations following treatment are analysed, but if a third generation cell, a 
granddaughter cell, is known to divide the maximum generation a lineage can reach in this analysis is 
actually the fourth generation. Examples of maximum generation scores are given in Figure 36. 
 
  
Figure 36: Lineage fitness can be assessed by three different metrics. 
Trees can be scored by the maximum generation reached, the Proliferation Index (PI) or the Survival Index (SI). Example 
lineage trees and their scores for each metric are shown. 




Figure 37: Heterogeneity and  NCS induced changes in lineage fitness can be better understood by scoring lineage fitness 
Piecharts indicating the proportion of lineages derived from MockTreated and NCSTreated FUCCI-NM U2OS cells with the given A) 
maximum generation, B) PI, or C) SI scores. 
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Of the mock treated lineages in Figure 24, almost 70% reach the great-granddaughter generation 
(Figure 37), suggesting the vast majority of lineages have high fitness as one would expect. A further 
11% reach the granddaughter generation indicating a reasonable fitness. The remaining 20% of 
lineages are composed of lineages failing to proceed beyond the lineage founder cell or daughter cells, 
which given the over five day experimental period clearly shows poor fitness. The change upon NCS 
treatment is dramatic. Now 30% of lineages fail to proceed beyond the treated generation and a third 
of lineages do not make it beyond the daughter generation. Only 15% of lineages now reach generation 
4, the previously most common score. Broadly, we can see that while there was a degree of 
heterogeneity in the mock treated lineages there was a dominant class of lineages and that the effect 
of NCS treatment has been to reduce the number of generations lineages reach within the 
experimental timespan and also increase the heterogeneity as the four possible classifications become 
much more evenly spread. These results may be explained by the stochastic nature of DNA damage 
hits induced by the NCS treatment and stochastic processes in DNA damage signalling leading to a 
distribution of outcomes following ostensibly the same treatment. Similar trends are observed in the 
other experiments shown in Figure 50 and Figure 58, with the major differences being the absolute 
level of fitness for either mock or NCS treated cells. This approach however, while illuminating, does 
not account for the survival of the cells within the lineage, nor does it account for differences in how 
many branches of the lineage reach that maximum generation. 
Therefore, an alternative measure was derived, termed the proliferation index (PI), which represents 
an average of the number of generations featuring in the lineage by taking the generation each 
terminal branch of the tree belongs to and weighting it by the fraction of the tree it represents. 
Examples of such a scoring system are given in Figure 36. Here the founder cell represents all of the 
tree, a typical daughter cell represents 
1
2




Given the analysis extends to the third generation the terminal branches may have a value of 1 in the 
case of the founder cell, 2 in the case of the daughter cells, 3 in the case of granddaughter cells that 
do not divide, and 4 in the case of granddaughter cells which are known to divide. In this case therefore 
although the great-granddaughters are not analysed they can be accounted for in this score. This 
includes more information than simply scoring by maximum generation by adjusting for the fact that 
not all branches may reach the maximum generation.  
Applying this method to the same lineages discussed above (Figure 24) allows greater understanding 
of the variety of lineage behaviour (Figure 37).  For instance, now half of the mock treated lineages 
reach the maximal score of 4, compared to 70% previously. Some lineages previously classed as 3 or 4 
by maximal generation now find themselves classed with scores between 2.5 and 3.75 clearly 
demonstrating how the maximal generation scores overrepresented their fitness. The percentages of 
lineages scoring 1 and 2 are unchanged by the alternative methodology.  
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PI values can also better describe the dramatic loss of the highest fitness lineages following NCS 
treatment, just over 3% score 4 compared to 50% in the mock treated lineages. Thus showing very few 
lineages now reach the highest possible fitness. The proliferation index also allows a better 
understanding of the heterogeneity change upon NCS treatment, the large drop in proportion of 
lineages scoring the maximal PI value of 4 is accompanied by the increased dominance of lineages 
scoring 1, 2 and 2.5. Therefore, the major change in heterogeneity is from one predominant score to 
three prominent pluralities. Once again, while Figure 37 shows a single experiment, results from 
independent experiments (Figure 50 and Figure 58) show very similar trends with the differences 
mostly being due to a degree of poorer fitness in the mock treated lineages to begin with and variation 
in how severe the NCS induced fitness reduction is. 
Alongside the number of generations a lineage features, another important contributor to assessing 
lineage fitness is the cell death and survival that occurs. Therefore, I defined a Survival Index (SI) which 
represents the fraction of the lineage that survives. Each time a member of the lineage dies, ending 
that branch, a percentage of the lineage is lost depending on how much of the lineage it represents, 
as was discussed above in the derivation of the proliferation index. Where abnormal numbers of cells 
result from a mitosis this can lead to abnormal fractions, for example the founder cell dividing to 
produce three daughter cells will leave each representing 
1
3
 of the lineage.  
Calculating the survival index for the mock treated lineages, Figure 37C, shows approximately 60% of 
lineages show no death at all and a further approximately 10% lost only a quarter of the lineage, i.e. 
one granddaughter cell. Even with only mock treatment, around 20% of the lineages completely die 
out during the experiment and the remaining approximately 10% of lineages exhibit various 
intermediate degrees of survival. Similarly to the PI results, it is clear that while there is heterogeneity 
in the SI scores of mock treated lineages, high survival lineages dominate. 
NCS treatment causes a large loss of fitness as assessed by the SI. Over half of all lineages now die out 
entirely within the three generations analysed leaving no descendants, and around 20% of lineages 
experience half or more of the tree dying within the three generations analysed. The high fitness 
lineages of 0.75 SI upwards now represent just a quarter of all lineages compared to around 70% 
previously. The level of heterogeneity in SI scores does not appear to change dramatically, instead the 
previously dominant high SI scores have swapped places with the low SI scores. Repeats of this 
experiment (Figure 50 and Figure 58) show similar trends but with different magnitudes. 





As the fitness of a lineage depends on both the proliferative capacity and survival of the cells two 
dimensional plots of PI and SI scores for lineage capture the fitness of lineages better than each alone, 
diagrams I refer to as ‘Lineage fitness space’. This is useful for comparing lineages that by one score 
appear identical but are clearly very different, for example a lineage which dies out completely and so 
scores SI=0 may do so by the founder cell dying or it could do so by death of four granddaughter cells. 
High scores for both proliferation and survival, are found in one corner while lineages with lower 
fitness populate the remainder of the space. This allows different fitness defects to be visualised in 
one instructive diagram, lineages featuring few divisions but no cell death (low PI high SI) will be 
located in a different part of the plot to lineages featuring many divisions but ultimately ending in all 
cells dying (high PI low SI). Both of these will also be separated from lineages where the founder cell 
itself dies (low PI low SI). For lineages analysed to three generations the different scores possible for a 
typical lineage are plotted in Figure 38, which also indicates the differing levels of fitness in the lineage 
space.  Note that some scores are not possible, for example the PI cannot have a value between 1 and 
2 as lineages cannot have terminal branches of both 1 and higher generations. Another example is the 
triangular region between PI scores of 3 and 4 and SI scores between 0 and 1. For a terminal branch of 
the tree to have a score of 4 it must belong to generation 3 and divide, if it dies instead then it will be 
scored as generation 3. Thus, as each granddaughter cell dies the maximum PI score possible is reduced 
by 0.25 from 4. Furthermore, irregular scores are possible when a lineage features abnormal divisions, 




 rather than 
1
2
, and these are evident where a lineage’s PI and/or S.I. score has an unusual fractional 
component. 
Figure 38: Lineage Fitness Space is defined by the various possible PI and SI scores. 
High fitness lineages, i.e. scoring highly for both PI and SI, are found in one corner. As fitness reduces lineages are found 
further from this corner. The different manifestations of reduced fitness are separated in space facilitating better 
interpretation of how treatments change lineage fitness. 
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Scores were calculated for lineages founded by the mock and NCS treated cells, i.e. ignoring the pre-
treatment cells, and the proportions of lineages with each pair of scores plotted in Figure 39. This 
visualisation permits a number of observations to be made. The most predominant component of 
mock treated lineages, Figure 39A, at around half of all lineages, are lineages scoring the maximum 
possible for both PI and SI [4,1], i.e. showing the greatest fitness. The remaining lineages are 
distributed across various pairs of scores with none forming a particularly large proportion of lineages. 
NCS treatment causes large changes in the distribution of lineage scores, Figure 39B. The highest 
fitness collapses to a very small proportion of all lineages and the biggest increases in proportion occurs 
for lineages dying out entirely through the death of the founder cell [1,0] or through the death of both 
daughter cells [2,0]. Smaller increases occur for the other possible lineage scores but there is a general 
shift of density away from the high fitness corner and a shift towards lower PI and SI scores for the 
intermediate lineages. The advantage of this method of scoring lineages is it permits a more complete 
understanding of the distributions of lineage fitness both in the mock and NCS treated populations 
analysed. Mock treated lineages predominantly divide many times to produce descendants which 
mostly survive. Following NCS treatment lineages are broadly undertaking fewer divisions and 
experiencing the death of most branches of the lineage as indicated by the shift from high PI high SI 
lineages being dominant to lower PI, low SI lineages becoming dominant after NCS treatment. There 
are relatively few lineages following NCS treatment that are high in one index and low in the other, for 
example [3,0] and [1,1]. This also indicates, consistent with the previous generational analyses, that 
there appears little evidence for any strong senescence response in these cells at the doses of DNA 
damage given. If this had occurred it would have been indicated by large increases in the lineages 
scoring having a low PI score and a high SI score, indicating cells that are alive but have stopped 
dividing. This scoring system therefore helps separate senescence-like lineage responses (low PI, high 
SI) from cell death response (low SI). This depiction also indicates how in each condition dominant or 
more abundant classes of lineage can be identified but that these represent at most half of all lineages, 
with the rest being distributed amongst various scores. This therefore reflects well the heterogeneity 
evident by eye from the lineage tree plots discussed earlier and indicates the variability of the 
underlying biology. Figure 51 and Figure 59 show the same dominance of high fitness lineages in the 
mock treated sample and the trend towards lineages with low PI and SI scores in the NCS treated 
samples. As has been commented throughout these other two experiments have tended to 
demonstrate slightly lower fitness in their mock treated samples and this can be seen in the increased 
proportions of lineages with slightly lower PI and SI scores. That these still cluster around the high 
fitness corner of the lineage space indicates that the defects are not very severe and indeed the still 
stark contrast with changes in distribution of lineages after NCS treatment further supports this. 
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In calculating these scores any lineages incomplete due to cells being lost during analysis were 
discarded. This is likely to have led to a bias towards trees of fewer generations as they will have 
produced fewer cells to be lost. Nevertheless, even with this bias the results are still illustrative of the 
changes in lineage fitness that results following NCS treatment. 
In summary, the description of lineage tree fitness permits us to better describe the complexity of 
single cell data. When treated with a DNA damaging agent, U2OS cell lineages experience a dramatic 
drop of fitness; however, this loss of fitness is experienced both by cells that die immediately upon 
treatment and by a population of cells that is still cycling leading to a very high degree of heterogeneity. 
It is also evident that despite this, a small number of NCS treated cells still give rise to reasonably high 
fitness lineages. 
1.8.6 Paired sister lineage comparisons 
These experiments were performed with cell lines derived from single clones and at low passage 
numbers. Therefore, in all effects, the high heterogeneity described is of non-genetic origin. Pairs of 
sister cells both receiving NCS treatment can be identified, such cells would be expected to be the most 
similar to each other possible, genetically and epigenetically, having presumably received very similar 
cell contexts, e. g. proteome composition, upon birth and being likely to have received the NCS 
treatment during similar periods of their cell cycle. Given this, I hypothesised that these sister lineages 
would tend to produce lineages that behave similarly, as measured by PI and SI scoring. Paired sister 
lineages that feature no lost cells, and thus no ambiguity, were identified and their PI and SI scores 
calculated. Correlation coefficients were 
then calculated for the PI scores and for 
the SI scores to examine whether either of 
the two components of the fitness scoring 
system demonstrated a degree of 
correlation. Considering the results across 
all three datasets together, Figure 40, 
indicate a moderate level of correlation 
for both indexes, but with large variation 
between the experiments in the 
magnitude of the calculated correlation 
coefficients for the proliferation index. 
To examine this variation the paired 
sisters were analysed by statistical 
bootstrapping. In this bootstrapping 
Figure 40: Mock and NCS treated sister lineages appear to moderately 
correlate in both PI and SI scores to varying extents across experimental 
repeats. 
Results of three experimental repeats shown 
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analysis, thousands of virtual populations of lineages were created by randomly sampling the sister 
pairs in the experimental populations. This sampling was with replacement meaning the virtual 
populations can feature the same sister pairs more than once. Undertaking the calculation of 
correlation coefficients on each of these virtual populations produces thousands of correlation 
coefficients. These thousands of calculated correlation coefficients were then used to estimate the 
average correlation coefficient, its confidence interval and the probability density function describing 
the distribution of estimates of the correlation coefficient. Furthermore, in order to control for the 
distribution of correlation coefficients in the case where no correlation due to lineage inheritance 
could exist, the same bootstrapping analysis was carried out on thousands of virtual populations of 
cells which had been randomly assigned as ‘sisters’ to each other, rather than using their actual known 
sisters. In summary, this statistical method allows the estimation of confidence intervals and 
probability density functions for the correlation coefficients using only the experimental data. The 
results for the three experimental repeats examined here are presented as histograms in Figure 41. 
These results allow an understanding of why the initially calculated correlation coefficients vary so 
from experiment to experiment. The probability density function histograms drawn for the PI and SI 
scores for both the Mock and NCS treated lineages in each of the experimental datasets are broad. 
This indicates that with these sample sizes and variance of the underlying data the correlation 
calculated in any experiment is likely to vary from other repeats. It is also clear from the overlap 
between Mock and NCS treated lineage histograms for both PI and SI scores across the three 
experimental repeats that there is no reproducible difference between the two conditions. The 
histograms for the randomised sister pairs for both PI and SI all centre around 0, indicating that the 
appropriate comparison of correlation for sister pairs is indeed with zero correlation and that the 
populations are not introducing any background artifactual correlation. 
From this I make the following conclusions. Firstly, in mock treatment conditions sister cells give rise 
to lineages that have low to moderate correlation for both their PI and SI score. That correlation is not 
higher was somewhat surprising as I expected these cells to be the closest to identical duplicates of 
each other as is technically possible to achieve and that having received only a mock treatment to have 
not received an obvious stimulus that would drive them to differ. This result indicates that while they 
do correlate to a degree there is significant non-genetic heterogeneity between even the cells that one 
would expect to be the most similar as they can give rise to dissimilar lineages. Secondly and 
remarkably, addition of the NCS treatment does not appear to change the strength of correlation. This 
would suggest that the induction of DNA damage in sister cells neither causes dramatic decorrelation 
between the lineages these cells found, nor does it induce greater similarities. The presence of low to 
moderate correlation in both mock and NCS treated conditions is consistent with a hereditary 
component to determining lineage behaviour, but that a great part is still due to chance. 
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It would be interesting to determining whether greater population sampling is sufficient to reduce the 
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1.8.7 Lineage progression in space and time 
During the image analysis and curation the location of each cell nucleus was recorded along with the 
FUCCI and nuclear marker probe intensities. This data can be used to virtually recreate the experiment 
for the analysed cells and artificially render cell migration traces through time and convey information 
via colour coding, such as G1 vs SG2M phases (Figure 42A), cell generation (Figure 42B) and cell lineage 
(Figure 42C). This can be done for individual lineages (Figure 42A and B) and for entire fields of view 
(Figure 42C). Spatial correlations were not analysed but may yield further insights. 
 
Figure 42: Cell lineages can be visualised in three dimensions with two-dimensional movement against time. 
Cells in each lineage may be coloured by which generation they belong to (A), by the FUCCI assigned cell cycle phases (B) and 
by which lineage they belong to (C). 
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1.8.8 Other cell lines 
 
The work presented here has featured U2OS cells, a cell line derived from a moderately differentiated 
sarcoma of the tibia of a 15 year old girl in 1964 (ATCC). These cells have been characterised as being 
highly altered chromosomally with chromosomal rearrangements and hypertriploid chromosome 
counts. They have been characterised as possessing wild type p53 but have been reported to lack 
p15INK4B and p16INK4 both of which are involved in cell cycle regulation and a known cancer mutation. 
These cells are clearly abnormal with respective to a typical cell in the body and so the findings 
described above are best interpreted with this in mind. These observations are still of great relevance 
to understanding the biology of checkpoint studies and cancer as such behaviour may be typical of 
many or certain types of tumour and insights into checkpoint recovery have already been made 
utilising these cells. In particular, these findings suggest that the observation of G2/M checkpoint 
negligence reported previously by Liang et al. in this cell line does not simply trigger cell cycle responses 
in the immediate next G1 phase in the daughter cells as might have been assumed. Instead the 
responses occur over many cell cycle phases and generations. 
Nonetheless, it would be advantageous to characterise more cell lines in order to understand whether 
phenomenon such as delayed death may also be observed in these, in particular utilising cell lines that 
have undergone fewer genetic changes and so should be more typical of the cells found in the body. 
Further cell lines were derived from HeLa and HPNE (Human Pancreatic Nestin-Expressing) hTERT cells 
expressing either the FUCCI-NM system or simply a nuclear marker amenable to cell tracking. HeLa 
cells are another cancer cell line that have been studied greatly but are also known to be abnormal in 
cell cycle regulatory components, for example p53. HPNE cells in contrast are much more normal 
having been derived from an acinar to ductal metaplasia immortalised through hTERT expression. 
These feature a relatively normal karyotype, albeit with reports of 50% of cells carrying a derivative 
chromosome 21, and so are likely to be more representative of human tissues than either U2OS or 
HeLa cells. Regrettably, HPNE hTERT cells did not prove amenable to microscopy experiments of 
Figure 43: FUCCI-NM in HPNE hTERT and HeLa cell line 
Microscopy based lineage tracing – cell fate following DNA damage 
83 
 
multiple days due to much greater cell motility than could be tolerated, resulting in it proving too 
difficult to track cells and generate lineages. Attempts to manipulate the speed of cell migration with 
different tissue culture vessel coatings proved unsuccessful. Preliminary data acquisition and analysis 
of the HeLa cells is ongoing. 
1.9 Discussion 
In summary, my experiments in lineage tracing have shown that with the levels of DNA damage 
induced by the concentrations of NCS used here most treated cells can continue to divide and produce 
descendants, the daughter and granddaughter cells. Interestingly many of these descendants then go 
on to die, delayed death, which can lead to the extinction of the entire lineage perhaps compensating 
for the failure of the initially DNA damaged cell to die. Intriguingly granddaughter cells may die even 
when their mother cell in the daughter generation has cycled with a phenotypically normal cell cycle 
length, a surprising finding given my initial assumptions that death in later generations would likely be 
triggered by inherited DNA damage capable of activating both cell cycle arrest and cell death processes. 
The cause of this delayed death has not been established but the possible causes are discussed further 
below. 
Furthermore, when studying even a comparatively simple phenomenon, such as cell death, at a single 
cell level, experimental observations become rather complex because of the heterogeneity that 
cellular behaviour exhibit. This is usually neglected when performing ensemble measurements 
assuming or trying to establish homogeneous and synchronous responses. Because of this complexity, 
I have presented here a range of analytical methods to facilitate the description of the experimental 
observations and to aid their interpretation. 
1.9.1 Descendant cell death 
The most notable observation has been that delayed death, where cell death most frequently occurs 
not in DNA damaged cells but in their descendants, is a significant phenomenon within a cancer cell 
line that has previously been described as having a negligent checkpoint. This confirms previously 
reported indications that the consequences of DNA damage can extend beyond the cell receiving the 
damage and raises the possibility that cell cycle checkpoints may operate in a co-ordinated manner 
whereby subsequent checkpoint processes are influenced by the actions of those previously. Such 
behaviour might be termed checkpoint cooperation or checkpoint memory. This could provide an 
explanation for how the apparent negligence of cell cycle DNA damage checkpoints can be tolerated 
if cell fate decisions are revisited in subsequent phases and generations. Indeed, in the experimental 
results presented here cell death is relatively uncommon in the NCSTreated generation, increasing to 
much greater frequencies in the subsequent generations. However, contrary to my initial expectations, 
rather than observing compensatory checkpoint activation in the first DNA damage checkpoint 
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following a negligent checkpoint, for example a negligent G2/M checkpoint in a treated cell followed 
by G1/S in the daughter cells, cell death can occur in granddaughter cells, i.e. having passed through 
many opportunities for the activation of checkpoint machinery, in many cases with little evidence of 
such intervening checkpoint activation  given the lack of obvious large cell cycle delays. 
The analysis of lineage fitness demonstrates that descendant cell death is an important component in 
the exhaustion of lineages, i.e. where no cells survive. Of all lineages that feature an SI score of 0 just 
under half of these tend to come from the treated cell dying, the remainder originate from lineages 
that feature the death of all the descendant cells, predominantly but not exclusively via death of both 
members of the NCSDaughters generation. As we typically think of the death of a cell that receives DNA 
damage as an evolutionarily adaptive response that protects the organism via sacrificing a potentially 
dangerously mutated cell, elimination of a DNA damaged cell’s lineage by the death of all its 
descendants may represent an extension of the same concept. With this in mind therefore,  
descendant cell death within just three generations is approximately as significant, in terms of 
percentages of all lineages analysed, as death of treated cells in achieving the exhaustion of the 
lineage. Furthermore, it is likely that further lineages would have exhausted if the experiment had 
been longer and more generations been analysed, suggesting the importance of descendant cell death 
in lineage exhaustion may be greater than observed here. In the first instance, therefore, descendant 
cell death represents an opportunity to compensate for the failure of DNA damaged cells to die by 
instead resulting in the death of all the founder cell’s descendants. 
This raises the question of what the mechanism for triggering death in descendant cells might be. To 
address this, I have considered three plausible explanations: 
1.9.2 Proposed delayed death mechanism: Inherited DNA damage 
Inheritance of unresolved DNA damage may simply activate cell cycle checkpoint mechanisms in 
descendant cells. DNA damage that remains unrepaired despite the activation of cell cycle checkpoint 
mechanisms for repair might then eventually trigger death in descendant cells. This would be the 
simplest explanation and does not rely on the existence of unknown mechanisms. However, the 
observation that NCSDaughters generation cells dividing after phenotypically normal cell cycle durations 
can produce NCSGranddaughters generation cells that go on to die complicates this explanation. If death is 
triggered in these NCSGranddaughters generation cells by inherited DNA damage why do their mother cells 
in the NCSDaughters generation often not show clear evidence of activation of checkpoint arrests? 
Checkpoint negligence, as discussed in 1.3.9, has been suggested to operate in two ways, either arising 
from DNA damage being detected too late for a proper arrest to initiate, timing negligence, or arising 
from a failure to meet a threshold of activation, threshold negligence. I have observed what might be 
interpreted as timing negligence where cells treated in late SG2M have typically short arrests. The 
Microscopy based lineage tracing – cell fate following DNA damage 
85 
 
simplest assumption therefore might be that a checkpoint that fails to prevent the transmission of 
DNA damage due to timing negligence will simply recognise it at the next competent checkpoint and 
address it then, either by arresting and repairing or by dying or senescing. Similarly, a checkpoint that 
fails to prevent the transmission of DNA damage due to negligence over the threshold of activation, 
for example a G2/M checkpoint faced with few lesions or high Plk1 activity, might simply result in the 
activation of the next more sensitive checkpoint, perhaps daughter cell G1/S checkpoints. Some of the 
delayed death observed here could be explained by this, daughter cells dying in G1 may be activating 
robust G1 checkpoint responses to inherited DNA damage that passed through their mother cell’s G1/S 
or G2/M checkpoints by one of these kinds of negligence. However, for death in later cell cycle phases 
and generations to be explained simply by a checkpoint response to persistent DNA damage requires 
that the intervening checkpoints that permitted continued passage of this DNA damage to also be 
negligent as they neither robustly induce cell death nor do they show much evidence of a cell cycle 
arrest. 
If this is the case, why are intervening checkpoints sometimes negligent and sometimes not? Timing 
should no longer be an issue as the damage will be present throughout that cell cycle phase but 
perhaps checkpoints in U2OS cells have a probabilistic threshold negligence to activation whereby the 
typical levels of damage inherited in these experiments has a chance of activating a checkpoint 
response and leading to cell death. However, it does not explain why cell death is the most common 
effect in later generations, rather than cell cycle arrests followed by a return to cycling. 
Another possibility is that cells in the daughter generation that do not die have inherited some DNA 
damage but not enough to trigger a cell cycle arrest due to checkpoint negligence. The processes of 
replication and/or mitosis upon damaged DNA in these cells may stochastically trigger a crisis of greatly 
increased damage so that there is now sufficient damage to trigger checkpoint responses leading to 
cell death. Micronuclei, for example, are an aberration that result from damaged DNA passing through 
mitosis. 
An alternative speculative explanation is provided by the work on telomere deprotection discussed in 
the Introduction (Cesare et al. 2013). Here, a particular lesion in the telomeric region of chromosomes 
was capable of activating some cell cycle checkpoint components leading to stable senescence in 
descendant cells but fails to trigger an arrest in the original cell. Furthermore, telomeric DNA is known 
to be resistant to typical DNA repair mechanisms (Fumagalli et al. 2012). This indicates that the cell 
cycle checkpoint machinery discriminates based on different genomic contexts. An analogous scenario 
could be happening here where DNA damage in a particular genomic context may fail to be repaired 
by the initial cell and upon inheritance by descendant cells be capable of triggering cell death responses 
but not cell cycle arrest. This context may not necessarily be telomeres, a relatively small stretch of the 
genome (average length in human populations 5-15 kb Samassekou et al. 2010), there may instead be 
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other undiscovered regions that are treated differentially. If this were the case then clinical 
interventions could be imagined that preferentially trigger damage in these genomic contexts in 
tumour cells to trigger high rates of lineage exhaustion and thus tumour regression. 
Alternatively, it may be that DNA damage passing through cell cycle checkpoints in the initially treated 
cell experience some process that leads to residual lesions being marked resulting in differential 
activation of cell cycle arrest and cell death mechanisms in descendant cells. Such a mark would have 
to be resistant to erasure by the processes of replication to explain responses beyond the G1 phase of 
daughter cells. One possible, albeit imperfect, analogy is the way aphidicolin induced partial replication 
results in the formation of persistent DNA damage and 53BP1-containing OPT domains in the G1 
phases of daughter cells (Harrigan et al. 2011) rather than in the G2 of the aphidicolin treated cell. 
1.9.3 Proposed delayed death mechanism: Checkpoint memory 
An alternative explanation is that cell death in descendant cells is governed instead by non-DNA 
damage mediated signals that are inherited and predispose cells to engaging cell death mechanisms. 
A precedent for such a mechanism has been set by the reporting that endogenous replication stress 
results in DNA damage being inherited by daughters, but importantly, so is hypophosphorylated Rb 
protein and elevated levels of p21. This then leads to the triggering of quiescence in the daughter cells 
immediately after birth (Arora et al. 2017). It is possible therefore that during the checkpoint activation 
in DNA damaged cells certain DDR components, for example p53, experience changes, perhaps in level 
or post-translational modification, that are inherited by the descendant cells leading to increased 
predisposition to cell death. It is also possible this effect would work in combination with inherited 
DNA damage. Inherited changes in the DDR mediators could alter checkpoint responses to favour cell 
death and disfavour cell cycle arrests in descendant cells. Such an effect would constitute a cellular 
memory whereby descendant cells ‘remember’ their ancestor experienced DNA damage. 
1.9.4 Proposed delayed death mechanism: DNA damage triggered cell deregulation 
A third possibility is that the DNA damage created in the treated cells results in severe consequences 
for the cell’s ability to maintain cellular homeostasis, manifesting as a predisposition to cell death in 
descendant cells. A plausible suggestion for the type of consequences posited here is structural 
rearrangement of the DNA during mitosis in cells with residual damage. The formation of micronuclei 
and chromosome loss/gain in daughter cells would be expected to lead to disruption of typical gene 
regulation, resulting in gene expression changes and alteration of homeostatic regulatory networks. 
Such changes might weaken the cell’s normally robust ability to respond to typical stresses during the 
cell cycle and so result in an increased chance of cell death. These changes might not trigger cell cycle 
arrest mechanisms, especially if the basic lesions themselves have been resolved or silenced in the 
process of generating these abnormal structural rearrangements, but would bring about an increased 
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probability of cell death. Delayed death in this case might therefore be triggered in the absence of DDR 
activation and it may thus be possible to distinguish this experimentally from death triggered by 
inherited DNA. This scenario would not represent a deliberate reassessment of inherited damage by 
later checkpoints, i.e. checkpoint cooperation, instead being the consequence of permanent damage 
to the genome. 
In conclusion, there are a number of possibilities for how cell death could be triggered in later 
generations and it should be possible in future to interrogate these experimentally, for example by 
searching for evidence of persistent DNA damage, by screening for the presence of aberrations such 
as micronuclei and by determining the activity of checkpoint machinery in cells over time and 
generations. 
1.9.5 Checkpoint negligence in U2OS cells 
Human and cancer cell checkpoint negligence has been increasingly studied in the past decade, as 
discussed in 1.3.9, and my analysis of the DNA damage based checkpoint responses in SG2M of the 
U2OS cells provides further characterisation of the checkpoint behaviour previously assessed by (Liang 
et al. 2014). I found that following transition into S phase the capacity for cell cycle arrests following 
DNA damage decreases as cells progress further into the combined SG2M phases, with arrests close 
to the normal time of mitosis approaching zero in length. Part of this explanation might be that cells 
damaged in S phase can experience elongation of the cell by the actions of the replication, intra-S-
phase and G2/M checkpoints, while cells irradiated in G2 can only experience cell cycle elongation by 
the G2/M checkpoints. This can be further explained, as the work by Liang et al suggested, by cells 
accumulating commitment to mitosis during G2 in the form of increasing Plk1 activity. The typically 
higher levels of Plk1 likely to be encountered when damage is induced in cells that have already 
progressed far into SG2M could then limit the extent of possible arrest relative to cells treated early in 
G2, i.e. a form of timing negligence. 
1.9.6 Correlations analysis 
I have here presented work that shows U2OS cells demonstrate similar correlation trends between 
mother-daughter and sister-sister cell pairs to the observations made by Sandler et al. Interestingly, I 
did not observe the same cousin-cousin pair correlation suggesting that these cells differ in that regard. 
Against my initial expectations I observed no clear trend of changes in correlation being induced by 
NCS treatment. I had expected that DNA damaged mother cells might pass on DNA damage to their 
daughters and in so doing induce correlation, for example mother cells with short arrests, and thus 
little time to repair damage, due to treatment late in G2 would tend to pass on more DNA damage to 
their daughter cells who might then be expected to have longer cell cycles than other cells inheriting 
less damage due the triggering of checkpoint responses. That this does not appear to be clearly 
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happening may reflect the previous observation that most daughter cells cycle with normal or near-
normal durations. These observations may be informative in future studies to determine the 
mechanism of this behaviour. 
Similarly, the lack of significant change in PI and SI correlations upon NCS treatment was also surprising. 
NCS treatment represents a strong perturbation to normal cell behaviour but it would appear the 
determinants of lineage behaviour are just as correlated after NCS treatment as they are in 
unperturbed mock treated lineages. 
1.9.7 Conclusions 
In conclusion, this work has analysed the scope and significance of responses to DNA damage both in 
treated cells and their descendants enabling the characterisation of the significant multigenerational 
consequences of DNA damage discussed above. Altogether this work has also presented a number of 
innovative and novel ways to describe, analyse and model the behaviour demonstrated by cells and 
lineages following treatment with DNA damage. These have enabled trends and concepts that may 
appear evident to the eye to be quantified and explored, for example both the heterogeneity in 
lineages and the changes induced by NCS treatment are well characterised by lineage fitness scoring. 
Characterisation of additional cell lines to establish whether delayed death is a more widespread 
phenomenon will be necessary to determine its wider biological relevance. Given the technical 
difficulty of generating large numbers of transgenic cell lines and analysing them via microscopy-based 
lineage tracing. Furthermore, microscopy is ill suited to probing the mechanistic basis of delayed cell 
death and it will be necessary to adopt other means to distinguish between the mechanistic 
possibilities outlined here. Once aware of the level of non-genetic heterogeneity and the observation 
of ‘delayed death’ that can be misinterpreted as prolonged cell arrest in population measurements, 
alternative assays to characterise lineage behaviour in different cell lines and begin to address 
mechanistic insight were developed as described in chapter 0.  
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1.10 Supplementary Figures 
1.10.1 Experimental repeat 2 
  Figure 44: Lineage trees from experimental repeat 2 




Figure 45: Generational analyses of experimental repeat 2 
A) Protocol, B) Generational terminology of lineage trees C) Swarm plot of generations analysed D) Half-violin plot 
For unknown reasons the median cell cycle duration of dividing MockTreated (34.75 hrs) is considerably elevated compared to 
MockDaughters and MockGranddaughters median cell cycle durations, (24.25 and 21 respectively). 





Figure 46: FUCCI-NM U2OS total cell cycle length swarm plot with dividing cells colour coded by daughter cell fates, data from 
experimental repeat 2. 





Figure 47: G1/SG2M duration swarm plots of FUCCI-NM U2OS cells with identifiable G1/S transitions, data from experimental 
repeat 2. 
A) G1 duration swarm plot coloured by cell fate and separated into their generations.  
B) SG2M duration swarm plot coloured by cell fate and separated into their generations. 




















































































































































Figure 49: Graphs of cell cycle timing dependencies of the effect of treatments upon SG2M duration, data from experimental 
repeat 2 
A) Total duration of SG2M for mockTreated or NCSTreated FUCCI-NM U2OS cells treated during SG2M that subsequently 
divide against the time of treatment relative to the G1/S transition. B) Time spent in SG2M after treatment for mockTreated 
or NCSTreated FUCCI-NM U2OS cells that divide. The modelled line of best fits summarise the trends in the data with slopes 
indicating cell cycle timing dependencies on inducing lengthening of SG2M. 
 





Figure 50: Lineage fitness as assessed by three different metrics, data from experimental repeat 2 
Piecharts indicating the proportion of lineages derived from MockTreated and NCSTreated FUCCI-NM U2OS cells with the given A) 
maximum generation, B) PI, or C) SI scores. 
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1.10.2 Experimental repeat 3 
 
  
Figure 52: Lineage trees from experimental repeat 3 




Figure 53: Generational analyses of experiment repeat 3 
A) Protocol, B) Generational terminology of lineage trees C) Swarm plot of generations analysed D) Half-violin plot 





Figure 54: FUCCI-NM U2OS total cell cycle length swarm plot with dividing cells colour coded by daughter cell fates, data from 
experimental repeat 3. 





Figure 55: G1/SG2M duration swarm plots of FUCCI-NM U2OS cells with identifiable G1/S transitions, data from experimental 
repeat 3 
A) G1 duration swarm plot coloured by cell fate and separated into their generations.  
B) SG2M duration swarm plot coloured by cell fate and separated into their generations. 






















































































































































Figure 57: Graphs of cell cycle timing dependencies of the effect of treatments upon SG2M duration, data from experimental 
repeat 3 
A) Total duration of SG2M for mockTreated or NCSTreated FUCCI-NM U2OS cells treated during SG2M that subsequently 
divide against the time of treatment relative to the G1/S transition. B) Time spent in SG2M after treatment for mockTreated 
or NCSTreated FUCCI-NM U2OS cells that divide. The modelled line of best fits summarise the trends in the data with slopes 
indicating cell cycle timing dependencies on inducing lengthening of SG2M. 




Figure 58: Lineage fitness as assessed by three different metrics, data from experimental repeat 3 
Piecharts indicating the proportion of lineages derived from MockTreated and NCSTreated FUCCI-NM U2OS cells with the given A) 
maximum generation, B) PI, or C) SI scores. 
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Generational tracing by flow cytometry 
1.11 Assay development 
Data provided by time-lapse microscopy has the great advantages of providing single cell resolution 
and lineage based information allowing the in-depth analyses and characterisation presented in the 
previous chapter. Nonetheless the technical constraints limiting which cell lines are suitable for such 
microscopy, the need to generate stable reporter cell lines and the laborious curation required even 
with semi-automated analysis place limits on the experimental conditions that can be tested. In order 
to provide corroborative evidence for the findings already observed, probe possible mechanisms and 
provide the opportunity to interrogate a greater range of cell lines it would be advantageous to 
develop alternative assays. I therefore sought to identify an assay that might allow descendant cell 
death to be inferred and compared across different conditions and cell lines.  
Such an assay should allow the ability to measure or infer information about cell generations and 
death, and be amenable to taking place over comparable timescales to the microscopy assay. Flow 
cytometry permits single cell resolution and is amenable to processing large samples quickly, and so 
provides a suitable basis for an alternative assay where cells can be harvested at various time points, 
fixed and analysed together. In order to confer the ability to infer generational information cells can 
be stained with CellTrace™ dye (ThermoFisher), a cell-permeable chemical that permanently labels 
amine groups in proteins via covalent reaction with a non-fluorescent ester that is converted to its 
fluorescent derivative by cellular esterases. With each cell division each daughter cell will inherit 
around half of the labelled amines and so have half the fluorescence of its mother cell (Figure 60). In 
this manner, the number of divisions undertaken since the cell was labelled can be inferred. This dye 
is reportedly suitable for experiments taking place over multiple days (ThermoFisher Scientific). Thus, 
cells can be stained and samples collected at time intervals over several days allowing the progression 
of the population through multiple generations to be identified. 
 Once progression through generations can be identified the expected relative change in population 
can be calculated given each dividing cell typically produces two daughter cells, aside from rare 
abnormal mitoses. By estimating the population size of each collected sample with cell counting 
technology the measured value can be compared to the expected over time. Significant deviations 
between the two will result from cells dying, causing the measured population to be lower than 
expected. This could be used to estimate differences in cell death between different conditions. For 
example, greater divergence from the expected population in particular experimental conditions 
would indicate greater cell death than in less divergent experimental conditions. Furthermore, with 
the use of fluorescent DNA intercalating dyes cell cycle distributions can be measured allowing changes 
to be identified, for example those resulting from cell cycle arrests after DNA damage. 
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In principle therefore, using the CellTrace dye, DNA intercalating fluorescent dyes and population 
counts should allow the changes in cell populations to be characterised over time, potentially allowing 
the indirect observation of phenomena such as descendant cell death. 
 
 
1.12 Generational tracing in U2OS cells 
1.12.1 Experimental setup 
In order to determine whether this approach could indirectly infer some of the observations made 
directly from microscopy, U2OS cells were perturbed with NCS or mock treatments according to the 
protocol outlined in Figure 61. The different cell culture vessels and ratio of culture media to cells 
presents a difficulty in determining equivalent NCS treatments in different assays. In microscopy, large 
volumes of NCS-containing media were washed over a small cell growth area whereas here an entire 
Figure 60: CellTrace dyed cells halve in fluorescence with each cell division allowing generational progression to be inferred 
via flow cytometric measurements. 
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dish of cells is treated with the typical volume of media required for the dish size. As NCS is a chemical 
that reacts with the DNA the number of NCS molecules per cell may be more important than simply 
the concentration of NCS in the culture media. Therefore, in these experiments one of the 
concentrations established successfully in microscopy experiments, 45 ng/ml NCS, was tested 
alongside a higher concentration of 100 ng/ml NCS to determine whether either was suitable. The 




Figure 61: Experimental protocol for generational tracing by flow cytometry 













































































































































































































Generational tracing by flow cytometry 
109 
 
1.12.2 CellTrace dilution characterisation 
CellTrace staining of the mock treated samples, despite optimisation, was unable to resolve 
generations into well separated peaks at each time point, instead producing unimodal or bimodal 
distributions, as indicated in Figure 62. Each distribution curve observed is likely the product of 
overlapping generation curves. This prevented determination of the proportion of cells belonging to 
any particular exact generation at each time point, but nonetheless still demonstrated the progressive 
loss of fluorescence with increasing time indicating the continued division of cells over the duration of 
the experiment. That the curves do not appear to broaden over time suggests that the cells are 
proceeding relatively synchronously through the generations, with the majority of cells at any 
particular time point belonging to a similar generation. 
The 45 ng/ml NCS treated cells show a visible decrease in the rate of loss of fluorescence compared to 
the mock treated, but cells are clearly continuing to divide as by the final time point the CellTrace 
fluorescence distribution is shifted far to the left of the initial time point curve. There is no evidence of 
a prolonged arrest in the cells at this concentration. A slight broadening of the curves suggests that 
with this treatment progression through the generations becomes less synchronous with greater 
differences between the cells at later time points, for example the broader 3 days curve. 
At the higher 100 ng/ml NCS concentration greater differences are evident. The 1 day time point 
CellTrace curve overlaps considerably more with the initial time point revealing that this dose of NCS 
has triggered a prolonged cell cycle arrest with far fewer cells having divided 1 day after treatment. 
After 2 days however, it is apparent that much cell division has resumed by the greater leftward shift 
of the peak. This continues with the 3, 4 and 5 days peaks each continuing to reduce in fluorescence 
indicating that cells continue to cycle throughout the experiment. These peaks are now considerably 
broader than in the mock treated, which may be a product of the initial cell cycle arrest. Some cells 
may have arrested for much longer than others, as observed via microscopy, and so the population 
may have become relatively less synchronous overall in the progression of through the generations. 
Alternatively, this could be due to an increase in the heterogeneity of cell cycle durations in descendant 
cells achieving the same result in desynchronising progression through generations. Nonetheless, by 
the end of the experiment, although not having lost as much fluorescence as the control, we see that 
the final time point curve only slightly overlaps with the initial time point, approximately 15% of final 
time point cells, suggesting few cells have arrested for the entirety of the experiment following the 
DNA damage at the beginning. 
1.12.3 Population size 
Examining the changes in population size over time indicates that, as one would expect, the mock 
treated cells population increases considerably, reaching around 14 times the starting population. 
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There is some evidence that at the last two time points the rate of growth begins to slow down, which 
at this point is likely due to the high confluency of the dish and consumption of growth factors and 
nutrients in the growth medium. The lower NCS concentration shows considerably reduced 
proliferation, having typically lower populations at each time point than the mock treatment and 
ending up around 9 times greater than the initial population. The higher NCS concentration again 
shows more distinct differences, the 24hr time point is slightly lower than the initial, which is consistent 
with the majority of cells having undergone a prolonged cell cycle arrest and possibly some cell death 
over this period. After this however the population begins to rise indicating they are cycling, albeit at 
a much slower rate than the mock treated eventually reaching a final population of around just 3 times 
greater than the initial population. Viable population, a measure of viable cells based on trypan blue 
viable cell discrimination, see Materials and Methods, is plotted in Figure 80 and shows similar trends. 
1.12.4 Comparing CellTrace dilution with population size 
Clearly there are differences between the treatments in both the CellTrace profiles and the population 
growth measured. However, it is difficult to link the progression of CellTrace curves with changes in 
population by eye. The high NCS dose results in dramatically fewer cells by the end of the experiment 
which could indicate that cells are dying throughout the experiment, or alternatively, is simply due to 
cells having gone through fewer divisions as the CellTrace profiles indicate has happened. To relate the 
two observations together I designed a simple model. If we assume a population of CellTrace stained 
cells divide regularly without cell death then by sampling this at time intervals approximating the 
duration of the cell cycle we would expect to see the population double and the CellTrace fluorescence 
to halve between each time interval, Figure 63A. This would be expected to manifest as CellTrace 
curves that on a logarithmic plot move from high fluorescence to low fluorescence with regular 
spacing, Figure 63B, similarly to what is observed for mock treated cells. Plotting the number of 
population doublings against the number of CellTrace halvings, i.e. taking a logarithmic value for each 
parameter, could allow a linear relationship to be obtained between the two, Figure 63C. For these 
idealised cells, this line would have a slope of 1, where each halving of the CellTrace fluorescence is 
accompanied by a doubling of the population. For more realistic populations where some cells die 
rather than divide each generation, a line drawn through such data would still show a linear 
relationship but have a shallower slope as each CellTrace halving would be accompanied by a smaller 
number of population doublings. Therefore, if each generation shows an increased rate of death 
following NCS treatment, i.e. a form of the delayed death observed previously, this might be evident 
by this form of analysis. However, if the death rate varies considerably within the experimental 
timeframe or changes significantly between generations a linear relationship would likely prove a poor 
fit for the data. In order to achieve such a modelling of the data it is necessary to derive a number that 
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describes the rate of CellTrace loss for each CellTrace distribution. This was served by using the median 
value of fluorescence for each distribution.  
 
Therefore, the population estimate and median CellTrace fluorescence for each replicate in each time 
point were normalised to the mean of the initial timepoint and converted to logarithmic values that 
represented the number of population doublings and CellTrace halvings with representative results 
plotted in Figure 64. Each experimental condition demonstrates a reasonably linear relationship 
between the two variables suggesting that modelling the data as having a reasonably similar rate of 
cell death per generation during this experiment is appropriate.  
Figure 63: Changes in CellTrace fluorescence and population size can be compared to infer generational behaviour. 
In principle as cells divide, the population should double while the fluorescence halves (A). This would be expected to manifest 
as movement of measured fluorescence curves from high fluorescence to low with each increasing timepoint (B). In this 
idealised scenario measured population doublings should have a linear relationship of slope 1 with CellTrace halvings (C). 




Figure 64: Comparing population changes to the dilution of CellTrace fluorescence allows generational death in U2OS cells to 
be inferred. 
One representative experiment with three conditions shown, mock (n=3), 45 ng/ml NCS (n=2) and 100 ng/ml NCS 
(n=3).Averages of triplicate measurements from each timepoint are shown with vertical and horizontal standard deviation 
errors bars. The approximately linear relationship for each condition suggests a constant death rate per generation. Linear 
regression through the origin allows approximation of this rate. Top) Using total population ViCell counts, Bottom) Using 
viable population ViCell counts. 
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As described previously we can see that the mock treated achieves both the greatest number of 
population doublings and the highest number of CellTrace halvings during the experiment. A line of 
best fit drawn through the origin has a shallower slope than the idealised 1:1 ratio of CellTrace halvings 
to population doublings. This would suggest that a small proportion of cells are dying in each 
generation. The 45 ng/ml NCS treated samples show a slightly smaller gradient in their line of best fit 
suggesting that the slightly reduced CellTrace dilution is not sufficient to explain the smaller population 
growth seen compared to the mock treated. This would indicate a greater rate of cell death per 
generation than in the mock treated, but not by a great deal. 
The 100 ng/ml NCS treated samples show the greatest difference to the mock treated. Here the line 
of best fit is considerably shallower than the mock treated, indicating the reduced progression through 
generations as shown by the CellTrace fluorescence is far from sufficient to explain the much reduced 
population relative to the mock treated. This suggests a much larger rate of death in these cells 
throughout the experiment than the mock treated and is supportive of the idea that delayed death 
occurs throughout the timespan of the experiment corroborating the findings from direct microscopy 
observation. Repeat experiment results are shown in Figure 81. 
1.12.5 Estimation of death rate 
This analysis may prove suitable for estimation of the proportion of cell death in each generation if the 
rate is assumed to be reasonably constant throughout the experiment, as a good linear fit would 
suggest. To achieve this estimation a mathematical derivation was determined by Dr Alessandro 
Esposito which allowed estimation of this generational cell death rate, see materials and methods 1.30.  
Using this on the data presented in Figure 64, gives an estimate of cell death per generation using the 
total population count in the mock treated condition of 14% cell death and 29% for the 100 ng/ml NCS 
treated samples. If the viable population count is used in the calculation instead of the total population 
count we see a greater estimate of cell death for the 100 ng/ml NCS treated samples of around 36%. 
Comparing across repeated experiments in Figure 81, shows that all three estimate reasonably similar 
values. These numbers are reasonably comparable to the microscopy data, the mock treated value is 
higher than expected but not alarmingly so. This may be a product of neglecting the 𝜌 value or may 
represent higher cell death in this assay. The generational death proportion in the 100 ng/ml NCS 
treated samples is consistent with being a slightly milder version of the phenotype demonstrated in 
the NCS treated lineages in the microscopy experiments. Therefore, with a number of assumptions, it 
would appear that the results from the flow cytometry experiments are consistent with the delayed 
death observed previously. The NCS concentrations required to demonstrate this are higher, but as 
addressed previously, this is likely due to the same concentrations of NCS not being comparable across 
different assays, necessitating the titration of NCS with new experimental setups. 




1.12.6 Cell Cycle analysis 
Samples taken at each time point following treatment were also analysed for changes in the cell cycle 
distribution, Figure 65, from which cell cycle arrests and cell death could be inferred. Mock treated 
samples show a normal cell cycle distribution 24 hours after mock treatment, the highest peak is the 
G1 peak but the G2 peak is only slightly smaller and a great many cells are in the intermediate S phase 
region. Very few cells are in the sub-G1 region indicating few cells are dying or hypoploid. Similarly, 
very few cells are in the hyperploid region beyond the G2 peak, indicating few cells are polyploid, 
relative to this cell line’s normal ploidy. With each later time point the G1 peak becomes more 
dominant relative to S and G2 indicating more and more cells are in G1. This is likely due to the 
depletion of nutrients and growth signalling factors over time and possibly due to effects of increasing 
confluency. U2OS cells are a cancer line and therefore unlikely to demonstrate typical contact 
inhibition but some changes may still occur. There is no apparent increase in irregular cells, either hypo 
or hyperploid, over the timespan of the experiment. 
45 ng/ml NCS treatment results in few changes to the cell cycle profiles at each timepoint. 24 hours 
after treatment there are fewer cells in S phase relative to the mock treated control which may indicate 
that cells are still arresting in G1 and G2 phase at this point causing relative accumulation in these 
phases of the cell. At subsequent time points the only difference appears to be a slightly less dominant 
G1 peak, likely due to the population being lower relative to the control at every time point and so will 
have experienced fewer media and confluency related changes. 
At 100 ng/ml NCS the differences are much starker. 24 hours after treatment cell cycle profiles are 
now greatly shifted to the G2 phase of the cell. This is consistent with the dominance of the G2 arrest 
Figure 65: Cell cycle distributions over time of U2OS cells receiving mock or NCS treatments. 
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seen with the FUCCI microscopy. The subsequent time points show a return to a larger G1 peak 
suggesting, as the CellTrace dye results indicate, that cells have resumed cycling by this time. The G2 
peak demonstrates an unusual humped distribution at the 48 and 72 hour time points which 
disappears by later time points. Further abnormalities are the increase in cells in the sub-G1 region 
and the small increase over time in cells with hyperploid DNA staining. The increase in sub-G1 cells is 
consistent with the inferred cell death and the hyperploid cells may have failed to carry out mitosis 
properly and acquired more copies of chromosomes than typical for this cell line. This may be via 
uneven segregation of chromosomes or the formation of binucleate cells after failed cytokinesis, as 
was occasionally observed by microscopy. Such abnormalities might drive death in these cells 
eventually, but are also a potential source of genomic instability which could allow, in a tumour setting, 
the selection of clones that acquire pro-survival mutations. 
1.12.7 The persistence of DNA damage 
As discussed previously, one possible cause of delayed death could be inherited DNA damage that fails 
to be adequately resolved by the descendant cells, ultimately leading to activation of cell death 
mechanisms. To investigate whether this is plausible, cells were also collected and fixed on coverslips 
at each time point to allow for detection of the presence of the DNA damage marker γH2AX (Löbrich 
et al. 2010) via immunofluorescence. Representative images from the mock treated and 100 ng/ml 
NCS treated cells are shown in Figure 66 and Figure 67. 
  









Figure 66: Mock treated cells show few γH2AX foci across the course of the experiment 
γH2AX foci visualised by immunofluorescence for mock treated cell samples harvested at each timepoint. Representative 
experiment of two repeats shown. 









Figure 67: 100ng/ml NCS treated cells show induction of DNA damage that persists over the five days of the experiment. 
γH2AX foci visualised by immunofluorescence for 100ng/ml NCS treated cell samples harvested at each timepoint. 
Representative experiment of two repeats shown. 
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At all time points, mock treated cells exhibit few obvious DNA damage foci suggesting the presence of 
low endogenous levels of DNA damage and/or unspecific faint nuclear background staining. 
Furthermore, DNA stained by Hoechst shows little change in nuclear morphology across the course of 
the experiment, only the expected increase in cell density. 
5 hours after 100 ng/ml NCS treatment, all cells exhibit bolder and a far greater number of γH2AX foci 
compared to the control images, confirming that NCS treatment has induced damage in all cells 
treated. Differences in the survival of cells or their descendants are unlikely therefore to be due to 
simply not being damaged to begin with. 
Many NCS treated cells exhibit DNA damage in all of the timepoints of the full 5 days span of the 
experiment even though the vast majority of cells appear to be cycling, based on the CellTrace dilution, 
Figure 62. Taken together, the data confirms that many descendant cells carry DNA damage and so 
DNA damage can be inherited by following generations, which die at a higher rate compared to control. 
By the final time point, treated cells display high heterogeneity in gH2AX staining and in nuclear 
morphology as indicated by the Hoechst stain. Some nuclei are rather large in size, some appear more 
ragged and irregular than normal, while others are indistinguishable from controls. NCS treated cells 
also exhibit an abundance of micronuclei, i.e. small clusters of DNA visible in close proximity to the 
nucleus, suggesting the presence of significant chromosomal abnormalities. These micronuclei 
typically stain highly for γH2AX. To depict the high variability in morphology and staining at the end of 
the experiment, a collection of images from the final NCS treated time point is given in Figure 68. 
To quantify these differences γH2AX foci were counted by computer software, with the results 
presented in Figure 69. As the images suggested the foci counts are similar across the mock treated 
cells representing endogenous damage and background staining. The 100 ng/ml NCS 5 hr time point 
in contrast shows the induction of DNA damage in all cells, albeit with a large range. By 24 hours after 
NCS treatment the number of foci is much reduced with many cells now comparable to the mock 
treated timepoint indicating that DNA repair is taking place in these cells and the damage being 
resolved. However, this reduction does not continue to completion. Instead elevated levels of DNA 
damage remain in some cells to the end of the experiment. 
  































































































































































Figure 69: Automatic γH2AX foci counts for each timepoint for mock and 100ng/ml NCS treated samples 
Mock treated samples show similar distributions of γH2AX foci across the experimental timepoints representing endogenous 
damage and background staining. 5 hours after NCS treatment γH2AX foci are elevated compared to mock treated cells. 
γH2AX foci initially decrease in abundance by the 1 day timepoint but thereafter remain consistently higher than their mock 
treated counterparts. Representative experiment of two repeats shown. 
Generational tracing by flow cytometry 
123 
 
1.13 Generational tracing in HeLa cells 
1.13.1 Initial HeLa comparison to U2OS 
So far, the consequences of DNA damage on subsequent generations have only been examined in 
U2OS cells. I sought to determine whether this assay could be used to make insights into the behaviour 
of other cell lines. HeLa cells are a very commonly used cancer line, suitable for many cell assays for 
which we also have multiple transgenic strains. If generational tracing by flow cytometry proves 
successful on the parental cell lines it should in principle be possible to probe pathways using existing 
mutant HeLa cell lines. Generational Tracing flow cytometry experiments were therefore conducted 
upon a HeLa strain called HeLa TetOn. As an untested cell line, it was therefore still necessary to titrate 
NCS treatments. 
The results of the CellTrace dilution are presented in Figure 70. The mock treated samples form a series 
of regular unimodal distributions that show progressively less fluorescence with each time point. The 
rate of fluorescence loss with each time point appears to decrease, indicating that by the later time 
points cell division is slowing. As in the U2OS cells these indicate cells moving relatively synchronously 
through multiple generations over the course of the experiment. 
The CellTrace dilution curves of the NCS treated samples show that these cells demonstrate an initial 
cell cycle arrest following DNA damage, evident as an increase in overlap between the 0 and 24 hour 
sample fluorescence distributions, but that division subsequently resumes with fluorescence being lost 
with each time point. Indeed, the peaks of each curve are almost as far to the left as in the mock 
treated suggesting a great many cells are dividing almost as much as the cells in the mock treated 
condition. Differences in the curves are more apparent in the size of the tail of cells with higher 
fluorescence. This tail increases for each time point with increasing doses of NCS treatment. Similarly 
to the broadening of peaks seen in the U2OS cells, this may indicate that cells have become relatively 
desynchronised with each other over the progression through generations. Importantly however, it is 
not the case that this is just due to the initially DNA damaged cells arresting permanently. The tail of 
cells stretches across a range of fluorescence with much of it lower than the 0 days distribution, 
indicating these cells are descendants of the damaged cells. 
The total population graph indicates similar trends to the U2OS cells, the mock treated cells divide 
abundantly, reaching population sizes much larger than at the start of the experiment. At all NCS 
concentrations the population does manage to grow but with increasing NCS doses this is reduced 
more and more. Viable population, a measure of viable cells based on trypan blue viable cell 
discrimination, see Materials and Methods, is plotted in Figure 82 and shows similar trends. 
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Undertaking the population growth vs CellTrace dilution analysis, Figure 71, reveals that all four 
experimental conditions demonstrate a linear relationship between the two measurements and that, 
as with the U2OS cells, increasing NCS concentrations, and thus increasing DNA damage, results in a 
shallower line of best fit slope. This suggests that NCS treatment increases the proportion of death in 
each generation and estimating the death rate per generation using the equation derived previously 
yields the indicated death rates. The estimates for mock treated and 45ng/ml treated cells are very 
similar to the U2OS cells, while the rate for 100 ng/ml is lower suggesting that 100ng/ml induced a 
milder increase in death in HeLa cells. The highest tested concentration of 150 ng/ml in HeLa cells gave 
a death rate similar to the 100 ng/ml in U2OS. 
Examining the cell cycle profiles of these cells, Figure 72, shows that the mock treated behave similarly 
to the U2OS cells, exhibiting a predominant G1 peak that grows larger relative to G2 as the experiment 
proceeds. The cell cycle arrest induced by the DNA damage is most evident in the 150 ng/ml 1 day time 
point where the G2 peak has become much larger indicating a strong G2 arrest. This arrest is however 
no longer present by 2 days after treatment and the majority of cells are now in a more normal G1, S 
phase and G2 peak pattern, suggesting they have resumed cycling. Cell death is more apparent in the 
NCS treated samples based on the increased sub-G1 fraction. There is also a larger tail of hyperploid 
abnormal cells compared to the mock treated cells. The profiles and the changes NCS induces are quite 
similar to the profiles obtained from the U2OS experiments. 
Overall, HeLa TetOn cells appear very similar in behaviour to the U2OS cells tested earlier, which 
indicates that they probably also feature an increase in cell death in descendant cells following DNA 
damage. 
  




Figure 71: Comparing population changes to the dilution of CellTrace fluorescence allows generational death in HeLa TetOn 
cells to be inferred 
Mock, 45 ng/ml NCS, 100 ng/ml NCS and 150 ng/ml NCS conditions evaluated. Averages of triplicate measurements from 
each timepoint are shown with vertical and horizontal standard deviation errors bars. The approximately linear relationship 
for each condition suggests a constant death rate per generation. Linear regression through the origin allows approximation 
of this rate. Top) Using total population ViCell counts, Bottom) Using viable population ViCell counts. (n=1) 
 






1.13.2 Interrogating the response of later generations to DNA damage 
This assay presents the opportunity to probe the progression through generations and cell death 
following DNA damage with a greater range of conditions than are feasible in a microscopy experiment. 
This could be done using chemical probes, for example inhibitors of checkpoint signalling, or through 
the use of transgenic cell lines that express molecular species that interfere with typical cell function. 
Once such cell line, HeLa BRC4.23, has been derived previously from the HeLa TetOn cell line allowing 
the controllable induction of a fragment of the tumour suppressor BRCA2 termed BRC4 (aa 1517-
1551). This fragment has previously been described as binding strongly to RAD51 and so inhibiting the 
interaction between the full length BRCA2 and RAD51, thus preventing the assembly of RAD51 at the 
site of DNA damage and interfering with the process of homologous recombination. Induction of this 
fragment was therefore used to test whether homologous recombination or other unknown processes 
disrupted by BRC4 play a role in generational progression and cell death. Cells were treated with mock 
or NCS treatment and 24 hours after this treatment cell samples were then split into two populations, 
one of which was treated with doxycycline to induce transgene expression, Figure 75. Induction of the 
BRC4 fragment was confirmed to occur in the induced, and not the uninduced, populations by Western 
blot, Figure 76. Induction of the transgene 24 hours after the initial treatment permits the initial period 
of DNA damage repair to proceed as normal without interference while probing the later time points 
for effects of BRC4 expression on delayed death and inherited DNA damage. 
The CellTrace dilution and population growth results are presented in Figure 73. The mock treated 
induced and uninduced samples are broadly similar in the shape of the fluorescence distributions at 
each time point, but differ slightly in how much the CellTrace dye is diluted. Induced samples show 
greater fluorescence for each timepoint following induction (i.e. after 1 day timepoint) suggesting 
Figure 72: Cell cycle distributions over time of HeLa TetOn cells receiving mock or NCS treatments 
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these cells have been slowed in progression through their generations. The NCS treated induced and 
uninduced samples show similar trends having curves of similar shapes but differing in the degree to 
which the dye has been diluted. The population curves show that the treatment with doxycycline 
reduces the population growth over the experiment, with this effect being most evident in the mock 
treated populations. Compared to the parental cell line experiment Figure 70, the 100 ng/ml NCS 
treatment was capable of inducing a greater arrest in this experiment, perhaps due to experimental 
variation or greater sensitivity of this derived cell line. Viable population counts are shown in Figure 
83. 
Comparing population growth against CellTrace dilution, Figure 74, shows that, as in the parental cell 
lines, the two measurements have a broadly linear relationship over the timespan of this experiment 
and that NCS treatment results in a much shallower slope in the line of best fit. It is also clearly apparent 
that although doxycycline treatment resulted in lower population growth, this is nearly completely 
explained by reduced progression through generations as the near identical linear relationships 
indicate. The lack of any observable difference between the induced and uninduced NCS treated 
samples suggests that disruption of the interaction between RAD51 and BRCA2 causes no 
consequences for delayed death, neither apparently increasing nor decreasing it. This would suggest 
that functional homologous recombination plays little role in the determination of cell death in later 
generations. 
The cell cycle profiles from this experiment, Figure 77, broadly recapitulate the findings from the 
parental cell line. Mock treatment results in normal cell cycle profiles that become more G1 dominated 
as time passes. Treatment with NCS results in an apparent cell cycle arrest visible 1 day later, 
resumption in cycling is apparent by the 2 day time point, and accumulation of dying cells and 
hyperploid cells evidenced by the increasing sub-G1 and super-G2 cells with time. There are no stark 
differences between the induced and uninduced samples suggesting that any cell cycle distribution 
changes resulting from transgene induction or doxycycline are relatively small. 
This assay has allowed me to identify changes in generational progression and population growth that 
occur following induction with doxycycline, either due to the presence of the transgene or the 
doxycycline itself, but show that these changes do not appear to operate on the processes that 
determine cell death in later generations following DNA damage. 
 
  








































































































































































































































































































































Figure 74: Induction of BRC4 expression appears to have little effect on generational death in NCS treated HeLa BRC4.23 cells 
Cells were treated with mock or 100 ng/ml NCS, and are split into induced and uninduced pairs after 24 hours (n=1). Averages 
of triplicate measurements from each timepoint are shown with vertical and horizontal standard deviation errors bars. The 
approximately linear relationship for each condition suggests a constant death rate per generation. Linear regression through 
the origin allows approximation of this rate. Top) Using total population ViCell counts, Bottom) Using viable population ViCell 
counts. 
 








Figure 75: Experimental protocol for testing whether the induction of the BRC4 fragment alters death in descendant cells as 
inferred by flow cytometry generational tracing 
Figure 76: Western blot confirming induction of HeLa BRC4 fragment in dox treated samples after dox/control media addition 
after the 1 day timepoint 
BRC4 is tagged with the myc epitopeand was detected using the antibody 4A6, see Materials and Methods. Equal lane loading 
(40µg of protein lysate per lane) was confirmed with blotting for Beta-actin. 




1.14 Generational tracing in HPNE cells 
HeLa cells are useful to establish that other cancer cell lines may exhibit a similar ‘delayed cell death’ 
phenotype but provide no information on the behaviour of non-cancerous cells. To probe if cells more 
representative of normal tissue exhibit the same phenotype, HPNE hTERT cells, were examined. 
The CellTrace dilution and population growth for this experiment are presented in Figure 78. The mock 
treated samples show similar progression through the generations to the two cancer cell lines for the 
first 48 hours but after this appear to slow down considerably, with very little difference between the 
last two time points. Both NCS treatments show a degree of cell cycle arrest in the 1 day sample having 
fluorescence distributions that are more overlapping with the initial timepoint. These too then appear 
to resume cycling but after 2 days show much reduced progression through generations. Clearly these 
cells are behaving in a distinct way to the previously interrogated cell lines. The population 
measurements show very different behaviour to previously observed, the mock treated cells initially 
grow in population, peaking at 3 days after mock treatment, then thereafter declining. The NCS treated 
cells peak 1 day later at 4 days after NCS treatment and then also decline in population. The 100 ng/ml 
NCS treatment does appear to cause a population drop over the first 24 hours indicating a degree of 
cell death being triggered initially. When considering population growth against CellTrace dilution it is 
clearly apparent that these cells do not demonstrate a linear relationship, as would be expected given 
the initial growth of population and then crash. In all three conditions it appears that cells initially 
divide but then this cell cycle progression slows and cells begin to die off. Given that it occurs in all 
conditions this behaviour does not appear to have been dramatically altered by the NCS treatment and 
may reflect an experimental difficulty in growing these cells without passaging. Why this is occurring 
is unclear and merits further investigation.  
Figure 77: Cell cycle distributions over time of HeLa BRC4.23 cells 
Distributions shown for populations receiving mock or NCS treatment and whether they experienced BRC4 induction 1 day 
after the mock/NCS treatments 


































































































































































































































































The cell cycle distributions of the HPNE hTERT cells indicate an increasing predominance of G1 cells 
with time in mock treated conditions similarly to the other tested cell lines. NCS treated conditions 
induce large increases in the sub G1 population which would suggest cell death is occurring in response 
to the treatment. It is unclear why the drop in population evident after 3 days in the mock treated 
condition does not manifest as a similarly dramatic increase in the sub-G1. The 100 ng/ml NCS 
treatments induce a clear arrest visible in the 24 hours sample as a reduced S phase proportion and 
greater G2 peak compared to the mock treated control. This pattern remains similar across time which 
may suggest the treatment triggers persistent changes in the cell cycle distribution, unlike in the U2OS 
and HeLa cell lines which return to a more normal cell cycle distribution by the second day. 
1.15 Discussion 
The results presented here have supported the use of generational tracing via flow cytometry to 
further characterise and probe the response of cells and their descendants in a complementary indirect 
way to the microscopy experiments. 
With this approach, the findings concerning delayed death in U2OS cells via microscopy based lineage 
tracing have been corroborated with reproducible trends across several generational tracing by flow 
cytometry experiments and new analyses have been designed to determine approximate death rates 
without direct observation. Furthermore, the combination of understanding generational progression 
via CellTrace dilution and the immunostaining for the DNA damage marker γH2AX allows us to 
indirectly infer that descendant cells can exhibit DNA damage markers and abnormal nuclear 
morphology. Possible mechanisms for triggering delayed death were discussed in the previous chapter, 
Figure 79: Cell cycle distributions over time of HPNE hTERT cells receiving mock or NCS treatment 
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one such possibility being the presence of persistent DNA damage triggering checkpoint mechanisms 
in descendant cell deaths and thereby causing cell death. Another possibility is that the initial DNA 
damage triggered severe consequences for the cell’s ability to maintain cellular homeostasis, for 
example via disrupting normal mitotic function and leading to abnormalities such as aneuploidy and 
micronuclei that deregulate normal programmes of cell behaviour. The results presented here provide 
evidence that both are plausible. DNA damage remains abundant for many days after the initial 
treatment and micronuclei and otherwise irregular nuclei are frequently observed. Why the apparently 
persistent DNA damage does not appear to trigger cell cycle arrests that can be observed in the cell 
cycle profiles measured is unclear and may be related to the previously identified question of why 
apparently normally cycling cells can frequently produce daughter cells that die. Characterising the 
sensitivity of checkpoint mechanisms to inherited DNA damage may well be essential for 
understanding why descendant cells die. Furthermore, understanding the immediate consequences of 
genomic rearrangements and micronuclei formation may also yield insights into descendant cell death. 
Beyond U2OS cells, preliminary findings indicating HeLa cells also display significant descendant cell 
death suggest that this phenomenon may not be specific to U2OS cells, but representative of cancer 
cells more generally, or those cancer cells that have experienced similar changes to checkpoint 
regulation by common mutations in oncogenes and tumour suppressors. It will be necessary to confirm 
this behaviour with repeated experiments. These results indicate that is of fundamental importance 
to understand how exactly cells die in response to DNA damaging treatments. Furthermore, 
preliminary work to utilise this assay to probe further experimental conditions was successfully 
undertaken using the HeLa BRC4.23 cell line. 
In summary, this approach has provided a novel alternative to the laborious microscopy approach to 
identifying behaviour across generations after DNA damage treatment. The resultant data is not as 
rich and complex but still allows meaningful comparisons to be made between different conditions. 
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Figure 80: Measured U2OS viable population, as determined by ViCell trypan blue discrimination, changes over time for each 
experimental condition 
Average of timepoint triplicates shown with standard deviation error bars. Representative experiment shown (n=3). 






Figure 81: Generational tracing with flow cytometry of U2OS cells experimental repeats show similar trends 






Figure 82: Measured HeLa TetOn viable population, as determined by ViCell trypan blue discrimination, changes over time 
for each experimental condition 
Average of timepoint triplicates shown with standard deviation error bars. (n=1) 






Figure 83: Measured HeLa BRC4.23 viable population, as determined by ViCell trypan blue discrimination, changes over time 
for each experimental condition 





This work exemplifies how the study of biological phenomena at single cell level is fundamental. When 
studying even simple phenomena, such as cell death in response to DNA damage, single cell 
information can reveal biological insight that would otherwise remain hidden potentially leading to 
misinterpretation of data. In this instance, treatments that induce DNA damage could appear to be 
cytostatic in ensemble measurements, disguising the reality, for cancerous U2OS and HeLa cells at 
least, that cells continue cycling with the cellular choice between proliferation and cell death 
apparently being revisited in each subsequent generation. This delayed death response to DNA 
damage has been the most notable observation of this work and represents a facet of cell behaviour 
that has to date been only poorly studied. 
It will be important to characterise whether cells from normal human tissue also demonstrate a 
delayed death response, thus indicating it plays a role in normal tissue physiology. Alternatively, 
normal cells may show different responses, perhaps initiating more robust arrests, senescence or 
apoptosis following damage. In this scenario, delayed cell death may only emerge prominently 
following the abrogation of typical tumour suppressive mechanisms and the selection of proliferative 
oncogenic mutations during tumour evolution. Understanding this will allow us to contextualise the 
importance of delayed cell death in restraining carcinogenesis. 
As discussed previously in Chapter 0 if delayed cell death is present in normal cells this provides a 
method of potential checkpoint cooperation by which the negligence of cell cycle checkpoints can be 
resolved in later generations by eliminating descendant cells. Why cell death does not occur in the first 
generation is unclear but it has been postulated that in a mutagenic environment stopping indefinitely 
to repair DNA damage can be more disadvantageous than simply continuing progression through the 
cell cycle (Breivik 2001). In these cases, it would be advantageous to revisit cell fate decisions in later 
cell cycles reaching an appropriate balance between cell death and proliferation for that tissue. If 
delayed death is not evident in normal cells then it would be interesting to determine whether it 
emerges as a ‘back-up’ tumour suppressive mechanism following the abrogation of more robust 
checkpoint behaviour in cancer evolution, or if delayed death simply emerges as cancer cells select 
more negligent checkpoints that allow larger amounts of DNA damage into descendant cells which 
then die stochastically as the ramifications of inherited DNA damage arise. Fully characterising the 
delayed death phenomenon will be necessary to more accurately model and understand the role of 
cell cycle checkpoints in carcinogenesis. 
Whether delayed death emerges as a by-product of carcinogenesis or is characteristic of normal 
human tissue cells this phenomenon is likely to be relevant to cancer treatment. Given the use of DNA 




clinical implications, much as the current characterisation and understanding of checkpoint 
mechanisms influences therapies now. If the mechanisms governing and determining this behaviour 
were identified it could be possible to design more effective therapeutic interventions, perhaps either 
by finding combinations of existing therapies and identifying dosing regimens, or even by finding new 
drug targets. It is possible to imagine using these to shift cancer cells to higher rates of descendant cell 
death or in earlier generations and thus promote lineage exhaustion to cause greater tumour 
regression. 
Furthermore, it has recently become apparent that the formation of micronuclei, which form after 
DNA damage is passed through mitosis and which I have observed here to accompany delayed cell 
death, may allow stimulation of the innate immune system (Mackenzie et al. 2017). Thus, the 
mechanisms we have described of checkpoint negligence and checkpoint cooperation could serve the 
purpose of generating immune stimulation within nascent tumours in the body for tumour 
suppression. 
Understanding how and when cells die may also have fundamental implications for tumour evolution 
upon treatment with DNA damaging agents. Continued cell cycling in the presence of damage may 
generate mutations and provide genetic material for the selection of clones more resistant to DNA 
damage induced cell death. Furthermore, in the context of genetically heterogeneous tumours, 
stochastic elimination of lineages via delayed cell death may trigger genetic drift. With high average 
cell death rates per generation of just under 50%, most lineages will die out and individual clones that 
survive merely by chance can repopulate an entire tumour (modelled by Dr Alessandro Esposito - data 
not shown). The resultant fixing of allelic frequencies may produce tumours that differ greatly from 
the pre-treatment tumour. The implications of delayed cell death on tumour evolution following 
treatments deserve further investigation. 
Cancers in the human body present as collections of cells heterogeneous in their responses to 
treatment due to both genetic and non-genetic causes. Treatments often cause fractional killing where 
even apparently very successful degrees of tumour regression can subsequently be undone by 
proliferation of the surviving clones. My work here has presented evidence that studying even 
something as simple as when cells dies, but at a single cell level rather than on cell populations, reveals 
behaviour that has to date not been properly characterised. Understanding how cells die is of 
fundamental importance in improving the success of treatments, and the phenotype of delayed cell 
death described here is likely to play a role.  
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Materials and Methods 
1.17 Cell culture 
1.17.1 Pre-existing cell lines 
U2OS (ATCC® HTB-96™) were obtained from ATCC. 
U2OS MDC1-mCherry were developed in our lab to stably express an MDC1-mCherry fusion construct. 
HeLa cells (CCL 2, ECACC #93021013) were obtained from the European Collection of Cell cultures. 
HeLa TetOn Advanced cells were obtained from Clontech. 
HeLa BRC4.23 were developed in our lab from the HeLa TetOn Advanced cell line as described in (Lee 
et al. 2011). 
hTERT-HPNE (ATCC® CRL-4023™) were obtained from ATCC. 
1.17.2 Cell culture media 
HeLa and U2OS cells were grown in DMEM+GlutaMAX™-I supplemented with 10% fetal bovine serum 
(FBS) and Pen Strep. HPNE cells were grown in 75% low glucose (1g/ml) DMEM supplemented with 
2mM L-Glutamine and 1.5g/L sodium bicarbonate and 25% Medium M3 Base (Incell Corp Cat No. 
M300F-500) supplemented with human recombinant EGF (10ng/ml), puromycin (CONC), Pen Strep 
and FBS (ratio 20:1 media to FBS). 
During microscopy HeLa and U2OS cells were cultured in phenol-red free DMEM supplemented with 
10% FBS, sodium pyruvate, Glutamax and Pen Strep or CO2-independent Leibowitz L15 medium 
supplemented with 10% FBS and Pen Strep. 
1.17.3 Cell culture vessels 
Cell cultures were maintained in Nunclon™ delta treated flasks, dishes and plates. 
Cells for imaging were grown in various dishes: poly-D-lysine-coated 35 mm glass bottom No. 1.5 
MatTek dish chambers, IbiTreat coated Ibidi 4-well Glass Bottom µ-slide (Catalogue numbers: 
80427/80447), IbiTreat coated 8-well Glass Bottom µ-slide and IbiTreat coated Ibidi III 3D perfusion µ-
slides. 
The preliminary FUCCI microscopy lineage tracing experiment was carried out in an Ibidi 4-well Glass 
Bottom µ-slide, while follow-up FUCCI microscopy lineage tracing experiments were carried out in Ibidi 
III 3D perfusion µ-slides and associated flow accessories from Ibidi. (Luer Lock Connector Female, 
Elbow Luer Connector, y tube fitting, Silicone Tubing. Catalogue numbers: 10825, 10802, 10827, 
10841). IbiTreat Ibidi µ-Slide VI0.4 and poly-L-Lysine coated µ-Slide I0.8 Luer (Catalogue numbers: 80606 
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80194) were tested but found unsuitable for imaging over multiple days and for allowing cells to 
withstand the high flow rates of treatment. 
Cells grown for flow cytometry generational tracing were cultured in Nunclon Delta surface 6cm dishes. 
1.18 Genetic manipulation 
1.18.1 Gene synthesis, plasmids and constructs 
Gene synthesis was provided by ThermoFisher LifeTechnologies (GeneArt Gene synthesis and GeneArt 
Strings) and cloning of plasmids was achieved by restriction enzyme, in-fusion and gateway cloning 
methods. 
mKO2-hCdt1(aa30-120) and mAG-hGeminin(aa1-110) gene sequences were synthesised according to 
the sequences detailed in (Sakaue-Sawano et al. 2008) (Genbank: AB370332.1 AB370333.1). mKO2 
was substituted for mCherry and the resultant mCherry-hCdt1(aa30-120) was cloned downstream of 
the CMV promoter in the dual-promoter plasmid pBudCE4.1 mAG hGeminin(aa1-110) was cloned 
downstream of the Ef1α promoter. 
iRFP682 was synthesised according to the sequences detailed in (Shcherbakova & Verkhusha 2013) 
(Genbank: KC991143) and NLS tagged variants generated via restriction enzyme cloning into the 
plasmid backbone pcDNA3.1(-). 
Plasmid vector name Source: 
pBudCE4.1 ThermoFisher Scientific 
pcDNA3.1(-) ThermoFisher Scientific 
pLenti6/V5-DEST ThermoFisher Scientific 
 
1.18.2 Transfection 
Transient transfection of cells was undertaken using JetPrime® (Polyplus) or Effectene® (Qiagen) as 
directed. DNA concentrations were optimised for gene expression. 
1.18.3 Viral particle production and transduction 
HEK293T cells were seeded on poly-L-lysine coated Nunclon Delta surface T175 flasks in order to be 
40-50% confluent at the time of transfection. Poly-L-lysine coating was applied to flasks using a solution 
of 0.001% poly-L-lysine in PBS and incubation at 37°C for 1 hour followed by aspiration. HEK293T cells 
were treated with 25uM chloroquine containing media and transfected by Calcium Phosphate 
transfection. Lentiviral plasmids were combined with packaging plasmids psPax2 and pMd2.g at a mass 
ratio of 3:2:1 in a solution of 0.4M CaCl2. This solution was added dropwise to an equal volume of 2x 
HBS solution while being gently vortexed and the resultant precipitate added to cells. 10 hours after 
Table 3: Plasmid vectors used for cloning constructs used in this work 
Materials and Methods 
144 
 
incubation at 37°C cell media was exchanged. 24 hours after transfection cells were transferred to 
incubation at 32°C. 
Viral particles were harvested by collecting and replacing cell culture media 48 hrs, 60 hrs and 72 hrs 
after transfection. Debris was removed from the collected media by pelleting or filtering through a 
0.45 µm filter. The media was then incubated at 4C with Lenti-X concentrator overnight, pelleted (1500 
g 45 minutes) and the resultant pellet resuspended in 
1
100
 of the original volume of PBS and frozen at -
80°C until use. 
HPNE cells were treated with cell culture media with 8µg/ml polybrene and viral particle solution 
added. The optimal amount of virus solution to add was determined by trial and error. These cells were 
incubated overnight at 32°C, washed with PBS thrice and fresh media replaced. 24 hours later cells 
were assessed for successful transduction by fluorescence microscopy. 
1.18.4 Stable cell line generation 
U2OS FUCCI-NM cells were obtained via JetPrime® transfection with pBudCE4.1 mCherry hCdt1(aa) 
mAG hGem(aa) and pcDNA3.1(-) (1+1)xNLS iRFP682 followed by selection with zeocin and G418. 
Monoclonal cell populations were obtained via fluorescence activated cell sorting which were then 
screened by microscopy for successful stable integration of the two plasmids. 
Monoclonal HPNE hTERT NM cells were obtained via electroporation (Lonza) with pcDNA3.1(-) 
(1+1)xNLS iRFP682 followed by selection with G418 and single cell clone picking. HPNE hTERT FUCCI 
NM cells were obtained by viral transduction of these cells with pLenti6/V5 mCherry hCdt1(aa30-120) 
IRESk mAG hGem(aa1-110) followed by Blasticidin selection. Monoclonal cell populations successfully 
expressing the three components were obtained via fluorescence activated cell sorting and transgene 
expression maintained with G418 and Blasticidin. 
Monoclonal HeLa NM cells were obtained via JetPrime® transfection with pcDNA3.1(-) (1+1)xNLS 
iRFP682 followed by selection with G418 and fluorescence activated cell sorting. Monoclonal HeLa 
FUCCI NM cells were obtained via JetPrime® transfection with pBudCE4.1 mCherry hCdt1(aa) mAG 
hGem(aa) and pcDNA3.1(-) (1+1)xNLS iRFP682 and viral transduction with pLenti6/V5 (1+1)xNLS 
iRFP682 followed by antibiotic selection with G418 and Blasticidin and fluorescence activated cell 
sorting. 
1.19 Cell culture fluorescent dyes 
1.19.1 Hoechst 33342 
Hoechst 33342 (Sigma-Aldrich Catalogue No. NUMBER) DNA-intercalating dye was used to stain DNA 
for microscopy and flow cytometry.  
Materials and Methods 
145 
 
1.19.2 CellTrace™ dyes 
CellTrace™ Yellow was purchased from ThermoFisher Scientific (Catalogue No. C34567/C34573). 
1.20 DNA damage induction 
1.20.1 Neocarzinostatin 
Neocarzinostatin was purchased from Sigma-Aldrich (Cas No. 9014-02-2, MDL No. MFCD01778130 
Catalogue No. N9162) as a 0.5 mg/ml solution in 20 mM MES buffer (pH 5.5). Neocarzinostatin-
containing media was prepared to the indicated concentrations while mock treatments were prepared 
with the equivalent volume of 20 mM MES buffer (pH 5.5). 
1.21 Western blotting 
1.21.1 Cell harvesting and Lysate preparation 
Cell culture media was collected, cells were washed with PBS and trypsinised. Trypsinised cells, PBS 
washes and culture media were pooled and the cells pelleted and frozen at -80°C until required. 
Pelleted cells were then lysed in RIPA buffer (300mM NaCl 1% NP-40, 0.5% sodium deoxycholate, 0.1% 
sodium dodecyl sulphate, 50 mM Tris-HCl pH8.0, with protease inhibitors (complete EDTA-free Roche: 
11873580001), Phosphatase inhibitor cocktail 2 (P5726) and Phosphatase inhibitor cocktail 3 (P0044)) 
for 30 minutes on ice, spun down and the supernatant taken as the protein solution. 
1.21.2 Protein concentration quantification 
Protein concentrations were assessed by BCA assay (Pierce). 
1.21.3 Polyacrylamide Gel Electrophoresis 
Proteins were denatured in NuPAGE LDS buffer (Invitrogen) with 80mM dithiothreitol at 70°C for 10 
minutes and loaded on a NuPAGE 4-12% Bis-Tris SDS PAGE gel (Invitrogen).  
1.21.4 Western blot protein transfer 
Protein samples were transferred to a Hybond ECL (GE Healthcare) nitrocellulose membrane using wet 
transfer at 30V for approximately 2 hours at 4°C (Transfer buffer 7.5% Methanol solution in NuPAGE 
Transfer Buffer (Invitrogen)). Protein transfer was verified by Ponceau-S solution (Sigma Catalogue 
Number: P7170) staining. 
1.21.5 Antibody probing 
Membranes were blocked with 5% (w/v) milk TBS-T (Tris Buffered Saline with 0.1% Tween-20) for 1 
hour before incubation overnight at 4C with primary antibodies at the dilution indicated in Table 4. 
Membranes were washed 5 minutes with TBST thrice and incubated with fluorescently labelled 
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secondary antibodies (IRDye Licor) in Odyssey blocking buffer (Catalogue Number. 927-40000) for 1 
hour at room temperature. Membranes were then washed with TBST for 5 minutes thrice and scanned 
with the Licor Odyssey scanner system. 
Antibody name/epitope: Supplier: Catalogue 
Number 
Species: Dilution ratio: 
Anti myc tag antibody 
clone 4A6 
Millipore 05-724 Mouse 1:2000 
Beta-actin Sigma A5441 Mouse 1:10,000 
IRDye®680RD anti-Mouse Licor 925-68070 Goat 1:5000 
 
1.22 Immunofluorescence sample preparation 
1.22.1 γH2AX staining 
Cells were fixed using a solution of 4% paraformaldehyde, permeabilised (0.1% TritonX-100 in PBS 5 
mins r.t.), blocked (Blocking solution: 2% BSA, 0.2% Tween, 0.1% Triton X-100 in PBS 60-90 mins r.t.)and 
incubated with primary antibodies in blocking solution for 1 hour at 37°C (anti-γH2AX (Millipore 
JBW301) 1:1000). Cells were washed thrice (washing solution: 0.2% Tween, 0.1% Triton X-100 in PBS) 
and incubated with secondary antibody and Hoechst dye in blocking solution (Hoechst 33342 1:1000, 
Alexafluor 594 goat anti-mouse IgG 1:500), washed in washing solution twice, washed twice in PBS, 
left in PBS and imaged on a  Leica SP5 confocal microscope. 
Images were acquired with a photo-multiplier tube detector using a 40x objective lens and the settings 
512x512 pixel image size, 400 Hz scan speed, 2x zoom, 2-4x line or frame averaging with sequential 
scanning. Laser power was adjusted based on the appropriate level for sample brightness, permitting 
clear visualisation of fluorophores but avoiding pixel saturation. 
1.23 Flow cytometry 
1.23.1 Fluorescence-activated cell sorting (FACS) 
FACS was used to sort cell lines stably expressed transfected plasmids and transduced DNA using laser 
lines and gating appropriate for the relevant fluorophores. 
1.23.2 Flow cytometry analysis 
Flow cytometric analysis was carried out using BD LSR Fortessa flow cytometers. Flow cytometric 
events were gated for analysis initially based on Forward Scatter vs Side Scatter followed by doublet 
discrimination by Forward Scatter Height vs Side Scatter Area or DNA-intercalating dye fluorescence 
Width vs DNA-intercalating dye fluorescence Area. 
Table 4: Antibodies used 
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Data analysis was carried out using Flowing Software version 2.5.1 provided online by Perttu Terho of 
the Turku Centre for Biotechnology, University of Turku. 
1.24 Generational tracing by flow cytometry 
1.24.1 CellTrace™ staining and seeding 
Cells were trypsinised and strained through a CellTrics filter to produce a population of cells in 
suspended. A sufficient number of cells for each experiment were pelleted and resuspended in a 37°C 
10 μM CellTrace™ Yellow solution in PBS at a concentration not greater than one million cells per ml 
and incubated at 37°C for 20 minutes. Residual dye was quenched by the addition of 5 volumes of 
culture media and cells incubated for a further 5 minutes at 37°C. The remaining cells were pelleted 
and resuspended in complete media, strained through a CellTrics filter again and seeded in 6 cm dishes 
at a surface density of typically 9000 cells cm-2 (approximately 190,000 cells) in a total volume of 4mls 
of complete culture medium. Cells were left for approximately 24 hours before treatment to allow 
attachment and recovery from seeding. Sufficient dishes were seeded to permit the harvesting of the 
desired number of dishes. 
1.24.2 Neocarzinostatin treatment 
At the start of the experiment cell culture media was aspirated from all dishes apart from the 0 hour 
samples and replaced treated with 3ml of culture medium containing the desired concentration of NCS 
or an equivalent volume of 20mM MES buffer (pH 5.5) in the case of control experiments. 1-2 hours 
later this was removed, dishes were washed with PBS and 4mls of fresh culture medium added. Any 
residual unreacted and undegraded Neocarzinostatin should therefore have been reduced to 
negligible levels. 
1.24.3 Cell sample harvesting 
Dishes were seeded allowing samples to be taken at 24 hour intervals for each condition. 
U2OS, HeLa TetOn and HeLa BRC4.23 experiments were conducted with triplicate dishes for each 
timepoint and condition, while HPNE hTERT experiments were conducted with a single dish per 
timepoint and condition. 
Additional dishes were seeded with coverslips to allow collection of these for immunofluorescence 
and collection of the cells bound to the dish for cell cycle profiling. 
During sample harvesting cells were trypsinised collecting their culture media and PBS washes. 
Trypsinised cells were then washed off the dish, collected together with culture media and PBS washes 
and pelleted. Cells were then resuspended in PBS, a fraction of which was taken to be counted, the 
remainder mixed with formaldehyde in PBS to a final concentration of 2% formaldehyde and incubated 
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for 15 minutes on ice. Cells were then washed twice in ice-cold PBS and stored at 4°C in PBS until 
analysis. 
In some experiments cell cycle profiles were obtained from separately harvested cells which were fixed 
in 70% EtOH in water and stored at -20°C until required after which they were washed once in PBS and 
analysed. 
1.24.4 Population Counting 
The fraction of the cell samples dedicated to population counting was diluted in PBS or Leibowitz L15 
medium supplemented with FBS and Pen Strep, and analysed on a Beckman Coulter “Vi-cell-XR cell 
viability analyzer” machine using default cell parameters. This machine provides information both on 
the estimated total cell concentration and the viable cell concentration based on trypan blue based 
cell viability discrimination. Both measures were subsequently used for analysing the relative changes 
in population over time. 
1.24.5 Data analysis 
Flow cytometry events were acquired as above. Following gating, fluorescent curves representing the 
CellTrace stained cells were obtained for each sample and the median value extracted to permit 
fluorescence comparison across samples. Fluorescence measurements were paired with their 
corresponding population estimates and plotted as indicated in the results. Linear regression was 
carried out by determining the line of best fit constrained by passing through the origin, i.e. the first 
time point measurements. Where experiments were carried out with multiple replicates per time point 
the origin was defined by the average of the first time point replicates. 
1.24.6 γH2AX foci counting 
Coverslips were stained for γH2AX as directed above, mounted on glass slides with Moviol and 
analysed on an SP5 confocal microscope, acquiring images of the Hoechst 33342 stained nucleus and 
the Alexa Fluor secondary antibody used. The resultant acquired images were exported and nuclear 
masks created based on the nuclear stain using custom MATLAB software. These masks were then 
used with an inbuilt module (CompartmentalAnalysis.V4 Version 6.0) of Cellomics vHCS™ Scan 
software (Version 6.3.1 Build 6585 ThermoFisher Scientific) to automatically count the number of 
γh2ax foci present in each nucleus. γH2AX foci were determined by intensity thresholds. The resultant 
data was examined and exported from Cellomics View (1.6.3.3 Build 6586 ThermoFisher Scientific). 




1.25.1 Widefield microscope 
Widefield microscopy was carried out using a Nikon Eclipse Ti inverted microscope controlled by NIS-
Elements AR software (Version 4.30.02). Imaging was achieved with a Zyla sCMOS camera (Andors).  
1.25.2 Confocal microscope 
Confocal imaging was undertaken on a Leica SP5 confocal microscope. 
1.25.3 Optogenetic stimulation 
The Nikon Eclipse Ti inverted microscope is coupled to a MOSAIC device for patterned illumination 
enabling stimulation of multiple definable regions of interest (ROI) with light from X-cite XLED devices 
(Lumen devices) capable of illuminating with one of four wavelength lights (460, 525, 635 and 735 nm) 
with variable intensity (5-100% in relative terms for each). 
1.26 Microscopy based lineage tracing data acquisition and analytical workflow 
1.26.1 Pre-imaging sample preparation 
Treatment before imaging experiments: 
FUCCI-NM cells were seeded in Ibidi 4-well µ-slides (surface density: 9000 cells cm-2) 
Treatment during imaging experiments: 
FUCCI-NM cells were seeded in Ibidi III 3D perfusion µ-slides (30 µl in each well of 30,000 cells per ml 
media, i.e. surface density: 3600 cells cm-2) and left to attach. The chamber slide was then charged 
with media. 
Approximately a day later flow tubing was attached allowing individual channels to subsequently 
receive treatment, and fresh media washed through. Slides were then attached to the microscopy 
stage, fresh media passed through and imaging begun. 
1 day after the start of image acquisition sufficient excess volumes of media, containing mock or NCS 
treatments, to wash through the entire flow tubing and chamber slide system were passed through 
the tubing (typically 6-10 mls). An hour later similar excess volumes of media was washed through the 
tubing to remove any residual neocarzinostatin containing media. 
1.26.2 Image acquisition 
Images were acquired at 30 minute intervals with 20x air objective lens magnification, 2560x2160 pixel 
size. Four channels were acquired a bright field transmitted light image and three fluorescence images, 
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far-red (Cy5 filterset), green (FITC filterset) and red fluorescence (TRITC filterset). Time-lapse 
microscopy continued for 5/6 days. 
1.26.3 Image segmentation 
Fluorescence images, using either just the nuclear marker or the nuclear marker and the G1 and SG2 
FUCCI probes, were segmented using the NIS-Elements AR built in segmentation function followed by 
morphological opening using the command: “OpenBinaryND(8,3,1,1,1);”  and separation of objects 
using: “MorphoSeparateObjectsND(15,7,1,1,1);” 
The resultant image overlays were exported as tif files and nuclear masks extracted from these. Where 
three fluorescent channels were used independently for segmentation the resultant three masks were 
combined to create a single final mask. 
1.26.4 Image tracking 
The nuclear masks produced from image segmentation were then tracked through time by custom 
MATLAB software. The centroids of each nucleus identified were compared to previous images and 
tracking achieved by comparing the distances between them. 
1.26.5 Nuclei measurements and curation 
The resultant tracked nuclei were used to make measurements of average FUCCI probe fluorescence 
for each cell. The resultant fluorescence traces were then corrected by manual validation to account 
for erroneous segmentation and tracking. Cell death and division were assessed by eye and their 
timings and identities of daughter cells recorded. Cell lineages were analysed to the third generation, 
the Granddaughter cells, following treatment. 
1.26.6 G1/S phase transition estimation 
The G1/S phase transition was estimated based on the peaking of the red fluorescent G1 probe 
mCherry-hCdt1(aa30-120). This was done by assessing both the raw fluorescence measurements and 
a median filtered version of the data that smoothed experimental noise. Multiple apparent G1 phases 
could be determined in cells where green SG2 probe fluorescence declined and red G1 probe 
fluorescence increased without the cell having gone through mitosis. 
1.26.7 Data annotation 
Cells could also be labelled with text annotations for later analysis. 
1.27 Numerical precision 
Reported values with many decimal places were typically rounded to an accuracy of one decimal place 
or two significant figures. 
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1.28 Modelling the effect of time of treatment relative to SG2M phase start 
The remaining time spent in SG2M for populations of dividing cells treated after their G1/S transition 
were modelled in MATLAB by two linear fits described below. These lines were defined by four 
variables, a, m, n and c, of which a, the time of treatment at which the two lines meet, was 
constrained to be at least 8 hours. 
 
 
equation = 'heaviside(a-x)*m*(x-a)+heaviside(x-a)*n*(x-a)+c'; 
fo_ = 
fitoptions('method','NonLinearLeastSquares','Robust','Bisquare','Startpoint
',[10 -1 0 4], 'Lower', [8 -inf -inf -inf], 'MaxFunEvals', 2000, 'MaxIter', 
3000); 
ft_ = fittype(equation, 'dependent', {'y'}, 'independent', {'x'}, 
'coefficients', {'a','m','n','c'}); 
 
1.29 Correlation analysis 
1.29.1 Correlations between paired sister lineages 
Paired sister lineages were identified by finding all known sisters cells present at the time of treatment 
that produced lineages with no ambiguity, i.e. no cells lost during analysis. PI and SI scores were 
calculated and the correlation coefficients and associated p values of these paired values calculated in 
MATLAB: 
[rho,p] = corr(sister1PI,sister2PI,'Type','Spearman'); 
[rho,p] = corr(sister1SI,sister2SI,'Type','Spearman'); 
Probability density functions describing these correlation coefficients were then calculated by 
bootstrap analysis of 5000 populations randomly resampled from the original pairs of sister lineages 
with replacement. The probability density functions describing the level of correlation of randomly 
paired cells were obtained similarly, but after scrambling sister lineages. 
1.29.2 Familial relationship correlations 
Spearman’s Rank correlation coefficients and associated p values for each familial relationship of 
interest were calculated using the MATLAB command: 
[rho,p] = corr(x,y,'Type','Spearman'); 
1.30 Modelling generational rate of cell death from CellTrace vs population growth 
plots 
Assuming that cellular fluorescence is determined by three factors, the initial fluorescence, 𝑓0, the 
number of cell generations that have taken place, 𝑑, and degradation of the probe over time, 𝛿(𝑡), for 
example as labelled proteins are turned over in the cells, then fluorescence is given by: 







If probe degradation is approximated as a linear decay of fluorescence with time where 𝑟 represents 
the fraction of fluorescence lost per unit time, 𝑡, the following function results. 
𝛿(𝑡) ~ 1 − 𝑟𝑡 
Introducing 𝑡𝑑 as the doubling time of cells we can rewrite this as: 
𝛿(𝑡) ~ 1 − 𝑟𝑡𝑑𝑑 
Rewriting the initial fluorescence equation with this gives 
𝑓 ~ 𝑓02
−𝑑(1 − 𝑟𝑡𝑑𝑑) 
The 𝑥 component in these graphs already represents a logarithmic value of the loss of fluorescence 
relative to the start of the experiment. This can be expressed as: 




Which using the equations above can be expressed as: 
𝑥 ~ −log2[2
−𝑑(1 − 𝑟𝑡𝑑𝑑)] =  𝑑 − log2(1 − 𝑟𝑡𝑑𝑑) 
Where probe degradation contributes relatively small losses in fluorescence relative to cell division we 
can approximate, using 𝜌 = 𝑟𝑡𝑑 as the loss of fluorescence per doubling time, 𝑥 as: 
𝑥 ~ 𝑑(1 + 𝜌) 
Considering now the number of cells in the sample if we assume a constant rate of cell death in each 
generation, the number of cells will be determined by the initial size of the population, 𝑛0 number of 
generations that have taken place, again 𝑑, and the proportion of cells dying in each generation, α. 
𝑛 ~ 𝑛02
𝑑(1 − 𝛼)𝑑 
The 𝑦 component of the graphs already represents a logarithmic value of the increase in cell population 





Using the equations for n above we can express 𝑦 as: 
𝑦 ~ log2[2
𝑑(1 − 𝛼)𝑑 = 𝑑[1 + log2(1 − 𝛼)]  
𝑦 and 𝑥 can now be related to each other as: 






[1 + log2(1 − 𝛼)]  
Using linear regression where 𝑦 = 𝑚𝑥 + 𝑐, we can use the slope of the line of best fit, 𝑚, to estimate 
the rate of cell death, α. 
𝑚 ~ 
1 + log2(1 − 𝛼)
1 +  𝜌
 
𝛼 ~ 1 − 2𝑚(1+𝜌)−1 
𝜌 could be calibrated by measurement, but if we assume 𝜌 is low we can neglect it to give 
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Appendix: Optogenetic tool development 
Part of my work has involved working with optogenetic tools, in particular I attempted to develop new 
optogenetic tools to facilitate novel methods of probing cell cycle checkpoints. These were not 
ultimately very successful but a brief example of this work is included in this appendix. 
1.31 Optogenetics 
Study of checkpoint signalling typically involve the induction of genomic lesions with chemicals or 
radiation, resulting in heterogeneity in the damage experienced by individual cells. Such treatments 
may not be very temporally precise with damage being generated over long timescales following 
initiation of treatment. Furthermore, the resultant repair of the lesions create difficulty in 
experimentally controlling the signalling and thus dissection of the checkpoint mechanisms. 
Optogenetic tools allow the specific control of events within cells by light through the use of genetically 
encodable light responsive proteins, exploiting the variety of photoresponsive protein domains 
present in nature. In principle, such systems could allow exquisite spatial and temporal control of 
activation of checkpoint signalling whilst also being tuneable in nature.  
There exist now a great many optogenetic tools, the earliest utilised light responsive photoreceptors 
that trigger transmembrane currents upon illumination which found great use in neurobiology 
(Zemelman et al. 2002), and since then a great range of light responsive proteins have been adapted 
to produce optogenetic tools, these now allow light control over protein interactions and activities. A 
number of examples are included here.  
 
Figure 84: Illustration of principle of use of LOV2 and PhyB-PIF6 light responsive domains 
A) The Jα helix of the LOV2 domain is bound closely in the dark state, upon illumination with blue light (<500nm) it is 
then exposed. Over time it returns to the dark state. 
B) Red light promotes the association of PhyB and PIF6 while far-red light reverses this association. 
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1.32 Optogenetic examples 
1.32.1 LOV2 
The LOV2 domain from plant phototropins is a blue light responsive (<500nm light) domain that 
undergoes a photocycle involving a bound chromophore flavin mononucleotide (FMN). Light 
illumination results in the formation of an adduct between FMN and a cysteine residue (Salomon et al. 
2000) which ultimately results in a structural change whereby an amphipathic helix (the Jα helix) 
undocks from the rest of the domain and is exposed (Harper et al. 2003), Figure 84A. Over a period of 
time without illumination, depending on the construct, there is spontaneous reversion to the 
dark/default state so allowing reversal of the effect after illumination. In the natural protein it is 
thought this undocking prevents an inhibitory association with a kinase so permitting kinase activity. 
This understanding has allowed the adaptation of the domain into various optogenetic tools. A few 
examples of which are discussed here. 
Fusion of Rac1, a GTPase involved in cytoskeletal regulation, to LOV2 at the Jα helix produced a 
construct whereby in the dark default state Rac1 activity was sterically blocked by the LOV2 domain. 
Upon illumination and Jα helix undocking Rac1 was no longer sterically hindered and so could be 
activated. Locating the activating light to specific regions of the cell allowed localised cell protusions 
and ruffling to be observed. This allowed investigation of the regulation of RhoA by Rac1 with respect 
to cell motility. (Wu et al. 2009) A similar use of LOV2 as a steric block allowed the production of a 
photoactivatable caspase 7 capable of stimulating apoptosis after sufficient period of illumination. 
(Mills et al. 2012) 
The LOV2 domain has the advantages that it is quite small in size and requires no external cofactors. It 
is also known to be tuneable with certain mutations allowing improvement of dynamic range (Hahn & 
Kuhlman 2010). The disadvantages of this domain are the necessity of using blue light, which being the 
most energetic of visible light is more likely to cause phototoxicity and that it is not actively reversible, 
instead reverting to the dark default state spontaneously. The half-life of reversion in the LOV2 domain 
from Avena sativa is 50 seconds (Swartz et al. 2001), but mutations are known to alter this in both 
LOV2 domains. 
1.32.2 PhyB-PIF3/6 
The PhyB-PIF3/6 systems are actively reversible systems of light-dependent binding interactions 
between two proteins, derived from the interactions between phytochrome B (PhyB) and 
phytochrome interaction factor 3 (PIF3). The phytochrome protein is capable of photoisomerisation 
between a Pr and Pfr form, red light will stimulate conversion of the Pr form to Pfr whilst far-red light 
stimulates the reverse conversion. As it is the Pfr form which is capable of interacting with PIF3, red 
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light essentially activates the light dependent binding, whilst far-red light reverses this (Ni et al. 1999). 
This requires the presence of  chromophore, phycocyanobilin (PCB), covalently linked to the 
phytochrome. As this is usually absent in heterologous cells expressing the phytochrome, it must be 
added (Shimizu-Sato et al. 2002). An optimised version of this for use in optogenetic tools was 
produced utilising a variant of PhyB and the N terminus of PIF6, creating the PhyB-PIF6 system 
(Levskaya et al. 2009), Figure 84B. Much like the LOV2 system, this has been utilised in a number of 
applications, examples of which are given here. 
Similarly to the LOV2 example given above, one study created a fusion of the RacGEF Tiam catalytic 
modules to PIF6, whilst the PhyB component was anchored to the membrane using a KRras(CAAX) 
membrane anchor. Upon global red light illumination of cells this recruited the RacGEF to the 
membrane, where it is activated normally and resulted in most co-transfected cells adopting a 
lamellipodial phenotype. Utilising a system with red light laser stimulation of specific regions and global 
illumination with far-red light allowed activation of the interaction in one local area, whilst ensuring 
the rest of the cell had the interaction repressed. This produced a localised lamellipodial 'bloom' which 
could be drawn out from the main body of the cell (Levskaya et al. 2009). 
1.32.3 Magnets 
The optogenetic tools pMag and nMag were developed by adapting the homodimerising Vivid system 
to produce a new system termed Magnets by introducing variants with positively and negatively 
charged amino acids that can now only heterodimerise with each other. The two components 
heterodimerise upon blue light illumination and in the dark spontaneously return to the unilluminated 
state and return to their monomeric state (Kawano et al. 2015). Furthermore, this study was able to 
show that the kinetics of this ‘switch-off’ process could be altered with certain amino acid 
substitutions. This tool was then used to control phosphoinositide production by controlling the 
membrane localisation by fusion of the inter-SH2 domain from the p85 regulatory subunit of PI3K to 
pMag and expressing nMag fused with a CAAX plasma membrane anchor. Upon illumination the inter-
SH2 domain is recruited to the plasma membrane where it stimulates PI3K activity resulting in 
phosphoinositide production. 
1.33 The development of novel optogenetic tools for probing checkpoint biology 
I sought to design two kinds of novel optogenetic tools. Firstly, tools that could directly trigger specific 
DNA lesions that would allow precise interrogation of cells with well-defined DDR stimuli. Secondly, 
tools to activate the signalling of DDR components in the absence of actual lesions. This approach 
would allow cellular responses to well defined signalling to be probed, allowing greater dissection of 
the pathway than that afforded by stimulating with DNA damage which diminishes over time as the 
cell repairs the lesions. 
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A general strategy for achieving such control was the creation of a tool that is typically sequestered in 
the cytoplasm but can be localised to the cell nucleus upon illumination. Fusing this tool to various 
‘cargo’ domains that have a defined activity in the nucleus but little activity in the cytoplasm would 
control their activity. Possible cargo domains include endonucleases that can induce either single or 
double strand breaks, or domains that can trigger checkpoint signalling. 
A suitable endonuclease for controllable 
induction of defined doses of DNA lesion is the 
CRISPR-Cas9 system which triggers DNA breaks 
at sequences determined by the presence of 
guide RNAs (Figure 85) (Gasiunas et al. 2012; 
Jinek et al. 2012; Cho et al. 2013). Whether a 
double strand break or a single strand results is 
determined by which variant of Cas9 is used. The 
wild type causes a double strand break but 
‘nickase’ variants exist that cause only one strand 
to be broken. 
An example of a domain that allows artificial 
stimulation of DDR components is the fragment 
of TopBP1 covering amino acids 978-1286, 
hereafter frTopBP1. This fragment has already 
been used to stimulate ATR signalling upon nuclear import in a chemical induction system (Toledo et 
al. 2008) and used to stimulate ATR signalling upon nuclear photobody formation in an optogenetic 
system (Ozkan-Dagliyan et al. 2013). 
The proposed nuclear import tool was designed based on the LOV2 domain (Figure 86). A constitutively 
active NES fused to the protein would drive cytoplasmic sequestration normally while a cryptic Nuclear 
Localisation Signal (NLS) merged with the Jα helix would be exposed only upon light illumination and 
subsequently drive nuclear localisation. After light illumination the protein would return to its initial 
state and the protein returned to the cytoplasm. 
Initial attempts to create this construct were not successful as the combinations of NES and NLS 
sequences used were incapable of triggering the switch in localisation following illumination, likely due 
to issues with their relative strength (Data not shown). I subsequently became aware that the Kuhlman 
and Hahn Groups (Department of Biochemistry and Biophysics and Department of Pharmacology, 
University of North Carolina) were working on the same tool design and had coupled this with another 
system, LOV TRAP, designed to suppress the background level of nuclear expression by further 
Figure 85: Illustration of Cas9 activity 
Specific sequences are cleaved by Cas9 as directed by 
targeting chimeric guide RNA 
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sequestering the dark state version of the optogenetic construct on the surface of mitochondria, Figure 
87 (Wang et al. 2016). Their LOV2 construct was subsequently published as was another group’s similar 
construct (Yumerefendi et al. 2015; Niopek et al. 2014). With their version of the tool, termed LANS, I 
was able to reliably induce nuclear localisation of frTopBP1 (Figure 88). Regrettably, preliminary 
analysis by Western blotting, immunofluorescence and flow cytometry failed to provide reliable 
evidence that this tool was triggering any ATR signalling upon nuclear translocation (Data not shown). 
The fusion of Cas9 to the construct similarly failed to demonstrate reliable control of its activity (Data 
not shown). Nonetheless the merits of attempting to develop such optogenetic tools are demonstrated 
by the subsequent development of an optogeneti Cas9 tool via light induced dimerisation of two Cas9 
fragments. (Nihongaki et al. 2015). 
 
Figure 86: Diagram of nuclear shuttling LOV2 based optogenetic construct 
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Figure 87: The nuclear import LOV2 optogenetic construct can be further sequestered at the mitochondria 
The LOV2 domain binds to NTOM20-Venus-Za98 (LOV TRAP) in its unilluminated state, light illumination disrupts this 
association releasing it from the mitochondria and allowing it to be imported into the nucleus. 
 
 
Figure 88: TopBP1-mCherry-LANS construct localises to the nucleus upon blue light stimulation 
 (Uppermost 5 panes) Over 25 minutes of illumination with blue light (460nm) results in nuclear accumulation of the TopBP1 
fragment LOV NLS construct relative to the start. Widefield fluorescence images of mCherry tag (Leftmost pane) Zoom view 
of cell with line segment region of interest. (Bottommost five panes) Normalised intensity across the line segment region of 
interest in the corresponding image pane above. Nuclear accumulation can be observed. 
 
1.34 Opto-Cre control of oncogenic signalling 
I also assisted in the production of a derivative of the Opto-Cre system (Kawano et al. 2016) that allows 
simultaneous expression of a fluorescent nuclear marker to facilitate tracing of cells by the addition of 
an NLS tagged mCherry sequence (Figure 89). This system allows control of Cre recombinase activity 
by light and will be used to allow the activation of oncogenic signalling in specific cells by triggering 
recombination to activate gene expression. This system has been tested using derivatives of the 
Brainbow system to allow visualisation of the activation of Cre in specifically light stimulated cells. The 
Brainbow system uses cassettes of different fluorescent proteins that recombine in the presence of 
active Cre causing a change in fluorescence expressed (Cai et al. 2013). Activation of the Opto-cre 
system triggers brainbow recombination, seen as a change in fluorescence colour, Figure 90. Our 
addition of a nuclear marker will allow future experiments involving cell tracing of Cre activated cells 
and their neighbours. 
 
Figure 89: Opto-Cre construct with the addition of an NLS flanked mCherry for cell tracing 
A single mRNA encodes three protein constructs that are separated by the self cleaving peptide fragments P2A and T2A. Cre 
fragments 1 and 2 are fused to nuclear localised Magnet proteins that heterodimerise upon stimulation with blue light. 
Heterodimerisation reconstitutes fully active Cre recombinase allowing DNA recombination of appropriate Lox sites in the 
nuclear genome. 
 




Figure 90: Activation of Opto-Cre in specific cells allows light control over gene expression 
Cells expressing nuclear localised mCherry (red) can be traced through time. Cells within the blue circle received stimulatory 
blue light activating the Opto-Cre which in some cells (indicated by arrows) causes recombination of the Brainbow system 
causing a change in fluorescence colour. 
Experimental work carried out and images provided by Dr Suzan Ber and Dr Alessandro Esposito. 
 
1.35 Conclusion 
There have been many exciting developments in the optogenetics field in recent years and the 
resultant tools have been used to probe interesting biology. Nonetheless it proved difficult in practice 
for me to develop novel tools even with well-reasoned strategies with experimental precedent. 
However, given the subsequent publishing of several similar tools to the ideas I had been working on 
by other research groups it demonstrates that these approaches were valid. As more experience in 
protein engineering and the suite of protein domains suitable for use in optogenetic constructs is 
gathered development of new tools is likely to become more successful.  
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Appendix: Microscopy based lineage tracing computational 
analysis 
A great part of my work involved development of the computational tools necessary to extract cell and 
lineage information from time lapse microscopy. I present here further detail on the computational 
steps developed. 
 
Figure 91: Cell nuclei segmentation in NIS Elements AR software 
 
Identifying nuclei by cell segmentation is essential for correct localisation of cells and accurate tracing 
of them through time. Computer based methods provide a quick and reasonably good level of accuracy 
but there are still considerable errors where adjacent cells are recognised as one cell or cells are simply 
not recognised at all. These problems necessitate the labour-intensive manual verification component 
of analysis as they impact on all further steps. 
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Figure 92: Extracted nuclei masks were tracked through time with custom MATLAB software 
 
Tracking was achieved through matching masks by comparison of centroids across time points, 
parameters that may be adjusted are the maximum distance a cell can move and still be recognised as 
the same cell and how many time points may be searched back in time to find a match. This process 
provides quick and reasonably accurate tracking but cannot compensate for errors in nuclear 
segmentation and can make errors of its own where many cells are close together. 
 
Figure 93: Custom MATLAB software to automatically extract fluorescence measurements and permit manual trace validation 
and curation 
 
Manual verification of the produced traces is the most labour intensive part of the analysis process. 
Each cell trace must be checked for errors in cell identification and be curated with the time of death 
or division as well as with the identity of any daughter cells in order to allow the construction of 
lineages. 




Figure 94: Reviewing FUCCI probe fluorescence is used to determine the G1/S transition 
 
 
Figure 95: Many of the analyses presented here required custom software to extract and depict the relevant information 
 
